Current Protocols in Protein Science Edited by: John E. Coligan (Bethesda, Maryland); Ben M. Dunn (University of Florida...
68 downloads
4819 Views
78MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Current Protocols in Protein Science Edited by: John E. Coligan (Bethesda, Maryland); Ben M. Dunn (University of Florida); David W. Speicher (The Wistar Institute); Paul T. Wingfield (Bethesda, Maryland); Past Editor: Hidde L. Ploegh Series Editor: Gwen Taylor
Copyright © 2007 by John Wiley and Sons, Inc. ISBN: 978-0-471-11184-9 0-471-11184-8 - Looseleaf 0-471-14098-8 - CD-ROM Last updated: 26 Apr 2007
PREFACE roteins are like people: they are highly diverse, with very few traits shared by the entire population. Even close relatives often have very different structural (physical) characteristics and behave quite differently. This heterogeneity presents challenges for scientists interested in studying protein structure and function. The need for a readily accessible, updatable reference for protein methods has grown in tandem with the ongoing protein science renaissance driven by advances in molecular biology, genetics, structural biology, and related disciplines. Using recombinant methods, it is now practical to overexpress both normal and reengineered forms of a protein and to create chimeric proteins with unique new properties. The ability to express proteins usually found in low abundance at high levels and to manipulate their amino acid sequences provides unprecedented opportunities to study a vast array of proteins and their associated biological processes (both in vitro and in vivo). The combination of biochemical, biophysical, and high-resolution structural analyses of proteins with manipulation of the associated genes (in cultured cells or an entire mammalian organism) has already led to spectacular advances in many areas of biotechnology and molecular medicine.
P
Because proteins are so diverse, a wide range of techniques must often be considered and tested empirically for a particular protein, and each researcher’s arsenal must include both recent innovations and techniques that have been used for many years. Moreover, methods appropriate for purifying and initially characterizing the protein(s) associated with a biological activity of interest are often not suitable for analyzing the corresponding overexpressed recombinant protein. This manual includes both specific detailed protocols as well as strategies for adapting methods to particular projects at hand. It is designed to meet the needs of scientists with little prior experience of protein isolation and characterization, including graduate students and scientists trained in other biological disciplines. At the same time, the broad range of techniques presented here should ensure that even seasoned experts will find new and useful approaches and will benefit from the manual’s convenient compilation of standard information and methods that typically must be culled from many sources. The quarterly updating service will allow ongoing expansion of the core volume to include chapters covering critical topics that were deferred due to initial space limitations and to keep pace with the “cutting edge” of developments in this fast-moving field.
HOW TO USE THIS MANUAL Format and Organization This publication is available in looseleaf, CD-ROM and online formats. For looseleaf subscribers, binders are provided to accommodate the growth of the manual via the quarterly updates. The looseleaf binder format allows easy insertion of new pages, units, and chapters that are added. The index and table of contents are updated with each supplement. CD-ROM subscribers receive a completely new disc every quarter and should dispose of their outdated discs. The online version is available through institutional license and offers many useful features such as downloadable PDF files of units, enhanced text searching for contents from all Current Protocols titles, real-time updating, and superior color graphics. The material covered in all three versions is identical. Subjects in this manual are organized by chapters and sections, and protocols are contained in units. Units generally describe a method and include one or more protocols with
Current Protocols in Protein Science
iii Current Protocols in Protein Science
Supplement 41
listings of materials, steps and annotations, recipes for unique reagents and solutions, and commentaries on the “hows” and “whys” of the method; there are also “overview” units containing theoretical discussions that lay the foundation for subsequent protocols. Page numbering in the looseleaf version reflects the modular arrangement by unit; for example, page 2.3.5 refers to Chapter 2 (Computational Analysis), UNIT 2.3 (Protein Secondary Structure Prediction), page 5 of that particular unit. Many reagents and procedures are employed repeatedly throughout the manual. Instead of duplicating this information, cross-references among units are used extensively. Crossreferencing helps to ensure that lengthy and complex protocols are not overburdened with steps describing auxiliary procedures needed to prepare raw materials and analyze results. Certain units that describe commonly used techniques and recipes (e.g., gel electrophoresis, ion-exchange chromatography) are cross-referenced in other units that describe their application. Thus, whenever it is necessary to isolate or identify a protein band in a protocol, the appropriate unit in Chapter 10—describing various procedures for gel electrophoresis—is cross-referenced (i.e., UNIT 10.1). For some widely used techniques (such as dialysis), readers are cross-referenced to APPENDIX 3.
Introductory and Explanatory Information Because this publication is first and foremost a compilation of laboratory techniques in protein science, we have not provided extensive instructive material. We have, however, included explanatory information where required to help readers gain an intuitive grasp of the procedures. Chapter 1 provides an overview of strategies for protein purification and characterization, to help the reader plan for all aspects of an experimental study. Some subsequent chapters begin with special overview units that describe the state of the art of the topic matter and provide a context for the procedures that follow. Chapter and unit introductions describe how the protocols that follow connect to one another, and annotations to the actual protocol steps describe what is happening as a procedure is carried out. Finally, the Commentary that closes each protocol unit describes background information regarding the historical and theoretical development of the method, as well as alternative approaches, critical parameters, troubleshooting guidelines, anticipated results, and time considerations. All units contain cited references and many indicate key references to inform users of particularly useful background reading, original descriptions, or applications of a technique. Protocols Many units in the manual contain groups of protocols, each presented with a series of steps. The basic protocol is presented first in each unit and is generally the recommended or most universally applicable approach. Alternate protocols are provided where different equipment or reagents can be employed to achieve similar ends, where the starting material requires a variation in approach, or where requirements for the end product differ from those in the basic protocol. Support protocols describe additional steps that are required to perform the basic or alternate protocols; these steps are separated from the core protocol because they might be applicable to other uses in the manual, or because they are performed in a time frame separate from the basic protocol steps.
Preface
Reagents and Solutions Reagents required for a protocol are itemized in the materials list before the procedure begins. Many are common stock solutions, others are commonly used buffers or media, while others are solutions unique to a particular protocol. Recipes for the latter solutions are provided in each unit, following the protocols (and before the commentary) under
iv Supplement 41
Current Protocols in Protein Science
the heading Reagents and Solutions. It is important to note that the names of some of these special solutions might be similar from unit to unit (e.g., SDS sample buffer) while the recipes differ; thus, make certain that reagents are prepared from the proper recipes. On the other hand, recipes for commonly used stock solutions and buffers are provided once in APPENDIX 2E. These universal recipes are cross-referenced parenthetically in the materials lists rather than repeated with every usage.
Commercial Suppliers Throughout the manual, we have recommended commercial suppliers of chemicals, biological materials, and equipment. In some cases, the noted brand has been found to be of superior quality or it is the only suitable product available in the marketplace. In other cases, the experience of the author of that protocol is limited to that brand. In the latter situation, recommendations are offered as an aid to the novice protein science experimenter in obtaining the tools of the trade. Experienced investigators are therefore encouraged to experiment with substituting their own favorite brands. Addresses, phone numbers, and facsimile numbers of all suppliers mentioned in this manual are provided in the SUPPLIERS APPENDIX.
Safety Considerations Anyone carrying out these protocols may encounter the following hazardous or potentially hazardous materials: (1) radioactive substances, (2) toxic chemicals and carcinogenic or teratogenic reagents, and (3) pathogenic and infectious biological agents. Readers are referred to APPENDIX 2A and APPENDIX 2B for guidelines regarding use, storage, and disposal of these materials. Although cautionary statements are included in the appropriate units with cross-references to this appendix, we emphasize that users must proceed with the prudence and precaution associated with good laboratory practice, and that all materials must be used in strict accordance with local and national regulations. Reader Response Most of the protocols included in this manual are used routinely in our own laboratories. These protocols work for us; to make them work for you we have annotated critical steps and included critical parameters and troubleshooting guides in the commentaries to most units. However, the successful evolution of this manual depends upon readers’ observations and suggestions. Consequently, a self-mailing reader-response survey can be found at the back of the manual (and is included with each supplement); we encourage readers to send in their comments. Feedback can also be submitted online from the Current Protocols homepage at http://www.currentprotocols.com using the “Contact Us” link. ACKNOWLEDGMENTS This manual is the product of dedicated efforts by many of our scientific colleagues who are acknowledged in each unit and by the hard work by the Current Protocols editorial staff at John Wiley and Sons. The publisher’s commitment and continuing support for a protein science manual, particularly through the efforts of Brian Crawford and Paul Majchrzyk, was essential for realizing this ambitious project. We are extremely grateful for the critical contributions by Virginia Chanda (Series Editor) who kept the editors and the contributors on track and played a key role in bringing the entire project to completion. Other skilled members of the Current Protocols staff who contributed to the project include Janet Blair, Hazel Chan, Elizabeth Konkle, Alice Ro, and Kathy Wisch. The extensive copyediting required to produce an accurate protocols manual was ably handled by Rebecca Barr, Karen Hopkin, Arline Keithe, Kathy Morgan, Connie Parks, and Allen Ranz, and electronic illustrations were prepared by Gae Xavier. Finally, we
Current Protocols in Protein Science
v Current Protocols in Protein Science
Supplement 41
would like to thank two people who played important roles in initiating this project. Sarah Greene initially conceived this project and had a critical role in developing it. John A. Smith made important contributions during the early planning phases of the project. Helpful advice and criticisms of the project during early planning stages were provided by Fred Ausubel, Charles S. Craik, Bruce A. Cummingham, Mark Hermodson, Tony E. Hugli, Robert Kingston, Albert Light, Paul Matsudaira, David Moore, George Rose, and Kevin Struhl. Mark Hermodson read and critiqued the entire manual and individual chapters were thoughtfully reviewed by John Freed and John Kay. Finally, we are especially grateful to our many colleagues, who contributed material to this manual, for sharing their procedures and experiences.
RECOMMENDED BACKGROUND READING Branden, C. and Tooze, J. 1999. Introduction to Protein Structure, 2nd edition. Garland Publishing, New York. Easy-to-read overview of basic structural principles of proteins with extensive illustrations. Fersht, A. 1998. Structure and Mechanism in Protein Science: A Guide to Enzyme Catalysis and Protein Folding. 3rd edition. W. H. Freeman. Well established and clear review of protein structure and function, with an emphasis on enzymes. Hunte, C., von Jagow, G. and Schagger, H., editors. 2003. Membrane Protein Purification and Crystallization: A Practical Guide (2nd edition). Academic Press. Deals with specific problems encountered when purifying membrane-associated proteins. Link, A.J. (editor). 1998. 2-D Proteome Analysis Protocols. Humana Press. Extensive treatment of 2-D gel analysis and its role in proteomics, including preparations of samples from diverse sources, alternative 2-D gel analysis methods and data analysis/interpretation. Petsko, G.A. and Ringe, D. 2004. Protein Structure and Function. New Science Press Ltd., London. An updated look at protein structure in the genomics age. Includes discussion of sequence-to-structure and structure-to-function correlations. Speicher, D.W. (editor). 2004. Proteome analysis: Interpreting the Genome. Elsevier. Overview of most current proteomics methods and supporting technologies. Voet, D. and Voet, J.G. 2005. Biochemistry, 3rd edition. John Wiley & Sons. An updated biochemistry textbook whose protein-related chapters provide a comprehensive background in biochemistry.
John E. Coligan, Ben M. Dunn, Hidde L. Ploegh, David W. Speicher, and Paul T. Wingfield
Preface
vi Supplement 41
Current Protocols in Protein Science
FOREWORD
O
ver the past five to ten years we have witnessed a revolution in biological research which is fueled by our increasing capacity to decipher biological information of three types: the digital information embedded in DNA with its four-letter alphabet; the three-dimensional information represented by proteins, the major executors of biological function; and the four-dimensional information of complex biological systems and networks representing the temporal and spatial interaction of multiple components. The analysis of complex systems and networks in their entirety is essential for scientists to understand the molecular basis of fascinating processes such as growth, development, and differentiation, and to extract the biological meaning of emergent properties such as consciousness, memory, and the ability to learn which evolved over billions of years. Not surprisingly, the linear nucleotide sequence in DNA has been the first type of information to be deciphered. Large-scale genetic mapping and DNA sequencing rapidly generate enormous amounts of biological information. In many ways, programs such as the human genome project represent some of the earliest attempts to understand biological complexity. Successful completion of the human genome and similar projects will pose the challenge of interpreting the information contained in billions of nucleotides and of explaining how the interplay of the products of perhaps 100,000 genes results in the myriad of biological phenotypes. Meeting these challenges will require new interdisciplinary strategies which draw from the expertise of scientists from disciplines as different as molecular biology, biochemistry, engineering, chemistry, applied mathematics, and computer science. Protein science is central to such integrated strategies. Separation of proteins from complex mixtures, followed by structural and functional analyses, control of protein function, post-translational processing, and modification and formation of macromolecular complexes of proteins and other biomolecules are but a few examples of topics which are essential for all those scientists who attempt to interpret the linear DNA sequence in terms of the three- and four-dimensional information of complex biological systems and networks. The following chapters detail the necessary protocols for this endeavor, provided by experts in experimental protein science. Two attractive features set this manual apart from other collections of research protocols. First, Current Protocols in Protein Science will be continuously updated and expanded by quarterly additions to the core edition. Secondly, this volume as well as the updates are also available on CD-ROM. Numerous cross-references within the manual by hypertext links, context based searching, and provisions for making individualized notebooks containing frequently used protocols are attractions of the CD-ROM version which are in tune with the increasing dependence on computers in biological research laboratories.
Current Protocols in Protein Science vii
Current Protocols in Protein Science
Protein science is a diverse, experimentally challenging, and rapidly evolving discipline. This book provides expert guidance in experiment design and execution and promises to remain up-to-date, in contents and in format, for many years to come. Leroy E. Hood1 and Ruedi Aebersold1 1 Seattle, Washington
Foreword viii Current Protocols in Protein Science
Table of Contents
Preface Foreword
Chapter 1 Strategies of Protein Purification and Characterization Unit 1.1 Overview of Protein Purification and Characterization Unit 1.2 Strategies for Protein Purification Unit 1.3 Protein Purification Flow Charts Unit 1.4 Purification of Glutamate Dehydrogenase from Liver and Brain Unit 1.5 Overview of the Physical State of Proteins within Cells
Chapter 2 Computational Analysis Introduction Unit 2.1 Computational Methods for Protein Sequence Analysis Unit 2.2 Hydrophobicity Profiles for Protein Sequence Analysis Unit 2.3 Protein Secondary Structure Prediction Unit 2.4 Internet Basics Unit 2.5 Sequence Similarity Searching Using the BLAST Family of Programs Unit 2.6 Protein Databases on the Internet Unit 2.7 Protein Tertiary Structure Prediction Unit 2.8 Protein Tertiary Structure Modeling Unit 2.9 Comparative Protein Structure Prediction Unit 2.10 Protein Charge Determination Unit 2.11 Basic Protein Sequence Analysis
ix Current Protocols in Protein Science
Unit 2.12 Minimotif Miner: A Computational Tool to Investigate Protein Function, Disease, and Genetic Diversity
Chapter 3 Detection and Assay Methods Introduction Unit 3.1 Spectrophotometric Determination of Protein Concentration Unit 3.2 Quantitative Amino Acid Analysis Unit 3.3 In Vitro Radiolabeling of Peptides and Proteins Unit 3.4 Assays for Determination of Protein Concentration Unit 3.5 Kinetic Assay Methods Unit 3.6 Biotinylation of Proteins in Solution and on Cell Surfaces Unit 3.7 Metabolic Labeling with Amino Acids Unit 3.8 Analysis of Selenocysteine-Containing Proteins Unit 3.9 Solid-Phase Profiling of Proteins
Chapter 4 Extraction, Stabilization, and Concentration Introduction Unit 4.1 Overview of Cell Fractionation Unit 4.2 Purification of Organelles from Mammalian Cells Unit 4.3 Subcellular Fractionation of Tissue Culture Cells Unit 4.4 Desalting, Concentration, and Buffer Exchange by Dialysis and Ultrafiltration Unit 4.5 Selective Precipitation of Proteins Unit 4.6 Long-Term Storage of Proteins Unit 4.7 Extraction of Proteins from Plant Tissues
x Current Protocols in Protein Science
Chapter 5 Production of Recombinant Proteins Introduction Unit 5.1 Production of Recombinant Proteins in Escherichia coli Unit 5.2 Selection of Escherichia coli Expression Systems Unit 5.3 Fermentation and Growth of Escherichia coli for Optimal Protein Production Unit 5.4 Overview of the Baculovirus Expression System Unit 5.5 Protein Expression in the Baculovirus System Unit 5.6 Overview of Protein Expression in Saccharomyces cerevisiae Unit 5.7 Overview of Protein Expression in Pichia pastoris Unit 5.8 Culture of Yeast for the Production of Heterologous Proteins Unit 5.9 Overview of Protein Expression by Mammalian Cells Unit 5.10 Production of Recombinant Proteins in Mammalian Cells Unit 5.11 Overview of the Vaccinia Virus Expression System Unit 5.12 Preparation of Cell Cultures and Vaccinia Virus Stocks Unit 5.13 Generation of Recombinant Vaccinia Viruses Unit 5.14 Characterization of Recombinant Vaccinia Viruses and Their Products Unit 5.15 Gene Expression Using the Vaccinia Virus/ T7 RNA Polymerase Hybrid System Unit 5.16 Choice of Cellular Protein Expression System Unit 5.17 Use of the Gateway System for Protein Expression in Multiple Hosts Unit 5.18 Wheat Germ Cell-Free Expression System for Protein Production
Chapter 6 Purification of Recombinant Proteins Introduction Unit 6.1 Overview of the Purification of Recombinant Proteins Produced in Escherichia coli Unit 6.2 Preparation of Soluble Proteins from Escherichia coli
xi Current Protocols in Protein Science
Unit 6.3 Preparation and Extraction of Insoluble (Inclusion-Body) Proteins from Escherichia coli Unit 6.4 Overview of Protein Folding Unit 6.5 Folding and Purification of Insoluble (Inclusion Body) Proteins from Escherichia coli Unit 6.6 Expression and Purification of GST Fusion Proteins Unit 6.7 Expression and Purification of Thioredoxin Fusion Proteins Unit 6.8 Automated Large-Scale Purification of a Recombinant G-Protein-Coupled Neurotensin Receptor
Chapter 7 Characterization of Recombinant Proteins Introduction Unit 7.1 Overview of the Characterization of Recombinant Proteins Unit 7.2 Determining the Identity and Purity of Recombinant Proteins by UV Absorption Spectroscopy Unit 7.3 Determining the Identity and Structure of Recombinant Proteins Unit 7.4 Transverse Urea-Gradient Gel Electrophoresis Unit 7.5 Analytical Ultracentrifugation Unit 7.6 Determining the CD Spectrum of a Protein Unit 7.7 Determining the Fluorescence Spectrum of a Protein Unit 7.8 Light Scattering Unit 7.9 Measuring Protein Thermostability by Differential Scanning Calorimetry Unit 7.10 Characterizing Recombinant Proteins Using HPLC Gel Filtration and Mass Spectrometry Unit 7.11 Rapid Screening of E. coli Extracts by Heteronuclear NMR
Chapter 8 Conventional Chromatographic Separations Introduction Unit 8.1 Overview of Conventional Chromatography Unit 8.2 Ion-Exchange Chromatography
xii Current Protocols in Protein Science
Unit 8.3 Gel-Filtration Chromatography Unit 8.4 Hydrophobic-Interaction Chromatography Unit 8.5 Chromatofocusing Unit 8.6 Hydroxylapatite Chromatography Unit 8.7 HPLC of Peptides and Proteins Unit 8.8 Expanded-Bed Adsorption Chromatography
Chapter 9 Affinity Purification Introduction Unit 9.1 Lectin Affinity Chromatography Unit 9.2 Dye Affinity Chromatography Unit 9.3 Affinity Purification of Natural Ligands Unit 9.4 Metal-Chelate Affinity Chromatography Unit 9.5 Immunoaffinity Chromatography Unit 9.6 Purification of Sequence-Specific DNA-Binding Proteins by Affinity Chromatography Unit 9.7 Purification of DNA-Binding Proteins Using Biotin/Streptavidin Affinity Systems Unit 9.8 Immunoprecipitation Unit 9.9 Overview of Affinity Tags for Protein Purification
Chapter 10 Electrophoresis Introduction Unit 10.1 One-Dimensional SDS Gel Electrophoresis of Proteins Unit 10.2 One-Dimensional Isoelectric Focusing of Proteins in Slab Gels Unit 10.3 One-Dimensional Electrophoresis Using Nondenaturing Conditions Unit 10.4 Two-Dimensional Gel Electrophoresis
xiii Current Protocols in Protein Science
Unit 10.5 Protein Detection in Gels Using Fixation Unit 10.6 Protein Detection in Gels Without Fixation Unit 10.7 Electroblotting from Polyacrylamide Gels Unit 10.8 Detection of Proteins on Blot Membranes Unit 10.9 Capillary Electrophoresis of Proteins and Peptides Unit 10.10 Immunoblot Detection Unit 10.11 Autoradiography Unit 10.12 Overview of Digital Electrophoresis Analysis Unit 10.13 Capillary Electrophoresis of Peptides and Proteins Using Isoelectric Buffers
Chapter 11 Chemical Analysis Introduction Unit 11.1 Enzymatic Digestion of Proteins in Solution Unit 11.2 Enzymatic Digestion of Proteins on PVDF Membranes Unit 11.3 Enzymatic Digestion of Proteins in Gels for Mass Spectrometric Identification and Structural Analysis Unit 11.4 Chemical Cleavage of Proteins in Solution Unit 11.5 Chemical Cleavage of Proteins on Membranes Unit 11.6 Reversed-Phase Isolation of Peptides Unit 11.7 Removal of N-Terminal Blocking Groups from Proteins Unit 11.8 C-Terminal Sequence Analysis Unit 11.9 Amino Acid Analysis Unit 11.10 N-Terminal Sequence Analysis of Proteins and Peptides Unit 11.11 Determination of Disulfide-Bond Linkages in Proteins
Chapter 12 Post-Translational Modification: Glycosylation Introduction
xiv Current Protocols in Protein Science
Unit 12.1 Overview of Glycoconjugate Analysis Unit 12.2 Metabolic Radiolabeling of Animal Cell Glycoconjugates Unit 12.3 Inhibition of N-Linked Glycosylation Unit 12.4 Endoglycosidase and Glycoamidase Release of N-Linked Oligosaccharides Unit 12.5 Detection of Glycophospholipid Anchors on Proteins Unit 12.6 Determining the Structure of Oligosaccharides N- and O-Linked to Glycoproteins Unit 12.7 Determining the Structure of Glycan Moieties by Mass Spectrometry Unit 12.8 Detection and Analysis of Proteins Modified by O-Linked N-Acetylglucosamine
Chapter 13 Post-Translational Modification: Phosphorylation and Phosphatases Introduction Unit 13.1 Overview of Protein Phosphorylation Unit 13.2 Labeling Cultured Cells with 32Pi and Preparing Cell Lysates for Immunoprecipitation Unit 13.3 Phosphoamino Acid Analysis Unit 13.4 Detection of Phosphorylation by Immunological Techniques Unit 13.5 Detection of Phosphorylation by Enzymatic Techniques Unit 13.6 Preparation and Application of Polyclonal and Monoclonal Sequence-Specific AntiPhosphoamino Acid Antibodies Unit 13.7 Assays of Protein Kinases Using Exogenous Substrates Unit 13.8 Permeabilization Strategies to Study Protein Phosphorylation Unit 13.9 Phosphopeptide Mapping and Identification of Phosphorylation Sites Unit 13.10 Use of Protein Phosphatase Inhibitors
Chapter 14 Post-Translational Modification: Specialized Applications Introduction Unit 14.1 Analysis of Disulfide Bond Formation
xv Current Protocols in Protein Science
Unit 14.2 Analysis of Protein Acylation Unit 14.3 Analysis of Protein Prenylation and Carboxyl-Methylation Unit 14.4 Analysis of Oxidative Modification of Proteins Unit 14.5 Analysis of Protein Ubiquitination Unit 14.6 Analysis of Protein S-Nitrosylation Unit 14.7 Tyrosine O-Sulfation Unit 14.8 Analysis of Protein Sumoylation Unit 14.9 Identifying and Quantifying Sites of Protein Methylation by Heavy Methyl SILAC
Chapter 15 Chemical Modification of Proteins Introduction Unit 15.1 Modification of Cysteine Unit 15.2 Modification of Amino Groups
Chapter 16 Mass Spectrometry Introduction Unit 16.1 Overview of Peptide and Protein Analysis by Mass Spectrometry Unit 16.2 Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Analysis of Peptides Unit 16.3 Sample Preparation for MALDI Mass Analysis of Peptides and Proteins Unit 16.4 In-Gel Digestion of Proteins for MALDI-MS Fingerprint Mapping Unit 16.5 Searching Sequence Databases Over the Internet: Protein Identification Using MS-Fit Unit 16.6 Searching Sequence Databases Over the Internet: Protein Identification Using MS-Tag Unit 16.7 Enzymatic Approaches for Obtaining Amino Acid Sequence: On-Target Ladder Sequencing Unit 16.8 Introducing Samples Directly into Electrospray Ionization Mass Spectrometers Using a Nanospray Interface Unit 16.9 Introducing Samples Directly into Electrospray Ionization Mass Spectrometers Using Microscale Capillary Liquid Chromatography
xvi Current Protocols in Protein Science
Unit 16.10 Protein Identification Using a Quadrupole Ion Trap Mass Spectrometer and SEQUEST Database Matching Unit 16.11 De Novo Peptide Sequencing via Manual Interpretation of MS/MS Spectra
Chapter 17 Structural Biology Introduction Unit 17.1 Overview of Protein Structural and Functional Folds Unit 17.2 Electron Microscopy and Image Processing: An Essential Tool for Structural Analysis of Macromolecules Unit 17.3 Principles of Macromolecular X-Ray Crystallography Unit 17.4 Crystallization of Macromolecules Unit 17.5 Introduction to NMR of Proteins Unit 17.6 Probing Protein Structure and Dynamics by Hydrogen Exchange–Mass Spectrometry Unit 17.7 Introduction to Atomic Force Microscopy (AFM) in Biology Unit 17.8 Raman Spectroscopy of Proteins Unit 17.9 Crystallization of Integral Membrane Proteins
Chapter 18 Preparation and Handling of Peptides Introduction Unit 18.1 Introduction to Peptide Synthesis Unit 18.2 Synthesis of Multiple Peptides on Plastic Pins Unit 18.3 Synthetic Peptides for Production of Antibodies that Recognize Intact Proteins Unit 18.4 Native Chemical Ligation of Polypeptides Unit 18.5 Synthesis and Application of Peptide Dendrimers As Protein Mimetics Unit 18.6 Disulfide Bond Formation in Peptides Unit 18.7 Guide for Resin and Linker Selection in Solid-Phase Peptide Synthesis
xvii Current Protocols in Protein Science
Chapter 19 Identification of Protein Interactions Introduction Unit 19.1 Analysis of Protein-Protein Interactions Unit 19.2 Interaction Trap/Two-Hybrid System to Identify Interacting Proteins Unit 19.3 Phage-Based Expression Cloning to Identify Interacting Proteins Unit 19.4 Detection of Protein-Protein Interactions by Coprecipitation Unit 19.5 Imaging Protein-Protein Interactions by Fluorescence Resonance Energy Transfer (FRET) Microscopy Unit 19.6 High-Throughput Screening for Protein-Protein Interactions Using Yeast Two-Hybrid Arrays Unit 19.7 Identification of Protein Interactions by Far Western Analysis Unit 19.8 Scintillation Proximity Assay (SPA) Technology to Study Biomolecular Interactions Unit 19.9 Identifying Protein Interactions by Hydroxyl-Radical Protein Footprinting Unit 19.10 Visualization of Protein Interactions in Living Cells Using Bimolecular Fluorescence Complementation (BiFC) Analysis Unit 19.11 Production and Use of Trimeric Isoleucine Zipper Fusion Proteins to Study Surface Receptor Ligand Interactions Unit 19.12 Fluorescence Quenching Methods to Study Lipid-Protein Interactions Unit 19.13 Overview of Biacore Systems and Their Applications Unit 19.14 Using Biacore to Measure the Binding Kinetics of an Antibody-Antigen Interaction Unit 19.15 Identifying Small-Molecule Modulators of Protein-Protein Interactions Unit 19.16 Determination of Protein Contacts by Chemical Cross-Linking With EDC and Mass Spectrometry
Chapter 20 Quantitation of Protein Interactions Introduction Unit 20.1 Overview of the Quantitation of Protein Interactions Unit 20.2 Measuring Protein Interactions by Optical Biosensors Unit 20.3 Analytical Centrifugation: Equilibrium Approach
xviii Current Protocols in Protein Science
Unit 20.4 Titration Microcalorimetry Unit 20.5 Reduced-Scale Large-Zone Analytical Gel-Filtration Chromatography for Measurement of Protein Association Equilibria Unit 20.6 Size-Exclusion Chromatography with On-Line Light Scattering Unit 20.7 Analytical Ultracentrifugation: Sedimentation Velocity Analysis Unit 20.8 Spectroscopic Methods for the Determination of Protein Interactions Unit 20.9 Application of Amide Proton Exchange Mass Spectrometry for the Study of Protein-Protein Interactions Unit 20.10 Circular Dichroism to Study Protein Interactions Unit 20.11 Quantitative Determination of Protein Stability and Ligand Binding by Pulse Proteolysis
Chapter 21 Peptidases Introduction Unit 21.1 Proteases Unit 21.2 Papain-like Cysteine Proteases Unit 21.3 Overview of Pepsin-like Aspartic Peptidases Unit 21.4 Metalloproteases Unit 21.5 Purification and Characterization of Proteasomes from Saccharomyces cerevisiae Unit 21.6 Purification of the Eukaryotic 20S Proteasome Unit 21.7 Serpins (Serine Protease Inhibitors) Unit 21.8 Caspases Unit 21.9 Use of GFP as a Reporter for the Analysis of Sequence-Specific Proteases Unit 21.10 An Overview of Serine Proteases Unit 21.11 Over-Expression and Purification of Active Serine Proteases and Their Variants from Escherichia coli Inclusion Bodies Unit 21.12 Assaying Proteases in Cellular Environments Unit 21.13 Expression, Purification, and Characterization of Caspases
xix Current Protocols in Protein Science
Unit 21.14 Expression, Purification, and Characterization of Aspartic Endopeptidases: Plasmodium Plasmepsins and “Short” Recombinant Human Pseudocathepsin Unit 21.15 Zymography of Metalloproteinases Unit 21.16 Monitoring Metalloproteinase Activity Using Synthetic Fluorogenic Substrates Unit 21.17 Applications for Chemical Probes of Proteolytic Activity
Chapter 22 Gel-Based Proteome Analysis Introduction Unit 22.1 Overview of Proteome Analysis Unit 22.2 Protein Profiling Using Two-Dimensional Difference Gel Electrophoresis (2-D DIGE) Unit 22.3 Laser Capture Microdissection for Proteome Analysis Unit 22.4 Preparing Protein Extracts for Quantitative Two-Dimensional Gel Comparison Unit 22.5 Isolation of Organelles and Prefractionation of Protein Extracts Using Free-Flow Electrophoresis Unit 22.6 Protein Profiling by Microscale Solution Isoelectrofocusing (MicroSol-IEF)
Chapter 23 Non-Gel-Based Proteome Analysis Introduction Unit 23.1 Analysis of Protein Composition Using Multidimensional Chromatography and Mass Spectrometry Unit 23.2 Quantitative Protein Profile Comparisons Using the Isotope-Coded Affinity Tag Method Unit 23.3 Proteomic Analysis Using 2-D Liquid Separations of Intact Proteins From Whole-Cell Lysates Unit 23.4 Quantitative Protein Analysis Using Proteolytic [18O]Water Labeling Unit 23.5 Protein Microarrays
Chapter 24 Targeted Proteomics Introduction Unit 24.1 Human Serum and Plasma Proteomics
xx Current Protocols in Protein Science
Unit 24.2 Organelle Proteomics Unit 24.3 Glycoproteomics Using Chemical Immobilization
Chapter 25 Proteome Bioinformatics Introduction Unit 25.1 Bioinformatics Analysis for Interactive Proteomics
Chapter 26 Protein Engineering Introduction Unit 26.1 Misincorporation Proton-Alkyl Exchange (MPAX): Engineering Cysteine Probes into Proteins Unit 26.2 Combinatorial Recombination of Gene Fragments to Construct a Library of Chimeras Unit 26.3 Incorporation of Isotopically Enriched Amino Acids
Appendix 1 Useful Data 1A Characteristics of Amino Acids 1B Commonly Used Detergents 1C Conversion Factors and Half-Life Information for Radioactivity 1D Common Conversion Factors
Appendix 2 Laboratory Guidelines, Equipment, and Stock Solutions 2A Laboratory Safety 2B Safe Use of Radioisotopes 2C Centrifuges and Rotors 2D Standard Laboratory Equipment 2E Commonly Used Reagents
xxi Current Protocols in Protein Science
Appendix 3 Commonly Used Techniques 3A Use of Protein Folding Reagents 3B Dialysis 3C Techniques for Mammalian Cell Tissue Culture 3D Importing Biological Materials 3E Silanizing Glassware 3F Protein Precipitation Using Ammonium Sulfate 3G Statistics: Detecting Differences Among Groups 3H Analyzing Radioligand Binding Data
Appendix 4 Molecular Biology Techniques 4 Molecular Biology Techniques 4A Media Preparation and Bacteriological Tools 4B Growth in Liquid or Solid Media 4C Preparation of Plasmid DNA 4D Introduction of Plasmid DNA into Cells 4E Purification and Concentration of DNA from Aqueous Solutions 4F Agarose Gel Electrophoresis 4G Southern Blotting 4H Hybridization Analysis of DNA Blots 4I Digestion of DNA with Restriction Endonucleases 4J The Polymerase Chain Reaction 4K Quantitation of Nucleic Acids with Absorption Spectroscopy 4L Growth and Manipulation of Yeast
xxii Current Protocols in Protein Science
Appendix 5 Biophysical Methods: Data Analysis 5A Theoretical Aspects of the Quantitative Characterization of Ligand Binding Suppliers Selected Suppliers of Reagents and Equipment
xxiii Current Protocols in Protein Science
Overview of Protein Purification and Characterization AIMS AND OBJECTIVES Protein purification has an over 200-year history: the first attempts at isolating substances from plants having similar properties to “egg albumen,” or egg white, were reported in 1789 by Fourcroy. Many proteins from plants were purified in the nineteenth century, though most would not be considered pure by modern standards. A century later, ovalbumin was the first crystalline protein obtained (by Hofmeister in 1889). The year 1989 may not go down in history as a milestone in protein chemistry, but since then there has been a resurgence of interest in proteins after more than a decade of gene excitement. The aims of protein purification, up until the 1940s, were simply academic. To then, even the basic facts of protein structure were not fully appreciated, and pure proteins were needed just to study structure and test the rival theories of the pre-DNA days. During the Second World War, an acute need for blood proteins led to development of the Cohn fractionation procedure for purification of albumin and other proteins from serum (Cohn et al., 1946). This was the inception of large-scale protein purifications for commercial purposes; Cohn fractionation continues to be used to this day. As more proteins, and particularly enzymes, were purified and crystallized, they started to be used increasingly in diagnostic assays and enzymatic analyses, as well as in the largescale food, tanning, and detergent industries. Many enzymes used in industry are not in fact very pure, but as long as they do the job, that is sufficient. “Process” enzymes such as α-amylase, proteases, and lipases are pro-duced in ton quantities, mainly as secretion products in bacterial cultures, and may undergo only limited purification processes to mini-mize costs. At the other extreme, enzyme products for research and analysis require a high degree of purification to ensure that contaminating activities do not interfere with the intended use. Anyone familiar with molecular biology enzymes will appreciate how minute levels of contamination of DNase or RNase can completely destroy carefully planned experiments. The 1960s and 1970s could be described as the peak years for protein and enzyme research, and most of the methods used in protein puri-
Contributed by R.K. Scopes Current Protocols in Protein Science (1995) 1.1.1-1.1.6 Copyright © 2000 by John Wiley & Sons, Inc.
fication were established by then, at least in their principles. More recent developments have been mainly in instrumentation designed to optimize the application of each methodology. Developments in instrumentation have been stimulated by the rapid progress in molecular biology, because gene isolation has often been preceded by isolation of the gene product. Because such products can now be characterized sufficiently (i.e., partially sequenced) using minute amounts of protein, the need for large-scale or even moderate-scale procedures has decreased. Hence there has been an explosive development of modern equipment designed specifically for dealing with amounts of protein in the milligram to microgram range. On the other hand, structural studies using X-ray crystallography and nuclear magnetic resonance (NMR) require hundreds of milligrams of pure protein, so larger-scale equipment and procedures are still needed in the research laboratory. The nature of the proteins studied has also changed substantially. Whereas enzymes were once the most favored subjects, they have now been superceded by nonenzymatic proteins such as growth factors, hormone receptors, viral antigens, and membrane transporters. Many of these occur in minute amounts in the natural source, and their purification can be a major task. Heroic efforts in the past have used kilogram quantities of rather unpleasant starting materials, such as human organs, and ended up with a few micrograms of pure product. It is now more usual, however, to take the genetic approach: clone the gene before the protein has been isolated or even properly identified, then express it in a suitable host cell culture or organism. The expression level may be orders of magnitude higher than in the original source, which will make purification a relatively simple task. It can be useful to know beforehand some physical properties of the protein, to facilitate the development of a suitable purification protocol from the recombinant source. On the other hand, there are now several ways of preparing fusion proteins, which can be purified by affinity techniques without any knowledge of the properties of the target protein. Moreover, there are ways of modifying the expressed product to simplify purification further.
UNIT 1.1
Strategies of Protein Purification and Characterization
1.1.1 CPPS
Overview of Protein Purification and Characterization
Thus the approach to protein purification must first take into account the reason it is being done, as the methods will vary greatly with different requirements. At one extreme is the one-of-a-kind purification, in a well-financed and equipped laboratory, that is carried out to obtain a small amount of product for sequencing so that gene isolation can proceed. In this case, expense of equipment and reagents may be no problem, and a very low overall recovery of product can be acceptable, provided it is pure enough. At the other extreme are the requirements of commercial production of a protein in large amounts on a continuing basis, where high recovery and economy of processing are the chief parameters to be considered. There are many intermediate situations as well. Many publications in the area of protein research are entitled “Purification and characterization of…,” and describe a purification procedure in sufficient detail that it can be reproduced in another laboratory. The characterization section may include structural, functional, and genetic information, and carrying out such studies is likely to require at least milligram quantities of pure protein. Ideally the purification should involve a small number of steps, with good recovery at each step. If the recovery is poor (<50% at any step), however, there should be some indication of what happened to the missing activity. Has it been discarded in the other fractions for the sake of purity, or does it represent a true loss of activity? If the latter, then the end-product may be less than fully active despite apparent homogeneity indicated by standard analysis. The choice between recovery and purification at each step can be problematical; taking a narrow cut of a chromatographic peak may provide a very pure fraction, at the expense of losing a good deal of less pure active component on either side. In making such decisions, the objective of the exercise must be kept in mind: if yield is not important, then the choice of poor yield for the sake of purity may be logical. By far the most important requirement of a publication is reproducibility of the method reported. It is not sufficient to have carried out the process only once if it is expected that other investigators will want to repeat it. There are always factors that influence the process that may be overlooked at first, and which if varied slightly can have a major effect on the purification procedure. The reported process should always be repeated exactly as described before submitting the manuscript for publication. There is one exception, namely, the case where
purification was conducted simply to obtain enough protein for sequencing and gene isolation; if that was achieved, there should be no need to provide instructions for repetition.
SOURCES OF MATERIAL FOR PROTEIN PURIFICATION For many people embarking on a protein purification project, there is no choice of material. They are studying a particular biological tissue or organism, and the objective is to purify a protein from that source. However, there may be approaches that can make the project simpler. If, for instance, the source is difficult to obtain in large amounts, it may be best to carry out at least preliminary trials on a source species more readily obtained. The most obvious and relevant example is when the species being studied is Homo sapiens, and tissue samples are not readily available for practical or ethical reasons, or both. In this case, it is usual to go to where mammalian tissue is readily available (i.e., an abattoir) and work with bovine, ovine, or porcine sources. Alternatively, if quantity of tissue is not a problem, the humble laboratory rat may suffice. Once a protocol for purifying the protein from substitute sources has been worked out, it will be much easier to develop one using human material—the identical procedure may work satisfactorily. Proteins differ to a fairly small extent between species that have diverged within about 100 million years, a time frame that groups together most higher mammals. Thus the behavior of proteins derived from different animals with respect to the various fractionation procedures is likely to be similar, and a protocol worked out for pig tissues is likely to need only minor adjustments for application to human tissues. A second example is where the interest is mainly on the function of a protein, especially an enzyme, for which functions and actions have generally been strongly conserved through evolution. In that case, a preliminary screening of potential sources, or, better still, the literature, should come up with a raw material that is best suited to the investigator’s purposes. Considerations should include the following: (1) What functions are required of the end product? For instance, an enzyme having a low Km may be needed, so selecting the source with the highest activity may not suffice. (2) How convenient is it to grow or obtain the raw material, and are there problems concerning pathogenicity or extractability? (3) Does the quantity of the protein vary with growth conditions or age, and does it deteriorate in situ
1.1.2 Current Protocols in Protein Science
if left too long? Obviously one requires a source that reliably produces the highest amount of the desired protein per unit volume to maximize the chances of developing a good purification procedure. (4) What storage conditions are required for the raw material? It is important to consider that fresh raw material may not be immediately available whenever a purification is attempted. The above considerations are relevant to the traditional situation for commencing a protein purification project. It is becoming increasingly common, however, for proteins to be purified as recombinant products using techniques in which the gene is expressed in a host organism or in cultured cells. This of course requires the gene encoding the protein of interest to be available. Until the mid-1980s, such material was usually obtained by hybridization of an oligonucleotide synthesized according to amino acid sequence information. This required the protein to have been purified first, so the initial task of protein purification still needed to be done at least once. More recently, genetic techniques have permitted the isolation of many genes encoding known proteins, even though the proteins may never have been studied directly. Moreover, with the expansion of the Human Genome Project and related DNA sequencing efforts, many genes for both known and unknown proteins will become available and will be able to be expressed in recombinant form without ever being purified from the host species. As a result some completely new considerations for protein purification come into play, including the possibility of modifying the gene structure not only to increase expression level and alter the protein product itself to enhance a desired function, but equally importantly to aid in purification. Recombinant proteins may be expressed in bacteria, yeasts, insect cells, and animal tissue cultures. Further details may be found in UNIT 1.2.
DETECTION AND ASSAY OF PROTEINS During a protein purification procedure there are two measurements that need to be made, preferably for each fraction. Measurements both of the total protein and of the amount (usually bioactivity) of the desired protein must be made. Details of the most commonly used assay methods are given in Chapter 3. It is not possible to isolate a protein without a method of determining whether it is present; an assay, either quantitative or at least
semiquantitative, indicating which fraction contains the most of the desired protein is essential. Assays may range from the quick-and-easy type (e.g., instantaneous spectrophotometric measurement of enzyme activity) to long and tedious bioassays that may take days to produce an answer. The latter situation is very difficult, because by the time one knows where the protein is, it may be “was,” owing to degradation or inactivation. Moreover, this may not become clear until the next step has been completed and its products assayed. Any assay that is quick is therefore advantageous, even if it means a sacrifice of accuracy for speed. Measurement of total protein is useful, as it indicates the degree of purification at each step. However, unless the next step critically depends on how much protein is present, total protein measurement is not extremely important: a small sample can be put aside and measured later, when the purification is complete. It is, however, very important to know how much protein is present in the final, presumed pure sample, as this will indicate the specific activity (if the protein has an activity), which can be compared with other preparations. The general object is to obtain as high a specific activity as possible (taking into account recovery considerations), which means retaining as much of the desired protein as possible while ending up with as little total protein as possible.
METHODS FOR SEPARATION AND PURIFICATION OF PROTEINS The methods available for protein purification range from simple precipitation procedures used since the nineteenth century to sophisticated chromatographic and affinity techniques that are constantly undergoing development and improvement. Methods can be classified in several alternative ways—perhaps one of the best is based on the properties of the proteins that are being exploited. Thus the methods can be divided into four distinct but interrelated groups depending on protein characteristics: surface features, size and shape, net charge, and bioproperties.
Methods Based on Surface Features of Proteins Surface features include charge distribution and accessibility, surface distribution of hydrophobic amino acid side chains, and, to a lesser extent, net charge at a given pH (see discussion of net charge). Methods exploiting surface fea-
Strategies of Protein Purification and Characterization
1.1.3 Current Protocols in Protein Science
tures mainly depend on solubility properties. Differences in solubility result in precipitation by various manipulations of the solvent in which the proteins are solubilized. Methods for obtaining an extract containing the desired protein in soluble form are given in Chapter 4. The solvent, nearly always water containing a low concentration of buffer salts, can be treated to alter properties such as ionic strength, dielectric constant, pH, temperature, and detergent content, any of which may selectively precipitate some of the proteins present. Conversely, proteins may be selectively solubilized from an insoluble state by manipulation of the solvent composition. The surface distribution of hydrophobic residues is an important determinant of solubility properties; it is also exploited in hydrophobic chromatography, both in the reversed-phase mode (UNIT 11.6) and in aqueousphase hydrophobic-interaction chromatography (UNIT 8.4). Also included in this group is the highly specific technique of immunoaffinity chromatography, in which an antibody directed against an epitope on the protein surface is used to pull out the desired protein from a mixture.
Methods Based on Whole Structure: Size and Shape Although the size and shape of proteins can have some influence on solubility properties, the chief method of exploiting these properties is gel-filtration chromatography (UNIT 8.3). In addition, preparative gel electrophoresis makes use of differences in molecular size. Proteins range in size from the smallest classified as proteins rather than polypeptides, around 5000 Da, up to macromolecular complexes of many million daltons. Many proteins in the bioactive state are oligomers of more than one polypeptide (see UNIT 1.2), and these can be dissociated, though normally with loss of overall structure. Thus many proteins have two “sizes”: that of the native state, and that (or those) of the polypeptides in the denatured and dissociated state. Gel-filtration procedures normally deal only with native proteins, whereas electrophoretic procedures commonly involve separation of dissociated and denatured polypeptides.
Methods Based on Net Charge
Overview of Protein Purification and Characterization
The two techniques that exploit the overall charge of proteins are ion-exchange chromatography (by far the most important) and electrophoresis (Chapter 10). Ion exchangers bind charged molecules, and there are essentially only two types of ion exchangers, anion and
cation. The net charge of a protein depends on the pH—positive at very low pH, negative at high pH, and zero at some specific point in between, termed the isoelectric point (pI). It should be stressed that at the pI a protein has a great many charges; it just happens that at this pH the total negatives exactly equal the total positives. The most charged state (disregarding the charge sign) is in the pH range 6.0 to 9.0. This is the most stable pH range for most proteins, as it encompasses common physiological pH values. Ion exchangers consist of immobilized charged groups and attract oppositely charged proteins. They provide the mode of separation that has the highest resolution for native proteins. High-performance reversedphase chromatography has equivalent or even better resolution, but it generally involves at least partial denaturation during adsorption and so is not recommended for sensitive proteins such as enzymes. Protein purification using ion-exchange chromatography has mainly employed positively charged anion exchangers, for the simple reason that the majority of proteins at neutral pH are negatively charged (i.e., have a low isoelectric point). Details of methodology are found in UNIT 8.2.
Methods Based on Bioproperties (Affinity) A powerful method for separating the desired protein from others is to use a biospecific method in which the particular biological property of the protein is exploited. The affinity approach is limited to proteins that have a specific binding property, except that proteins are theoretically able to be purified by immunoaffinity chromatography (UNIT 9.1), which is the most specific of all affinity techniques. Most proteins of interest do have a specific ligand: enzymes have substrates and cofactors, and hormone-binding proteins and receptor molecules are designed to bind specifically and tightly to particular hormones and other factors. Immobilization of the ligand to which the protein binds (or of antibody to the protein) enables selective adsorption of the desired protein in the technique known as affinity chromatography (Chapter 9). There are also nonchromatographic modes of exploiting biospecific interactions.
CHARACTERIZATION OF THE PROTEIN PRODUCT Once a pure protein is obtained, it may be employed for a specific purpose, such as enzymatic analysis (e.g., glucose oxidase and lac-
1.1.4 Current Protocols in Protein Science
tate dehydrogenase), or as a therapeutic agent (e.g., insulin and growth hormone). However, it is normal, when a protein has been isolated for the first time, to characterize it in terms of structure and function. Several features are generally expected in characterization of a new protein. These include molecular weight, or at least the size of the subunit(s), determined by SDS-polyacrylamide gel electrophoresis (Chapter 10) and/or gel filtration (UNIT 8.3). Spectral properties such as the UV spectrum (Trp and Tyr content), circular dichroism (CD) spectrum (secondary structure), and special characteristics of proteins with prosthetic groups (e.g., quantitation and spectra) may be presented. The quantity and nature of carbohydrates on glycoproteins should be determined (Chapter 12). Also, if the gene has not already been reported, some amino-terminal sequence analysis should be given, if at all possible, along with the results of a database search for similar sequences (UNIT 2.1). Functional proteins should be demonstrated to have the appropriate function, and for enzymes detailed kinetic characterization is appropriate. Ultimately the full three-dimensional structure of the protein may be determined, which will require crystals: any successful crystallization attempts should be reported.
THE PROTEIN PURIFICATION LABORATORY The requirements for a protein purification laboratory cannot be exactly formulated because they depend greatly on the types and amounts of proteins being isolated. To cover all eventualities, it would be necessary to have one set of equipment to deal with submicrogram quantities and another set to deal with multigram quantities—a range of around 108! One laboratory dedicated to protein purification may not need small-scale equipment if, for example, it works with plasma proteins that are always available in large quantities. Another may have all the latest in high-performance equipment but not be able (nor need) to handle quantities of protein in excess of a few milligrams. If it is assumed that neither extreme in quantity is to be attempted, and that the laboratory is handling a variety of protein types and sources, then certain basic pieces of equipment are needed. Obtaining the starting material and making an extract of it require homogenization equipment and centrifuges to remove insoluble residues. Preliminary fractionation, when starting with a crude extract of tissue or cells,
requires equipment and materials that will not become clogged by particulates. Adsorbents and similar materials used at the first step should be relatively inexpensive so that when performance falls off after a few uses, owing to intransigent impurity buildup, they can be discarded. It is also relevant that a larger amount is handled at the initial step than later steps; therefore, reagent expense can be an important consideration. After the first one or two steps, the sample should be sufficiently clean and clear to enable use of high-performance equipment. High-performance liquid chromatography, or HPLC, is a term with a variety of meanings. To some it refers exclusively to reversed-phase chromatography; to others it includes all sorts of chromatography provided that the equipment is fully automated and high-performance adsorbents are used. A high-performance system designed specifically for proteins—introduced by Pharmacia Biotech (see SUPPLIERS APPENDIX) called Fast Protein Liquid Chromatography, or FPLC—uses standard protein chromatographies such as ion exchange, hydrophobic interaction, and gel filtration. Scaleup is possible with larger equipment based on the FPLC design, so that laboratory development can be quickly translated to large-scale production. FPLC is designed to separate proteins in their native active configuration, whereas reversed-phase HPLC often causes at least transient denaturation during adsorption and elution. Reversed-phase HPLC has a high resolving power, but it is best suited to peptides and proteins smaller than ∼30 kDa. Chromatography run with older-style low-pressure adsorbents is sometimes referred to as “low-performance” or “open-column” chromatography; neither of those descriptions is necessarily accurate. Simple fraction collector and monitoring equipment is needed. This equipment will be used for larger-scale operations (tens of milligrams of protein and upward), probably at an earlier stage in the protocol than with HPLC. Various columns, both prepacked with proprietary adsorbents and empty for self-packing, will be needed, with the sizes and types depending on the scale of operations. Several anionexchange columns (different sizes), one or two cation-exchange columns, and gel-filtration media are essential, along with a range of alternative adsorbents such as hydrophobic interaction materials, dyes, hydroxyapatite, and chromatofocusing and specialist affinity media. Fully equipped protein purification laboratories should also have preparative electropho-
Strategies of Protein Purification and Characterization
1.1.5 Current Protocols in Protein Science
resis and isoelectric focusing apparatuses for rare occasions when other techniques fail to give sufficient separation. In addition to equipment used in the actual fractionation processes, a variety of other items are needed. In particular it should be possible to change buffers quickly and to concentrate protein solutions with ease. These operations require such things as dialysis membranes (APPENDIX 3B), ultrafiltration cells, and gel-exclusion columns of various sizes (UNIT 8.3). Finally, equipment for assaying and analyzing the preparations is needed. Most such equipment is fairly standard in biochemical laboratories and includes spectrophotometers, scintillation counters, analytical gel and capillary electrophoresis apparatuses, immunoblotting materials, and immunochemical reagents. A listing of standard equipment is found in APPENDIX 2D.
Literature Cited Cohn, E.J., Strong, L.E., Hughes, W.L., Mulford, D.J., Ashworth, J.N., Melin, M., and Taylor, H.L. 1946. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the proteins and lipoprotein components of biological tissues and fluids. J. Am. Chem. Soc. 68:459-475.
Key References Deutscher, M.P. (ed.) 1990. Guide to protein purification. Methods Enzymol. 182:1-894. Extensive collection of purification methods with some general protocols and examples. Janson, J.-C. and Ryden, L.G. 1989. Protein Purification: Principles, High Resolution Methods, and Applications. VCH Publishers, New York. A useful collection of methods and examples. Kennedy, J.F. and Cabral, J.M. (eds.) 1993. Recovery Processes for Biological Materials. John Wiley & Sons, New York. A useful introduction to the problems of large-scale methods. Kenny, A. and Fowell, S. (eds.) 1992. Practical protein chromatography. Methods Mol. Biol. 11:1-327. Extensive descriptions of affinity chromatographic techniques with protocols and recipes. Scopes, R.K. 1993. Protein Purification, Principles and Practice, 3rd ed. Springer-Verlag, New York and Heidelberg. General principles of all the main techniques used in purifying proteins. A useful laboratory handbook; does not include recipes or procedures for specific proteins.
Contributed by R.K. Scopes La Trobe University Bundoora, Australia
Overview of Protein Purification and Characterization
1.1.6 Current Protocols in Protein Science
Strategies for Protein Purification CLASSIFICATION OF PROTEINS As with most heterogeneous collections of things, proteins can be classified in several different ways, such as by function, by structure, or by physicochemical characteristics. Each protein species consists of identical molecules with exactly the same size, amino acid sequence, and three-dimensional shape. In this way a solution of a mixture of proteins differs from a solution of synthetic polymers or sheared DNA, both of which contain a complete spectrum of possible sizes centered around the average. The protein mixture has only discrete sizes of molecules corresponding to each type of protein present. Although we could classify proteins by size, it would be of limited use, as there is usually no obvious relationship between size and function. A more useful structural classification takes into consideration shape and oligomeric structure (Table 1.2.1). In part, structure reflects biological location and origin. Simple, fairly rigid protein molecules occur in the extracellular environment, more complex and readily deactivated molecules are found intracellularly, and hydrophobic proteins are associated with membranes. Classification by function is more relevant (Table 1.2.2). Proteins can be simply stores of amino acids, can be structural, or can have specific binding functions. The most “funcTable 1.2.1
UNIT 1.2
tional” proteins are enzymes, which have both binding and catalytic roles. In part, this reflects the degree to which the detailed structure is a requirement for the protein’s function, which in turn relates to conservation of structure through evolution. But as with every attempt at classification, there are going to be examples that do not fit the pattern well. Most proteins of interest to the pharmaceutical industry belong to the general class of binding proteins, for instance, hormones [e.g., insulin and bovine somatostatin (BST)], viral antigens (e.g., hepatitis B antigen), growth factors [e.g., interferons, interleukins and colony-stimulating factors (CSFs)], and antibodies.
STRATEGIES FOR PROTEIN PURIFICATION Soluble Extracellular Proteins The source of soluble extracellular proteins is the extracellular medium, whether it be an animal source such as blood or spinal fluid, or a culture medium in which bacterial, fungal, animal, or plant cultures have been grown. Generally these do not contain a large number of different proteins (blood is an exception), and the desired protein may be a major component, especially if produced as the result of recombinant expression. Nonetheless, the protein in the starting material may be quite dilute,
Classification of Proteins by Structural Characteristics
Structural characteristic
Examples
Comments
Monomeric
Lysozyme, growth hormone
Usually extracellular; often have disulfide bonds
Glyceraldehyde-3-phosphate dehydrogenase, catalase, alcohol dehydrogenase, hexokinase Aspartate carbamoyltransferase, pertussis toxin
Mostly intracellular enzymes; rarely have disulfide bonds
Mitochondrial ATPase, alkaline phosphatase
Readily solubilized by detergents
Integral
Porins, cytochromes P450, insulin receptor
Require lipid for stability
Conjugated
Glycoproteins, lipoproteins, nucleoproteins
Many extracellular proteins contain carbohydrate
Oligomeric Identical subunits
Mixed subunits Membrane-bound Peripheral
Contributed by R.K. Scopes Current Protocols in Protein Science (1995) 1.2.1-1.2.4 Copyright © 2000 by John Wiley & Sons, Inc.
Allosteric enzymes; different subunits have separate functions
Strategies of Protein Purification and Characterization
1.2.1 CPPS
Table 1.2.2
Classification of Proteins by Function
Function
Examples
Amino acid storage
Seed proteins (e.g., gluten), milk proteins (e.g., casein)
Structural Inert With activity Binding Soluble Insoluble With activity
Collagen, keratin Actin, myosin, tubulin Albumin, hemoglobin, hormones Surface receptors (e.g., insulin receptor), antigens (e.g., viral coat proteins) Enzymes, membrane transporters (e.g., amino acid uptake systems, ion pumps)
and a large volume may therefore need to be processed. The starting fluid may also contain many compounds other than proteins, whose behavior must be taken into account. The first stage should aim mainly to reduce the volume and get rid of as much nonprotein material as possible; some protein-protein separation is also useful, but not essential. No general rules can be given, but a batch adsorption method using an inexpensive material such as hydroxyapatite, ion-exchange resin, immobilized metal affinity chromatography (IMAC) medium, or affinity adsorbent is best, if feasible. Following the first step, the sample should be in a form that is amenable to standard purification processes such as precipitation and column chromatography (Chapter 8).
Intracellular (Cytoplasmic) Proteins
Strategies for Protein Purification
To obtain soluble intracellular proteins (which are mainly enzymes), cells must be broken open or lysed to release their soluble contents. The ease with which cell disruption can be accomplished varies considerably; animal cells are readily broken, as are many bacteria, but plants and fungi have tough cell walls. Methods for obtaining cell extracts are given in Chapter 4. The macromolecular soluble contents of cells are mainly proteins, with nucleic acids as a minor but significant component. Bacterial extracts may be viscous unless DNase is added to break down the long DNA molecules. Although chromatographic procedures can be applied to crude extracts, valuable highperformance materials should not be employed in the first step, as there are always compounds, including unstable proteins, that may bind to them and be difficult to remove.
Membrane-Associated Proteins There are two approaches to isolating a membrane-associated protein. In one method, the relevant membrane fraction can first be prepared and then used to isolate the protein. Alternatively, whole tissue can be subjected to an extraction that solubilizes the membranes and releases the cytoplasmic contents as well. The former is much better in that purification is accomplished by isolating the membranes: the specific activity of the solubilized membrane fraction will be much higher than in the second method. However, the process of purifying the membrane fraction may lead to substantial losses, and it may be difficult to scale up. If total recovery of the protein is more important than purity, a whole-tissue extract is likely to be more appropriate. Although this means that a greater degree of purification is needed, the fact that membrane proteins have, by definition, properties somewhat different from those of cytoplasmic proteins permits some very effective purification steps (e.g., hydrophobic chromatography or fractional solubility separation). Peripheral membrane proteins are only loosely attached and may be released by gentle conditions such as high pH, EDTA, or low (nonionic) detergent concentrations. Once in solution, some peripheral proteins no longer require the presence of detergent to maintain their solubility. Integral membrane proteins are much more difficult—they require high concentrations of detergent for solubilization (i.e., complete solubilization of the membrane is needed to release them) and generally are neither soluble nor stable in the absence of detergent. It is sometimes necessary to maintain
1.2.2 Current Protocols in Protein Science
natural phospholipids in association with the proteins in order to maintain activity. Even though the final objective may not require activity (e.g., amino acid sequencing), there is a need for some sort of assay during the purification process to determine where the protein is. If a particular band on a gel is known to be the desired protein, then no other assay is needed and loss of bioactivity can be allowed. Purification processes may be affected by the presence of detergents. The problem of association with detergent micelles makes purifying integral membrane proteins difficult; the close association of the different proteins originating from membranes often results in very poor separation in conventional fractionation procedures.
Insoluble Proteins Natural proteins that are insoluble in normal solvents are generally structural proteins, which are sometimes cross-linked by posttranslational modification. The first stage of purification is obvious—it involves extracting and washing away all proteins that are soluble, leaving the residue containing the desired material. Further purification in a native state, however, may be impossible; extracting away other proteins using more vigorous solvents or attempting to solubilize the target protein may destroy the natural structure. Cross-linked proteins such as elastin or aged collagen cannot be dissolved without breaking the cross-links, and the individual proteins may even be crosslinked together.
Insoluble Recombinant Proteins (Inclusion Bodies) A major new class of insoluble proteins are recombinant proteins expressed (usually in Escherichia coli) as inclusion bodies. These are dense aggregates found inside cells that consist mainly of a desired recombinant product, but in a nonnative state. Inclusion bodies may form for a variety of reasons, such as insolubility of the product at the concentrations being produced, inability to fold correctly in the bacterial environment, or inability to form correct, or any, disulfide bonds in the reducing intracellular environment. Their purification is simple, since the inclusion bodies can be separated by differential centrifugation from other cellular constituents, giving almost pure product; the problem is that the protein is not in a native state, and is insoluble. Some methods for obtaining an active product from inclusion bodies are described in UNIT 6.3.
Soluble Recombinant Proteins Recombinant proteins that are not expressed in inclusion bodies either will be soluble inside the cell or, if using an excretion vector, will be extracellular (or, if E. coli is the host, possibly periplasmic). They can be purified by conventional means. In some systems, expression is so good that the desired product is the major protein present and its purification is relatively simple. In systems where the expression level is low, the purification process can be tedious, though easier, it is hoped, than isolation from the natural source. It should be remembered that a procedure developed for isolating a protein from natural sources may not work successfully with the recombinant product, because the nature of the other proteins present influences many fractionation procedures. Because of the difficulties often experienced in purifying recombinant proteins, a variety of vector systems (see UNIT 6.1 and Sassenfeld, 1990, for some examples) have been developed in which the expressed prod-uct is a fusion protein containing an N-terminal polypeptide that simplifies purification. Such “tags” can be subsequently removed using a specific protease. A further advantage is that the expression level is dictated mainly by the transcription and translation signals for the fusion portion of the protein, which are optimized. Tags used include proteins and polypeptides for which there is a specific anti- body, binding proteins that will interact with columns containing a specific ligand, polyhistidine tags with affinity to immobilized metal columns, sequences that result in biotinylation by the host and enable purification on an avidin column, and sequences that confer insolubility under specified conditions (UNIT 6.1 & UNIT 6.5). Unstable proteins may be modified by the molecular biological technique of site-directed mutagenesis to remove the site of instability— for instance, an oxidizable cysteine. Such techniques are appropriate for commercial production of proteins, but may of course alter natural functioning parameters. Increased thermostability can be one modification, although it is not easy to predict mutations that will improve that parameter. Thermostable proteins originating from thermophilic bacteria do not need structural modification and, if expressed in large amounts, can be purified satisfactorily in one step by simply heat-treating the extract at 70°C for 30 min, which denatures virtually all the host proteins (e.g., see Oka et al., 1989). The host bacteria used for production of recombinant proteins are usually Escherichia
Strategies of Protein Purification and Characterization
1.2.3 Current Protocols in Protein Science
coli, or Bacillus subtilis; they may express proteins at 1% to over 50% of the cellular protein, depending on such variables as the source, promoter structure, and vector type. Generally the proteins are expressed intracellularly, but leader sequences for excretion may be included. In the latter case, the protein is generally excreted into the periplasmic space, which limits the amount that can be produced. Excretion from gram-positive species such as B. subtilis sends the product into the culture medium, with little feedback limitation on total expression level.
Literature Cited Oka, M., Yang, Y.S., Nagata, S., Esaki, N., Tanaka, M., and Soda, K. 1989. Overproduction of thermostable leucine dehydrogenase of Bacillus stearothermophilus and its one-step purification from recombinant cells of Escherichia coli. Biotechnol. Appl. Biochem. 11:307-316. Sassenfeld, H.M. 1990. Engineering proteins for purification. Trends Biotechnol. 8:88-93.
Key References Deutscher, M.P. (ed.) 1990. Guide to protein purification. Methods Enzymol. 182:1-894.
Janson, J.-C. and Ryden, L.G. 1989. Protein Purification: Principles, High Resolution Methods, and Applications. VCH Publishers, New York. A useful collection of methods and examples. Kennedy, J.F. and Cabral, J.M. (eds.) 1993. Recovery Processes for Biological Materials. John Wiley & Sons, New York. A useful introduction to the problems of large-scale methods. Kenny, A. and Fowell, S. (eds.) 1992. Practical protein chromatography. Methods Mol. Biol. 11:1-327. Extensive descriptions of affinity chromatographic techniques with protocols and recipes. Scopes, R.K. 1993. Protein Purification, Principles and Practice, 3rd ed. Springer-Verlag, New York and Heidelberg. General principles of all the main techniques used in purifying proteins. A useful laboratory handbook; does not include recipes or procedures for specific proteins.
Contributed by R.K. Scopes La Trobe University Bundoora, Australia
Extensive collection of purification methods with some general protocols and examples.
Strategies for Protein Purification
1.2.4 Current Protocols in Protein Science
Protein Purification Flow Charts Protein purification flow charts are presented to give a broad outline of the methods used for different types of proteins. They cannot give any detail, as the process appropriate for each protein will have its own variations at each stage. In most cases, the first stage is to obtain a solution containing the desired protein, after which it can be dealt with by the many separation techniques described in the following chapters. In some cases the insolubility of the desired protein can be exploited by removing soluble fractions. Purification procedures are commonly divided into three stages: (a) the primary steps, which deal with crude mixtures of proteins and other molecules present in the raw material; (b) the secondary processing, which generates a product near to homogeneity; and (c) the polishing steps, which remove minor contaminants, a process that is especially important for therapeutic proteins.
SOLUBLE RECOMBINANT PROTEINS Proteins expressed in a recombinant manner may be (1) soluble in the cytoplasm, (2) insoluble as inclusion bodies (see section on Insoluble Recombinant Proteins), (3) excreted from the cells into the culture medium, (4) excreted into the periplasmic space (e.g., in gram-negative bacteria), or (5) associated with organelles or membrane fractions. In addition they may be expressed (6) as the normal, mature, naturally occurring protein, (7) containing a natural leader peptide that would normally be processed, (8) as a fusion protein with a peptide that is not natural to the protein, or (9) lacking glycosylation or other post-translational modification, or incorrectly modified. Possibilities (1) to (5) affect the method of extraction used to obtain the starting material for purification. Cases (6) to (9) can affect the methods used for purification. The scheme for purifying soluble recombinant proteins is outlined in Figure 1.3.1. The first stage is to obtain a clarified solution containing the desired protein, with as little in the way of unwanted proteins as possible. For soluble cytoplasmic proteins, case (1), it is not normally possible to exclude any significant amount of unwanted soluble proteins, but in cases (2) to (5) the compartmentalization away from the cytoplasm allows such separation in the initial stage. It may be necessary to carry out a concenContributed by R.K. Scopes Current Protocols in Protein Science (1995) 1.3.1-1.3.7 Copyright © 2000 by John Wiley & Sons, Inc.
UNIT 1.3
tration step before proceeding, especially if the protein has been excreted into the culture medium. Normally ultrafiltration is used, although other techniques are possible, especially if the extract contains particulates that block ultrafiltration membranes. Recombinant expression in the cytoplasm of bacteria, followed by extraction via total cell disruption, results in large amounts of nucleic acids being solubilized with the protein. A number of treatments to remove nucleic acids are possible. Streptomycin is used to precipitate ribosomal material, and cationic polymers such as protamine (a basic protein) and polyethylenimine will form insoluble complexes (at low ionic strength) with nucleic acids. In addition, viscosity caused by DNA can be reduced by adding small amounts of DNase.
INSOLUBLE RECOMBINANT PROTEINS It has been found that many proteins expressed in bacteria (mainly in Escherichia coli) do not fold correctly, and as a result aggregation occurs, leading to large insoluble inclusion bodies within the cytoplasm of the cells (see Chapter 6). Although this creates major difficulties in obtaining satisfactory amounts of active native product, it greatly simplifies the initial stage of purification. The purification scheme for recombinant insoluble proteins is outlined in Figure 1.3.2. After cell disruption, inclusion bodies can be obtained in a fairly pure state by differential centrifugation. They must now be solubilized, however, and the active protein generated by encouraging correct folding. Solubilization is usually accomplished with guanidine hydrochloride and/or urea, and thiols such as 2-mercaptoethanol or glutathione are included to disrupt any disulfides that have formed and prevent more from forming. Folding the protein correctly may require a variety of additions to the solution, as well as slow removal of the denaturant. The latter can be carried out by simple dilution or by dialysis. Folding occurs best at low protein concentrations, so dilution may be adequate. If the native protein does contain disulfides, then it is important to create redox conditions such that some (but not excessive) oxidation of thiols can occur. A combination of oxidized and reduced glutathione is commonly used. In addition, the action of the enzyme protein disulfide isomerase, which can
Strategies of Protein Purification and Characterization
1.3.1 CPPS
cells with protein soluble in cytoplasm
cells with protein excreted to medium
cells with protein in periplasmic space
cells with protein organelleassociated
break up cells; centrifuge or ultrafilter to remove insolubles
centrifuge or filter to remove cells
gently treat with lysozyme to minimize cell lysis
separate organelles; perform differential centrifugation
treat to remove nucleic acids
remove protoplasts and cell debris
extract to solubilize proteins, remove insolubles
perform concentration step
starting material: soluble fraction containing the protein
perform purification steps use salt fractionation, ion-exchange chromatography, hydrophobic chromatography, affinity and pseudoaffinity chromatography, gel filtration, or other less conventional steps (i.e., preparative electrophoresis)
for tagged fusion protein, use affinity column chromatography and polishing steps
purified protein
Figure 1.3.1 Purification scheme for soluble recombinant proteins, which may be excreted or located in the periplasm, in the membrane fraction, or most commonly the cytoplasm. The first step is to obtain an extract containing the desired protein in soluble form. After this, conventional purification steps may be carried out, or affinity purification of tagged fused proteins can be performed.
Protein Purification Flow Charts
make and unmake disulfides by exchange reactions, has been found to be beneficial in many cases. If the native protein is of intracellular origin, it probably will not contain disulfides; it will, however, contain cysteines, so a full reducing potential should be maintained. Specific methodology is discussed in UNIT 6.5. Not all proteins can fold unassisted by other cellular components. Chaperonins are proteins whose role is to refold denatured proteins such as those that form during heat shock (Zeilstra-
Ryalls et al., 1991). The most studied, and just becoming commercially available as of 1995, are the E. coli chaperonins GroEL and GroES, both of which are needed, together with ATP, to renature many proteins. Proline residues can adopt two isomeric conformations in proteins, and the wrong conformation is switched to the correct one by the enzyme prolyl isomerase, aiding the process of protein folding. At present these are not large-scale prospects, both because of the cost of the chap-
1.3.2 Current Protocols in Protein Science
cells containing protein
disrupt cells perform differential centrifugation
wash inclusion bodies dissolve in denaturing agents
dilute with buffer or dialyze to dilute denaturing agents add appropriate reducing agents and/or folding factors concentrate perform purification procedure: remove unwanted proteins and incorrectly folded species (e.g., by ion-exchange chromatography, immunoaffinity methods, gel filtration)
purified protein
Figure 1.3.2 Purification scheme for insoluble recombinant proteins that are produced as inclusion bodies in the cytoplasm of host cells. The cells must be broken open, and then the insoluble inclusion bodies are separated by differential centrifugation. Solubilization is achieved by the use of denaturing solvents, and renaturation of the dissolved protein occurs on removal of the denaturant. Further polishing steps will be needed to remove small amounts of contaminating proteins as well as incorrectly folded species. Additional information can be found in UNIT 6.3-6.5.
eronins and because the agents operate best in vitro at very low protein concentrations. Once the proteins are folded, the purification process consists of removing small amounts of still incorrectly folded protein plus any other host proteins that were trapped with the original inclusion bodies. The former may be difficult, since incorrectly folded species have a size and charge similar to those of the correct product. However, subtle differences arising from the folded conformation can be exploited by chromatographic techniques. In ideal cases immunoaffinity techniques using antibodies specific for either the incorrectly folded form or the correct one can be used to resolve the mixture.
SOLUBLE NONRECOMBINANT PROTEINS There are so many sources of soluble proteins that it is not possible to give a complete overview of methods used to obtain starting extracts from which a desired protein can be isolated. The sources can be classified as either microorganisms, plants, or animals, as shown in Figure 1.3.3, but these in turn should be subdivided according to how the starting extract is obtained. In particular there is a distinction between extracellular and intracellular proteins. With the latter it is necessary to disrupt the cells and release the proteins, whereas with the former, if the extracellular fluid can be obtained directly, there need be no contamination with intracellular proteins. Extracellular
Strategies of Protein Purification and Characterization
1.3.3 Current Protocols in Protein Science
microorganisms
plants
animals
disrupt cells, e.g., using French press, bead mill, or sonication with 5-10 vol buffer
disrupt cells, e.g., using French press or by grinding with sand using 1-2 vol buffer
homogenize with 2-5 vol buffer or mince and stir with buffer
treat to remove nucleic acids
treat to remove phenols
centrifuge
starting extract (5-20 mg/ml protein)
extracellular proteins
perform initial fractionation: use salt fractionation, precipitation with organic solvents, affinity methods, and/or two-phase partitioning perform secondary fractionation: use ion-exchange chromatography, hydrophobic chromatography, affinity methods, other adsorbents, and/or gel filtration perform polishing step: use HPLC– reversed phase, HPLC– ion exchange, or isoelectric focusing
purified protein
Figure 1.3.3 Purification scheme for soluble proteins present in their natural host cells. Cells must be disrupted to release the proteins, usually in the presence of 2 to 10 ml of a suitable buffer per gram weight. After removal of insoluble material, the process will generally require several steps, using various standard fractionation procedures in a suitable order. For production of highly pure protein, a final polishing step may be required to remove final trace contaminants. Additional information can be found in UNIT 6.2.
Protein Purification Flow Charts
sources include microorganism culture medium, plant and animal tissue culture medium, venoms, milk, blood, and cerebrospinal fluids. Soluble proteins may also occur within organelles such as mitochondria; these may be best obtained by first isolating the organelle, then disrupting it to release the contents. The starting extract normally contains be-
tween 5 and 20 mg protein per milliliter, though lesser concentrations can be dealt with, especially if working on a small scale. It may be necessary to include a concentration step before starting the purification process in order to approach that level. There are exceptions to every rule, however, and very high protein concentrations can be handled, for example,
1.3.4 Current Protocols in Protein Science
whole tissue homogenize without detergent; centrifuge
supernatant
disrupt cells; gently isolate organelles
residue homogenize with detergent; centrifuge
supernatant containing membrane-associated proteins perform primary fractionation: use hydrophobic chromatography, precipitation with organic solvents, ion-exchange chromatography, and/or phase partitioning perform secondary fractionation: use ion-exchange chromatography, affinity methods, and/or gel filtration
residue containing insoluble proteins
suspend and extract with other solvents (e.g., ethanol, urea, or SDS)
purified protein
insoluble residue
perform polishing step: use HPLC or isoelectric focusing
purified protein
Figure 1.3.4 Purification scheme for membrane-associated and poorly soluble proteins (nonrecombinant). An initial purification can be achieved by isolation of organelles containing the desired protein. Membrane proteins are normally solubilized with a nonionic detergent, although loosely associated proteins may be extracted without detergent at high pH, with EDTA, or with small amounts of an organic solvent such as N-butanol. Normal fractionation procedures may need some modification if the detergent is required throughout to maintain the integrity of the protein.
with two-phase partitioning (Walter and Johansson, 1994). When isolating proteins on a large scale, the volumes being manipulated become of increasing concern, so maximizing protein concentration can be an important aim. The starting extract should be clarified, usually by centrifugation; on a large scale, ultrafiltration methods are becoming more widely used. Pretreatment of certain extracts to remove ex-
cessive amounts of nucleic acids, phenolics, and lipids may be necessary in order to obtain an extract that is amenable to standard fractionation procedures. Fractionation procedures can somewhat arbitrarily be divided into three steps: initial fractionation, secondary fractionation, and polishing. Initial processing, which deals with a large amount of extract that is not all protein, may
Strategies of Protein Purification and Characterization
1.3.5 Current Protocols in Protein Science
involve materials that become soiled and unable to be used many times. Consequently, preferred methods do not require expensive reagents or adsorbents such as are used in highperformance liquid chromatography (HPLC). Classic salt fractionation and the less-used organic solvent fractionation can achieve, if not a high degree of purification, a useful level of concentration and removal of much unwanted nonproteinaceous material. Alternatively, a highly selective affinity procedure may be used as the first step, but only if the affinity material is inexpensive to make and/or the extract is a simple, clear solution, as opposed to a turbid whole-cell homogenate. Secondary processing achieves the main purification, and may involve two or more steps in difficult situations. Ion-exchange and hydrophobic-interaction chromatography, gel filtration, and affinity techniques (see Chapter 8 and Chapter 9) are the main procedures. Finally, it may be necessary to remove traces of contaminants by “polishing,” using high-resolution procedures such as reversed-phase HPLC (UNIT 11.6) and isoelectric focusing (IEF; UNIT 10.2 & UNIT 10.4). Because every protein has unique characteristics, it is impossible to make general statements about procedures to be followed.
MEMBRANE-ASSOCIATED AND INSOLUBLE NONRECOMBINANT PROTEINS
Protein Purification Flow Charts
Proteins that are not physiologically soluble can be purified after extracting and removing soluble proteins, thereby achieving a substantial degree of purification at the extraction step (Fig. 1.3.4; also see UNITS 6.1 & 6.2). To carry out a purification it is nearly always necessary to obtain the desired protein in a soluble form, which will often require the addition of solubilizing agents such as detergents. Some proteins remain insoluble even with detergent treatment, and so can be substantially purified by removing the soluble fractions. Some membrane-associated proteins become partly solubilized during breaking up of the tissue, and recovery in the particulate fraction may be poor. In such cases it may be best to solubilize the whole tissue by including detergent in the homogenizing buffer. Extraction of insoluble residues using detergents can be done differentially; some proteins are released at low detergent concentration, whereas others require complete solubilization of the membrane fraction. Suitable detergents include nonionic (e.g., Triton) and weakly acidic types (e.g., cholic acid deriva-
tives). Strongly acidic detergents such as sulfate esters (e.g., sodium dodecyl sulfate) usually result in denaturation. Detergents can be removed either by adsorption of the protein on a column, and subsequent elution without detergent, by use of special detergent-adsorbing beads, or even by extraction with nonmiscible organic solvents in which the detergent partitions. On the other hand, many membrane proteins require the presence of detergent at all times in order to remain in solution and in a native conformation. These include most integral membrane proteins, for example, cytochrome: P450, transmembrane receptors, and transporters. The most sensitive proteins require a particular combination of natural lipids (in addition to the detergent) to maintain structural integrity. Purification methods include most of those used for soluble proteins, but some techniques are not recommended if detergent is needed at all times. For instance, ammonium sulfate precipitation will often cause a detergent-protein complex to come out of solution and float rather than sink on centrifugation—this can be useful, but the “floatate,” when redissolved, may have a high detergent content. Hydrophobic chromatography can be very useful, as membrane proteins are naturally hydrophobic. Integral membrane proteins that are completely insoluble in normal detergents may be solubilized by denaturation using compounds such as sodium dodecyl sulfate and guanidine hydrochloride. Some cross-linked proteins such as elastin are not soluble without disruption of the covalent linkages.
Literature Cited Walter, H. and Johansson, G. (eds.) 1994. Aqueous two-phase systems. Methods Enzymol. 228:1725. Zeilstra-Ryalls, J., Fayet, O., and Georgopoulos, C. 1991. The universally-conserved GroE (Hsp60) chaperonins. Annu. Rev. Microbiol. 45:301-325.
Key References Deutscher, M.P. (ed.) 1990. Guide to protein purification. Methods Enzymol. 182:1-894. Extensive collection of purification methods, with some general protocols and examples. Janson, J.-C. and Ryden, L.G. 1989. Protein Purification: Principles, High Resolution Methods, and Applications. VCH Publishers, New York. A useful collection of methods and examples.
1.3.6 Current Protocols in Protein Science
Kennedy, J.F. and Cabral, J.M. (eds.) 1993. Recovery Processes for Biological Materials. John Wiley & Sons, New York. A useful introduction to the problems of large-scale methods. Kenny, A. and Fowell, S. (eds.) 1992. Practical protein chromatography. Methods Mol. Biol. 11:1-327. Extensive descriptions of affinity chromatographic techniques with protocols and recipes.
Scopes, R.K. 1993. Protein Purification, Principles and Practice, 3rd ed. Springer-Verlag, New York and Heidelberg. General principles of all the main techniques used in purifying proteins. A useful laboratory handbook; does not include recipes or procedures for specific proteins.
Contributed by R. K. Scopes La Trobe University Bundoora, Australia
Strategies of Protein Purification and Characterization
1.3.7 Current Protocols in Protein Science
Purification of Glutamate Dehydrogenase from Liver and Brain
UNIT 1.4
Because of the wide variety of procedures that may be used to purify any given enzyme, it is not possible to provide a single protocol that includes them all. In this unit two protocols for the purification of glutamate dehydrogenase (GDH)—also referred to as + L-glutamate-NAD(P) oxidoreductase (deaminating; EC 1.4.1.3:GDH)—have been selected as examples because they present two very different approaches to the purification of the enzyme. In the first (see Basic Protocol 1), affinity chromatography using a column consisting of the allosteric inhibitor guanosine 5′-triphosphate (GTP) bound to Sepharose is described. Support protocols detail the preparation of the GTP-Sepharose needed for this procedure (see Support Protocol 1), assessment of incorporation of GTP into the GTP-Sepharose gel, if necessary (see Support Protocol 2), the activation of Sepharose 4B with CNBr, if necessary (see Support Protocol 3), and reuse and equilibration of the chromatography media (see Support Protocols 4 and 5). An alternative purification procedure (see Alternate Protocol) uses a bifunctional ligand composed of two NAD+ molecules linked together by a spacer arm to precipitate the enzyme. Protocols for the synthesis of the bis-NAD compound (see Support Protocol 7), resolution of NAD+ derivatives (see Support Protocol 8), and instructions for a pilot affinity study (see Support Protocol 9) complement this alternative approach. Of value to both studies are methods for concentrating the protein product (see Support Protocol 6), determining the protein concentration (see Basic Protocol 2), and assaying for GDH activity (see Basic Protocol 3). Although some of these techniques can be found elsewhere in this manual, instructions are included in this unit that are specific to the systems mentioned here. As discussed below, some tissues, including the brain but not the liver, contain an additional isoenzyme of glutamate dehydrogenase (GLUD2) as a relatively minor component. The procedures described here are for purifying the major form (GLUD1). Since this unit is concerned with the purification of mammalian glutamate dehydrogenase, a detailed review of its properties and functions is not appropriate. However, some of the essential properties are briefly summarized below. Further details can be found in the references cited. References to earlier work on the enzyme can be found in Tipton and Couée (1988) and are not repeated here. GDH catalyzes the reversible oxidative deamination of glutamate to 2-oxoglutarate (α-ketoglutarate). Either NAD+ or NADP+ can serve as cofactor, although the kinetic and regulatory behavior depend on which is used. The native enzyme is a hexamer of six identical subunits, each consisting of 505 amino acids, with approximate relative molecular mass of 56,700. However, at high protein concentrations, the hexamers may aggregate further to form high-molecular-weight polymers. The crystal structure of the enzyme has been recently determined (Peterson and Smith, 1999; Smith et al., 2001). The enzyme activity is allosterically modulated by a range of metabolites, including adenosine, guanosine, and inosine di- and trinucleotides, as well as L-leucine (see Couée and Tipton 1989a). The exact behavior of these compounds depends on the conditions under which activity is measured and whether NAD+ or NADP+ is used as cofactor. The kinetic behavior in the direction of glutamate oxidation is complex. Substrate inhibition by high concentrations of 2-oxoglutarate occurs in the reaction leading to NADPH oxidation, but this is not apparent in the reaction pathway leading to NADH oxidation. For that reason, activity determinations are usually performed in the direction of 2-oxoglutarate amination with NADH as the cofactor. Phospholipids, such as cardiolipin, also
Strategies of Protein Purification and Characterization
Contributed by Martha Motherway, Keith F. Tipton, Alun D. McCarthy, Ivan Couée, and Jane Irwin
1.4.1
Current Protocols in Protein Science (2002) 1.4.1-1.4.34 Copyright © 2002 by John Wiley & Sons, Inc.
Supplement 29
affect enzyme activity (Couée and Tipton, 1989b) and the enzyme is also inhibited by antipsychotic drugs such as perphenazine (Couée and Tipton, 1990a,b; Yoon et al., 2001). GDH is localized in the mitochondrial matrix, although small amounts of the activity have been detected associated with microtubules (Rajas and Rousset, 1993) and endoplasmic reticulum (Lee et al., 1999). A nuclear-associated activity has also been reported (McDaniel, 1995) and the enzyme has been found to be capable of functioning as an RNA-binding protein (Preiss et al., 1993). In addition to the ubiquitously distributed GDH isoenzyme (GLUD1), which is encoded by a gene on chromosome 10, brain, retina, and testis tissue also contain a second form of the enzyme (GLUD2), encoded on the X chromosome (see Shashidharan et al., 1994). This isoenzyme differs in its kinetic and regulatory properties from the major form of GDH (see e.g., Cho et al., 1995; Shashidharan et al., 1997). The possible functions of these two GDH isoenzymes in brain have been discussed by Plaitakis and Zaganas (2001). NOTE: Unless otherwise stated, all required chemicals can be obtained from SigmaAldrich or BDH. They should be of the highest purity available. BASIC PROTOCOL 1
PURIFICATION OF OX BRAIN OR LIVER GLUTAMATE DEHYDROGENASE BY AFFINITY CHROMATOGRAPHY ON GTP-SEPHAROSE The initial steps in this protocol involve the classical procedures of salt precipitation and ion-exchange chromatography. These are then followed by affinity chromatography on GTP Sepharose. GTP is an allosteric inhibitor of glutamate dehydrogenase when NAD+ is used as the substrate (see McCarthy and Tipton, 1985; Couée and Tipton, 1989a). The procedure described here is that of McCarthy et al. (1980). The steps involved are summarized in Figure 1.4.1. Materials Fresh ox (beef) brain (∼400 g) or liver (∼50 g) from slaughterhouse 0.32 M sucrose (optional; if tissue samples are to be stored before use) Homogenization buffer (see recipe), 4°C Ammonium sulfate [(NH4)2SO4] 20 mM and 200 mM sodium phosphate buffer, pH 7.4 (APPENDIX 2E), 4°C Affinity chromatography buffer (see recipe) 400 mM KCl in affinity chromatography buffer (see recipe for buffer) Glycerol
Purification of Glutamate Dehydrogenase from Liver and Brain
Scissors Waring blender or kitchen liquidizer Refrigerated centrifuge (e.g., Sorvall RC-5C) Dounce (hand-held) homogenizer with loosely-fitting pestle (clearance, ∼0.03 cm) 250 ml or 500 ml polycarbonate centrifuge tubes Dialysis tubing, 12,000 molecular weight cut-off (MWCO) Conductivity meter Gradient mixer (e.g., UNIT 8.2) Chromatography columns (see Support Protocol 5 for equilibration; column lengths may be varied somewhat according to availability): 40 × 3–cm packed to height of 30 cm with DEAE-cellulose (DE-52, Whatman) and equilibrated with 20 mM sodium phosphate buffer, pH 7.4 (see APPENDIX 2E for buffer) 30 × 2.5–cm packed to height of 22 cm with Sephadex G-25 (Pharmacia Biotech) and equilibrated with affinity chromatography buffer (see recipe for buffer)
1.4.2 Supplement 29
Current Protocols in Protein Science
ox brain (400 g)
homogenize for 1 min in 3 volumes (w/v) of 4 mM sodium phosphate buffer, pH 7.4, containing 0.5mM EDTA and 0.1 mM PMSF
ox liver (50 g)
homogenize for 1 min in 500 ml of 4 mM sodium phosphate buffer, pH 7.4, containing 0.5 mM EDTA and 0.1 mM PMSF
stage 1 (homogenate) add solid (NH4)2 SO4 (113 g/liter), stir for 20 min
centrifuge discard pellet
stage 2 (NH4)2 SO4 supernatant
add solid (NH4)2 SO4 (188 g/liter), stir for 20 min
stage 3 (dialyzed pellet)
centrifuge discard supernatant dialyse against 20 mM sodium phosphate buffer, pH 7.4 and apply to DEAE-cellulose column elute with 20 to 200 mM sodium phosphate, pH 7.4, gradient
stage 4 (DEAE eluate)
gel-filter into affinity chromatography buffer; pass through hydrazide-Sepharose; and apply to GTP Sepharose column
stage 5 (GTP-Sepharose eluate)
elute with 0 to 15 mM KCl gradient in affinity-chromatography buffer concentrate by ultrafiltration dialyze against 20 mM sodium phosphate buffer, pH 7.4 purified glutamate dehydrogenase
Figure 1.4.1 Flow chart for the purification of ox liver and brain glutamate dehydrogenase according to the Basic Protocol 1. Full details of the steps involved are given in the text.
6 × 2–cm packed to height of 4 cm with ∼10 ml of hydrazide-Sepharose 4B and equilibrated with affinity chromatography buffer (see Support Protocol 1, steps 1 to 3 for resin; see recipe for buffer) 6 × 2–cm packed to height of 4 cm with GTP-Sepharose 4B and equilibrated with affinity chromatography buffer (see Support Protocol 1, steps 1 to 7 for resin; see recipe for buffer)
Strategies of Protein Purification and Characterization
1.4.3 Current Protocols in Protein Science
Supplement 29
Additional reagents and equipment for dialysis (UNIT 4.4 and APPENDIX 3B), determining protein concentration (see Basic Protocol 2 and UNIT 3.4), assaying GDH activity (see Basic Protocol 3), and concentrating protein solutions by ultrafiltration (see Support Protocol 6) NOTE: Unless indicated otherwise, all steps are performed at 0° to 4°C in a cold room or refrigerated cabinet. Prepare and homogenize the tissue 1. Obtain one ox brain (∼400 g) or liver (∼50 g) from a freshly slaughtered animal transported to the laboratory on ice to be used as the starting material for the purification. The brain may be used fresh or stored at −70°C, using the procedure as follows: Place the fresh tissue in ice-cold 0.32 M sucrose solution and keep it in a −20°C freezer until it has frozen. Transfer to a −70°C freezer until required. Before use place the vessel containing the frozen material in a water bath at 37°C and allow it to thaw, with occasional agitation. The larger amount of enzyme in ox liver permits the use of a smaller amount of starting material (e.g., 50 g in the example purification shown here) to be used.
2a. For brain tissue: Divide the brain tissue into three equal portions, weigh, and suspend each portion in 3 volumes (w/v) of cold homogenization buffer. 2b. For liver tissue: Weigh the liver tissue and suspend in 10 volumes (w/v) of cold homogenization buffer. 3. Chop the tissue into smaller pieces using scissors, then homogenize in a Waring blender at full speed for 1 min. Retain a small aliquot of this homogenate for determining protein concentration by the biuret procedure (see Basic Protocol 2) and assaying GDH activity (see Basic Protocol 3). A kitchen liquidizer can be used instead of a Waring blender. However, extra care is then needed with any biohazard material (see Critical Parameters) since kitchen liquidizers can release aerosols. These are generally less powerful than the Waring blender and it is thus necessary to increase the homogenization time (e.g., 1.5 min using a Kenwood liquidizer at full speed). The volumes given in the subsequent steps refer to the preparation of GDH from brain. The corresponding values for liver are given in Table 1.4.6 (see Critical Parameters and Troubleshooting).
Precipitate with ammonium sulfate 4. Add solid (NH4)2SO4 slowly in four approximately equal amounts to the homogenates while they are still in the blender, homogenizing for 1 min between each addition, to yield a final 20% saturated solution (113 g/liter). Continue homogenization for another 30 sec at full speed after the final addition. For brain tissue, repeat this procedure with the other two tissue homogenates. 5. Combine the ammonium sulfate–treated homogenates in a beaker on ice and stir the mixture for 20 to 30 min. Centrifuge 30 min at 14,000 × g, 4°C. Carefully decant the supernatants and discard the pellets. Retain a small aliquot of this material for determining protein concentration by the biuret procedure (Basic Protocol 2) and assaying GDH activity (Basic Protocol 3). Purification of Glutamate Dehydrogenase from Liver and Brain
6. Add 188 g/liter of solid (NH4)2SO4 slowly with continuous stirring. Stir the mixture for an additional 20 to 30 min, then centrifuge again as described in step 5. This results in 50% saturation with ammonium sulfate.
1.4.4 Supplement 29
Current Protocols in Protein Science
7. Decant and discard the supernatants. Resuspend the pellets in 20 mM sodium phosphate buffer, pH 7.4, using a Dounce homogenizer, to yield a total volume of 200 to 250 ml (160 ml for liver). Retain a small aliquot of this material for determining protein concentration by the biuret procedure (Basic Protocol 2) and assaying GDH activity (Basic Protocol 3). The ammonium sulfate pellet can be resuspended by careful stirring if a Dounce homogenizer is not available.
8. Dialyze (UNIT 4.4 and APPENDIX 3B) for 18 hr against 20 volumes (v/v) of cold 20 mM sodium phosphate buffer, pH 7.4, with at least two changes of buffer, using an MWCO 12,000 dialysis membrane. 9. Centrifuge the material from the dialysis bag 30 min at 40,000 × g, 4°C, and retain the supernatants. Resuspend the pellets in the 20 mM sodium phosphate buffer, pH 7.4, and centrifuge again for 30 min at 40,000 × g, 4°C. Combine the supernatants with those from the first centrifugation and discard the pellets. Retain a small aliquot of this material for determining protein concentration by the biuret procedure (Basic Protocol 2) and assaying GDH activity (Basic Protocol 3). Extraction by resuspension and recentrifugation of the pellet after dialysis and centrifugation increases the yield of enzyme, since otherwise some glutamate dehydrogenase activity is lost in the pellet. As is common with salt precipitation in enzyme purification, this step does not give a high degree of purification of glutamate dehydrogenase. However, it is an effective way of reducing the volume of material for the subsequent steps, and it also removes some contaminants.
Perform chromatography on DEAE-cellulose 10. Pour the supernatant carefully onto the top surface of a 40 × 3–cm chromatography column packed to 30 cm with DEAE-cellulose, equilibrated with 20 mM sodium phosphate buffer, pH 7.4 (Support Protocol 5). After the protein solution has run into the column, continue to pass buffer through it and determine the absorbance of aliquots of the effluent at 280 nm (A280). Continue washing the column until the A280 of the effluent is <0.1. 11. Pass a 2-liter linear gradient from 20 to 200 mM sodium phosphate buffer, pH 7.4, through the column. Collect fractions (∼10 ml) and determine their A280 (see Basic Protocol 2), conductivity, and enzyme activities (see Basic Protocol 3). Pool the fractions containing glutamate dehydrogenase activity. Retain a small aliquot of this pooled material for determining protein concentration by the biuret procedure (Basic Protocol 2) and assaying GDH activity (Basic Protocol 3). The combined active fractions require concentration before the next step; this can be done either by ultrafiltration or ammonium sulfate precipitation. The authors have used both of these procedures and they work equally well.
12a. Concentrate protein by ultrafiltration: Concentrate the combined fractions containing GDH activity in an Amicon ultrafiltration cell using either an Ultracel Amicon YM 30 or Ultracel PLTK membrane, as described in Support Protocol 6, until the volume remaining in the cell is reduced to ∼20 ml. 12b. Concentrate protein by ammonium sulfate precipitation: Add 312 g/liter solid (NH4)2SO4 slowly, over a period of 30 min with continuous stirring (this brings the saturation to 50%). Continue stirring for a further 20 min, then centrifuge 20 min at 14,000 × g, 4°C. Discard the supernatant and resuspend the pellet in ∼20 ml of 20 mM sodium phosphate buffer, pH 7.4.
Strategies of Protein Purification and Characterization
1.4.5 Current Protocols in Protein Science
Supplement 29
Perform chromatography on GTP-Sepharose 13. Desalt the sample by passing the concentrated enzyme solution through a 30 × 2.5–cm chromatography column packed to 22 cm with Sephadex G-25, equilibrated with affinity chromatography buffer. The next chromatographic steps should be performed as quickly as possible, since the enzyme is slightly unstable in the affinity chromatography buffer.
14. Apply the enzyme solution to a 6 × 2–cm chromatography column packed to 4 cm with hydrazide-Sepharose 4B equilibrated with affinity chromatography buffer. Elute by passing an additional 50 ml of affinity chromatography buffer through the column. Glutamate dehydrogenase activity is not appreciably retarded by this material, and essentially complete recovery of the applied activity is obtained when the applied volume plus an additional 50 ml of buffer has been passed through the column. This procedure removes any components which bind nonspecifically to the Sepharose or to the spacer arm.
15. Apply the enzyme solution eluted from the above column to a 6 × 2–cm chromatography column packed to 4 cm with GTP-Sepharose 4B, equilibrated with affinity chromatography buffer. Use a flow rate of not more than ∼1 ml/min. Pass affinity chromatography buffer through the column until the A280 of the effluent has fallen to <0.01 (∼150 ml of buffer should be required). Once the enzyme solution has passed into the column the flow rate may be increased to 1.5 ml/min, and this flow rate should be used for step 16.
16. Elute the enzyme activity with a linear 400-ml gradient from 0 to 400 mM KCl in affinity chromatography buffer. Collect fractions (∼10 ml) and monitor the A280 (see Basic Protocol 2), conductivity, and enzyme activity (see Basic Protocol 3) in each. 17. Combine fractions containing glutamate dehydrogenase activity and concentrate by ultrafiltration, followed by osmotic dehydration, as described in Support Protocol 6, to yield a protein concentration of at least 3 mg/ml. 18. Dialyze (UNIT 4.4 and APPENDIX 3B) overnight against 3 liters of 20 mM sodium phosphate buffer, pH 7.4, using MWCO 12,000 dialysis membrane. Add glycerol to the dialyzed enzyme solution to yield a final concentration of 30% (v/v) and store in a sealed container, which has been flushed with N2, at 4°C. There may be some small variations between different preparations of the GTP-Sepharose in the sharpness of the peak of activity that emerges and in the salt concentration necessary to elute the enzyme. This may reflect varying concentrations of bound ligand, but does not affect the degree of purification obtained. SUPPORT PROTOCOL 1
PREPARATION OF GTP-SEPHAROSE Although GTP-agarose is available from Sigma, the preparation described in this protocol generally yields more satisfactory and reproducible results than commercial preparations. The steps involved are outlined in Figure 1.4.2. GTP is coupled to Sepharose 4B by the method of Jackson et al. (1973) as modified by Godinot et al. (1974), where L-glutamic acid γ-methyl ester is used as the spacer instead of ε-aminohexanoic acid methyl ester. After the spacer is coupled to the activated Sepharose and the ester group is treated with hydrazine (Godinot et al., 1974), a portion of the gel (∼10 ml) is retained and used as the hydrazide gel in the purification procedure.
Purification of Glutamate Dehydrogenase from Liver and Brain
1.4.6 Supplement 29
Current Protocols in Protein Science
OH OH Sepharose CNBr
O C O
NH CH2OPOPOP
HO L-glutamic acid γ -methyl ester
COOH
GTP
O
NHCHCH2 CH2COCH3 OH
G
NaIO4
H2NNH2 COOH
O
HO
CH2OPOPOP
O
O
NHCHCH2 CH2CNHNH2 OH hydrazine derivative
O
O G
CH2OPOPOP
COOH
O
NHCHCH2 CH2CNHN OH GTP-Sepharose
O G
Figure 1.4.2 The chemical processes involved in the synthesis of GTP-Sepharose according to the method described in Support Protocol 1. The activation of Sepharose by cyanogen bromide (Support Protocol 3) is also shown in simplified form; alternative activated products are formed in this step.
Materials Cyanogen bromide–activated Sepharose 4B (Pharmacia Biotech, or see Support Protocol 3). Sodium bicarbonate buffer: prepare 0.1 M NaHCO3 and adjust pH to 9.0 with NaOH L-glutamic acid γ-methyl ester Hydrazine hydrate Guanosine 5′-triphosphate (GTP) 0.1 M disodium hydrogen phosphate adjusted to pH 5.0 with 1 M citric acid Sodium periodate Ethylene glycol
Strategies of Protein Purification and Characterization
1.4.7 Current Protocols in Protein Science
Supplement 29
Nitrogen source 50 mM sodium phosphate buffer, pH 6.8 (APPENDIX 2E) containing 5 mM EDTA Butanol Sintered-glass filter funnel (Pyrex, porosity G2) 70°C water bath Prepare the hydrazide gel 1. Wash ∼4.5 g of cyanogen bromide–activated Sepharose 4B in a sintered-glass filter funnel with ice-cold water, then wash with 100 ml ice-cold sodium bicarbonate buffer. Finally, suspend the resin in sodium bicarbonate buffer to a volume of 16 ml. The cyanogen bromide–activated Sepharose 4B contains dextran and lactose as stabilizers. It is necessary to remove these by washing. It is possible to activate Sepharose with cyanogen bromide in the laboratory as described in Support Protocol 3. This is a less expensive alternative, but cyanogen bromide is toxic and should be handled with great care.
2. Dissolve 1.12 g of L-glutamic acid γ-methyl ester in 4 ml sodium bicarbonate buffer. Add this solution to the ∼16 ml of the gel suspension and stir this mixture for 16 to 18 hr at 4°C. Finally, filter the mixture and wash it with cold water in a sintered-glass filter funnel before suspending it in water to a volume of 30 ml. The following steps should be performed in a fume hood.
3. Add 28 ml of hydrazine hydrate (99% to 100%) slowly to 30 ml of the suspended gel and heat the reaction mixture to 70°C in a water bath for 15 min. Allow the mixture to cool and then filter and wash with cold water on a sintered-glass filter. This material, the hydrazide gel, may be overlaid with butanol to impede bacterial growth, and stored at 4°C. Retain a 10-ml portion of this hydrazide gel for use in the purification procedure. After use, the hydrazide gel can be recycled as described in Support Protocol 3.
Prepare GTP-Sepharose 4. Dissolve 14.2 mg of GTP in 5 ml of 0.1 M disodium hydrogen phosphate that has been adjusted to pH 5.0 with 1 M citric acid. Dissolve 8.6 mg of sodium periodate in 0.4 ml of the same buffer. Mix these two solutions and incubate in the dark for 30 min at room temperature. Add 8 µl of ethylene glycol to remove the excess periodate, and incubate the mixture for a further 15 min. Bubble nitrogen through the solution for 5 to 10 min. Bubbling with N2 is effected by connecting a Pasteur pipet to a nitrogen cylinder by plastic tubing. The Pasteur pipet is placed in the tube containing the reacted mixture and the nitrogen is allowed to bubble through slowly. This procedure removes any formaldehyde produced during the reaction, which would compete with the oxidized GTP for reaction with the hydrazide gel.
5. Dilute the mixture from step 4 (oxidized GTP solution) to 10 ml with 0.1 M disodium hydrogen phosphate that has been adjusted to pH 5.0 with 1 M citric acid. If necessary, remove the butanol layer from the hydrazide gel (from step 3) by aspiration and wash the gel with cold water, then suspend it in 20 ml of cold water. Mix 10 ml of this gel suspension with the oxidized GTP solution and stir the mixture at room temperature for 2 hr. Purification of Glutamate Dehydrogenase from Liver and Brain
1.4.8 Supplement 29
Current Protocols in Protein Science
6. Filter the gel on a sintered-glass funnel and wash with at least 100 ml of cold 50 mM sodium phosphate buffer, pH 6.8, containing 5 mM EDTA. Retain washings if step 8 is to be performed. Store the resultant GTP-Sepharose at 4°C with an overlay of butanol to retard bacterial growth. Remove this butanol layer by aspiration and wash the gel with buffer prior to use of the gel. After use, the GTP-Sepharose gel can be recycled as described in Support Protocol 4.
ASSESSMENT OF INCORPORATION OF GTP INTO THE HYDRAZIDE GEL The following modification to Support Protocol 1 may be applied if there are any problems using the GTP-Sepharose medium prepared in Support Protocol 1 in the affinity purification steps (see Basic Protocol 1, steps 13 to 16). It is generally not necessary to resort to this procedure.
SUPPORT PROTOCOL 2
CAUTION: When working with radioactivity, take appropriate precautions to avoid contamination of the experimenter and the surroundings. Carry out the experiment and dispose of wastes in an appropriately designated area, following the guidelines provided by the local radiation safety officer (also see APPENDIX 2B). Additional Materials (also see Support Protocol 1) [8-14C]GTP (Amersham Pharmacia Biotech) 250:500:1 (v/v/w) Triton X-100/toluene/2,5-diphenyloxazole (PPO) Carry out Support Protocol 1 with the following modifications at the indicated steps. 4a. Add 2.7 µCi of [8-14C]GTP to the solution of unlabeled GTP before periodate oxidation. 7b. Determine radioactivity in a sample of the gel washings by scintillation counting in a mixture by scintillation counting in 250:500:1 Triton X-100/toluene/PPO. About 35% of the added GTP should be found to be tightly bound to the gel, corresponding to 0.6 ìmol of GTP per ml of settled gel (see Table 1.4.1).
Table 1.4.1 Recovery of [8-14C]GTP After Coupling to Sepharose 4B
Aqueous phase
Radioactivity (cpm)a,b
Total radioactivity (cpm)a,b
10 µM of initial 14C-GTP solution + 1 ml H2O 1 ml gel washings (from 475 ml) 10 µM of initial 14C-GTP solution + 1 ml gel washings
14760 5167 20100
3.77 × 106 2.44 × 106 —
a9 ml of 250:500:1 (v/v/w) Triton X-100:toluene:PPO were mixed with 1 ml of the aqueous phase and the
radioactivity determined in a liquid scintillation counter. bSince the cpm obtained with the 10 µl 14C-GTP solution + 1 ml gel washings equals the sum obtained for the
two solutions separately, there is no significant difference in the quenching for the two solutions and therefore it is unnecessary to convert the results to dpm.
Strategies of Protein Purification and Characterization
1.4.9 Current Protocols in Protein Science
Supplement 29
SUPPORT PROTOCOL 3
ACTIVATION OF SEPHAROSE 4B WITH CYANOGEN BROMIDE This protocol is given as an alternative to the purchase of preprepared cyanogen-bromideactivated Sepharose. Materials Sepharose 4B (Pharmacia Biotech) Cyanogen bromide Acetonitrile 5 M sodium hydroxide Sodium bicarbonate buffer: prepare 0.1 M NaHCO3 and adjust pH to 9.0 with NaOH CAUTION: Because cyanogen bromide is very toxic, it should be handled with extreme care. See APPENDIX 2A for general precautions. 1. Wash 10 ml Sepharose 4B with water and suspend in 40 ml water. 2. Stir this mixture slowly in an ice-bath in a fume-hood. Add 2.4 g cyanogen bromide dissolved in 1.7 ml acetonitrile and monitor the pH of the resultant mixture constantly, maintaining it at ≥pH 11 by the addition of 5 M sodium hydroxide. Use extreme caution as hydrocyanic acid may be formed in this step.
3. After hydrogen ion release has subsided (i.e., the pH ceases to fall), filter the gel on a sintered-glass funnel. Wash with at least 100 ml of ice-cold sodium bicarbonate and resuspend in 16 ml of that buffer. SUPPORT PROTOCOL 4
REUSE OF CHROMATOGRAPHY MEDIA Hydrazide-Sepharose (prepared as in Support Protocol 1, steps 1 to 3) Wash the resins after use with 500 ml of 2 M KCl, followed by 1 liter of water. Store at 4°C with an overlay of butanol, to retard bacterial growth. Remove the butanol layer by aspiration and equilibrate with affinity chromatography buffer (see recipe) immediately before use. GTP Sepharose (prepared as in Support Protocol 1, steps 1 to 7) Follow the same procedure as described for the hydrazide-Sepharose, above. Over a period of several months, the properties of the GTP-Sepharose change and the enzyme activity is eluted earlier in the gradient, probably as a result of instability of the bound GTP. The gel should therefore be discarded after 6 months. DEAE-Cellulose The manufacturers provide full instructions for recycling this material for reuse. After use, remove tightly bound material from the ion-exchange material by passing 2 column volumes of 2 M NaCl through the column. Equilibrate the column with the buffer to be used and then pass 1 column volume of the same buffer containing 0.02% sodium azide through the column. Before use, wash the column with azide-free buffer.
Purification of Glutamate Dehydrogenase from Liver and Brain
If a small portion at the top of the column becomes discolored as a result of tightly bound material, that portion may be removed and replaced by fresh DEAE-cellulose. Removal of the top few centimeters from the column may also be effective if the flow rate through the column becomes excessively slow. After removing the discolored top resin, transfer the remaining resin from the column to a beaker. Add the appropriate amount of fresh
1.4.10 Supplement 29
Current Protocols in Protein Science
DEAE-cellulose from which the fines have been removed and which has been equilibrated with 20 mM sodium phosphate buffer, pH 7.4 (see Support Protocol 5), and repack the column. If the characteristics of the DEAE-cellulose change after protracted use, it may be regenerated by the following procedure. 1. Empty the contents of the column into a beaker. Stir with 15 volumes of 0.5 M HCl for 30 min. Stirring can be continued for up to, but no longer than, 2 hr if convenient.
2. Filter the DEAE-cellulose on a sintered-glass funnel and wash it with water until the pH of the effluent reaches 4. 3. Stir the DEAE-cellulose with 15 volumes of 0.5 N NaOH for 30 min. 4. Allow to settle, remove the supernatant by decantation, and repeat step 3. 5. Filter on a sintered glass funnel and wash with water until the pH of the effluent is close to neutrality. The DEAE-cellulose is then ready for re-equilibration and reuse, although it may be necessary to remove the fines (see Support Protocol 5). For longer-term storage, remove the DEAE-cellulose from the column and store it in a saturated solution of NaCl, in a tightly-sealed container. Sephadex G-25 Sephadex G-25 is supplied in dry form and must be swollen before use. Full instructions for swelling and recycling this material are provided in the literature from the manufacturers. EQUILIBRATION OF CHROMATOGRAPHIC MEDIA The chromatographic medium must never be allowed to dry. When using it in columns there should always be a layer of the appropriate buffer above the surface.
SUPPORT PROTOCOL 5
Equilibration of DEAE-Cellulose DEAE-cellulose (Whatman DE-52) may contain small amounts of relatively small-sized particles (“fines”) which can slow down the rate of flow through a column if not removed. The following steps are appropriate for the DEAE-cellulose chromatography performed in Basic Protocol 1 and the Alternate Protocol. For the DEAE-cellulose chromatography performed in Support Protocol 7 (i.e., step 15 of that protocol), the procedure is the same as that described below except that 1 M NH4HCO3 may be used for removing the fines. A total of 10 column volumes of 1 M NH4HCO3 should then be used to equilibrate the column, which is then washed with 8 liters of water. Materials DEAE-cellulose (Whatman DE-52) 200 mM and 20 mM sodium phosphate buffer, pH 7.4 (APPENDIX 2E) Chromatography column; 40 × 3–cm (length × diameter) Conductivity meter (e.g., Linton, type WPA CMD80) 1. Suspend the DEAE-cellulose resin in 5 volumes of 200 mM sodium phosphate buffer, pH 7.4. Allow the mixture to settle and remove the buffer and fines by decantation. Repeat this process at least three times, after which the supernatant, upon settling, should be clear.
Strategies of Protein Purification and Characterization
1.4.11 Current Protocols in Protein Science
Supplement 29
2. Pour a suspension of this material into a 40 × 3–cm chromatography column to produce a final bed volume of 30 × 3 cm. Allow 20 mM sodium phosphate buffer, pH 7.4, to flow through the column until the effluent has the same pH and conductivity as the in-flowing buffer. The column is now ready for use.
Equilibration of Dowex AG 1X2 Dowex AG 1X2 medium is used in Support Protocol 7. Suspend the Dowex AG 1X2 (200 to 400 mesh, Cl− form) in 3 M HCl and pour into a column of 4 cm diameter to give a settled bed volume of 10 cm. Wash the column before use with 1 liter of 3 M HCl, followed by exhaustive washing with at least 20 liters of water, until the pH of the effluent reaches neutrality. Equilibration of Sephadex G-25 Pass at least 2.5 column volumes of the appropriate buffer through the packed column before use. SUPPORT PROTOCOL 6
CONCENTRATION OF PROTEIN-CONTAINING SOLUTIONS Some of the purification procedures used in Basic Protocol 1 and the Alternate Protocol result in some degree of concentration. Precipitation with ammonium sulfate followed by resuspension of the pellet in a smaller volume, as well as ion-exchange chromatography, can also be effective concentration procedures. In contrast, however, dialysis and gel filtration tend to dilute samples. The procedures described below are specifically for concentration purposes. For additional information, see UNIT 4.4. It is important to note that in both of the procedures described below, inattention may result in the concentration proceeding until all the fluid has been removed. It is essential to monitor the progress of the procedure and stop when the desired volume has been reached, because attempts to recover enzyme activity from material that has been taken to dryness by either of these procedures will result in significant losses. Ultrafiltration The Amicon ultrafiltration cell uses pressure of nitrogen gas to force the solution through a membrane that retains molecules above a pre-determined size. Prepare the apparatus according to the manufacturer’s instructions using the ultrafiltration cell from Amicon either an Amicon Ultracel YM 30 or Ultracel PLTK membrane. Slowly stir the contents during the concentration process, which is carried out at 4°C. Continue until the required volume remains in the cell. Earlier work used Amicon Diaflo XM-50 membranes for this procedure, but these are no longer readily available. The Ultracel Amicon YM 30 or Ultracel PLTK membranes are appropriate substitutes.
Purification of Glutamate Dehydrogenase from Liver and Brain
Centriplus concentrators (Amicon) may be an alternative for concentrating the enzyme from volumes of less than 60 to 70 ml. They rely on centrifugation to force solvent through a membrane (e.g., Centriplus 50, MWCO 50 kDa). The sample containing enzyme is retained by the membrane. The authors have found this procedure to be successful with several other dehydrogenases.
1.4.12 Supplement 29
Current Protocols in Protein Science
Osmotic Dehydration Although ultrafiltration is a highly effective procedure for concentrating relatively large volumes, it may be less effective and convenient with small volumes and high protein concentrations. Osmotic dialysis relies on the use of a high concentration of material outside a dialysis tube to draw water and small-molecule solutes from its contents by osmosis, leaving a more concentrated protein solution within the dialysis tubing. Either sucrose or polyethylene glycol (PEG; Mr = 15,000 to 20,000) may be used. However the purity of PEG can be variable and it is important to use preparations that are as pure as possible to avoid contamination of the enzyme solution from low-Mr impurities that may be inhibitory. Put the enzyme solution in a length of dialysis tubing (see APPENDIX 3B for preparation) that has been knotted at the lower end, and then tie a knot in the other end of the tubing. Surround the resulting tube with solid sucrose or PEG. This may be done by heaping the sucrose or PEG on a sheet of cooking foil, embedding the dialysis tubing in the sucrose, and then folding the foil to form a parcel around the sucrose or PEG-covered dialysis tube. Alternatively, the dialysis tubing may be buried in the material within a plastic box of appropriate dimensions. Leave at 4°C until the solution in the dialysis bag has reached the required volume; this will take several hours. Rinse the outside of the dialysis tube with water or buffer to remove adhering sucrose or PEG. This also dampens the dialysis membrane, which becomes brittle during the concentration procedure. Whereas with ordinary dialysis it is necessary to leave an empty space in the tubing to allow for the osmotic volume increase, this need not be done for osmotic dehydration where a decrease in volume occurs. In Basic Protocol 1 and the Alternate Protocol, this concentration procedure is followed by dialysis. In order to avoid too great a degree of dilution occurring at this stage, reknot the dialysis tube to confine the enzyme solution in a smaller volume of the tubing. DETERMINATION OF PROTEIN CONCENTRATION The first two methods presented under this heading are the Biuret and Bio-Rad protein assays. A spectrophotometer and 1-cm light-path cuvettes (either glass or plastic) will be required for each of these determinations. In the case of the third method presented below, determination of protein concentration by absorbance at 280 nm (A280), the cuvettes must be quartz or some other UV-transmitting material.
BASIC PROTOCOL 2
Other procedures for determining protein concentration may also be used, including the Lowry-Folin method, which is described in adequate detail in Dawson et al. (1989). UNIT 3.4 also provides additional information on determination of protein concentration. Biuret Protein Assay Materials Biuret reagent (see recipe). 1.5% (w/v) sodium deoxycholate (1.5 g sodium deoxycholate in 100 ml distilled H2O) 50 mg/ml bovine serum albumin (BSA), or alternative protein calibration standard 1. Prepare a series of standards in triplicate according to the scheme described in Table 1.4.2.
Strategies of Protein Purification and Characterization
1.4.13 Current Protocols in Protein Science
Supplement 29
Table 1.4.2
Preparation of Standard Curve for Biuret Protein Assay
mg protein
50 mg/ml BSA (µl)
1.5% (w/v) sodium deoxycholate (µl)
H2O (µl)
Biuret reagenta (ml)
0 0.25 0.5 0.75 1.0 1.5 2.0
0 5 10 15 20 30 40
100 100 100 100 100 100 100
900 895 890 885 880 870 860
4 4 4 4 4 4 4
aSee recipe in Reagents and Solutions.
2. For enzyme protein determination use 20 to 100 µl of appropriately diluted sample and prepare as described in Table 1.4.2. 3. Mix each sample and allow the reaction to proceed at room temperature for ∼30 min. 4. Measure absorbance at 540 nm using the samples containing no protein as blanks. 5. Prepare a standard curve by plotting absorbance at 540 nm against the protein concentration. 6. Use the standard curve to determine the protein concentration of the enzyme sample from its absorbance. Determine the absorbance of the sample against a blank containing the same medium. Dilute, if necessary, to ensure that the absorbance is <1.0. Bio-Rad Protein Assay Materials Bio-Rad Dye Reagent Concentrate 0.1 mg/ml bovine serum albumin (BSA), or alternative protein calibration standard (this can be conveniently prepared by diluting some of the stock solution prepared for the biuret assay; see above) Method 1. Prepare a series of standards in triplicate according to the scheme described in Table 1.4.3. 2. For enzyme protein determination use 20 to 100 µl of appropriately diluted sample and prepare as described in Table 1.4.3.
Purification of Glutamate Dehydrogenase from Liver and Brain
Table 1.4.3
Preparation of Standard Curve for Bio-Rad Protein Assay
µg protein
0.1 mg/ml BSA (µl)
H2O (µl)
Bio-Rad Dye Reagent Concentrate (µl)
0 2 5 10 15 20
0 20 50 100 150 200
800 780 750 700 650 600
200 200 200 200 200 200
1.4.14 Supplement 29
Current Protocols in Protein Science
3. After mixing, leave for a period of 5 to 60 min, then determine the absorbance at 595 nm using the samples containing no protein as blanks. 4. Prepare a standard curve by plotting absorbance at 595 nm against the protein concentration. 5. Use the standard curve to determine the protein concentration of the enzyme sample from its absorbance. Determine the absorbance of the sample against a blank containing the same medium. Dilute, if necessary, to ensure that the absorbance is <1.0. Note that the Bio-Rad assay involves determination of the absorbance of 1 ml of mixture. The optical arrangements of some spectrophotometers may not permit this in standard 1-cm2 cross-section cuvettes. In such cases microcuvettes should be used. However, some older spectrophotometers may not focus the light beam to pass through the narrower path of a microcuvette. It is a good idea to check the instructions supplied with the spectrophotometer in regard to this. If all else fails, the volumes shown for this procedure can all be increased proportionally.
Absorbance at 280 nm Using quartz or other non-UV-absorbing cuvettes, determine the absorbance at 280 nm of the sample against a blank composed of the medium in which the sample is dissolved. A UV-Vis spectrophotometer is required. Use the rough approximation that a 1 mg/ml protein solution has an absorbance of 1.0 at this wavelength. ASSAY OF GLUTAMATE DEHYDROGENASE ACTIVITY Glutamate dehydrogenase catalyzes the reaction:
BASIC PROTOCOL 3
2-oxoglutarate + NH 3 + NADH + H + U L-glutamate + H 2 O + NAD +
The assay described here determines the decrease of absorbance at 340 nm as NADH is oxidized to NAD+ concomitant with the reductive amination of 2-oxoglutarate to L-glutamate. Materials Enzyme preparation (see appropriate steps of Basic Protocol 1 or Alternate Protocol) 0.4% (v/v) Triton X-100 in 50 mM sodium phosphate buffer, pH 7.4 100 mM potassium cyanide (KCN) 50 mM sodium phosphate buffer, pH 7.4 (APPENDIX 2E) 2.5 M ammonium sulfate in 50 mM sodium phosphate buffer, pH 7.4 4 mM NADH in 50 mM sodium phosphate buffer, pH 7.4 (prepared fresh on day of use) 0.25 M 2-oxoglutarate (α-ketoglutarate), in 50 mM sodium phosphate buffer, pH 7.4 Spectrophotometer with cuvette holder set at 37°C 1-cm path-length cuvettes (quartz or plastic with good light transmittance at 340 nm) NOTE: All GDH enzyme assays are performed at 37°C. In order to ensure rapid temperature equilibration, the assay buffer should be prewarmed to that temperature.
Strategies of Protein Purification and Characterization
1.4.15 Current Protocols in Protein Science
Supplement 29
Other hints on the performance and validation of enzyme assays can be found in Tipton (2002). 1. For crude enzyme preparations (see Basic Protocol 1, step 1): Incubate 50 µl of the enzyme solution with 2.68 ml of 0.4% Triton X-100 in 50 mM sodium phosphate buffer, pH 7.4, and 30 µl of 100 mM KCN (which will give a final KCN concentration of 1 mM in the complete assay) for 2 min at 37°C before proceeding to step 2. For assaying the enzyme at later steps of the purification, begin with step 2. Triton X-100 serves to disrupt particulate material, and KCN decreases any contaminating NADH oxidase activity. It has been shown that neither Triton X-100 nor KCN affect the activity of purified GDH at these concentrations. These assays are performed in phosphate buffer. Do not attempt to perform them in Tris buffer since the enzyme is unstable in Tris and either no activity or a rapid decrease in activity may be observed.
2. Add reagents to the cuvettes in the order listed, in a final volume of 3 ml: 2.71 ml 50 mM sodium phosphate buffer, pH 7.4 60 µl 2.5 M ammonium sulfate (final concentration 50 mM) 120 µl 4 mM NADH (final concentration 160 µM) 50 µl enzyme preparation. 3. Cover the cuvette with Parafilm, mix the contents by inversion and incubate in the spectrophotometer for 3 min. Initiate the reaction by the addition of 60 µl of 0.25 M 2-oxoglutarate (final concentration 5 mM), invert to mix and allow the reaction to proceed for 10 min in the spectrophotometer. 4. Determine the initial (linear) rate of decrease in absorbance as NADH is oxidized to NAD+, subtracting any blank rate occurring before the addition of the 2-oxoglutarate (see Critical Parameters). The initial absorbance resulting from the NADH present will be ∼1.0, although impurities in the enzyme solution may add to this. The assay has been found to proceed in a linear fashion until the absorbance has decreased by 0.15 absorbance units. In all cases it will be necessary to dilute the enzyme preparation in order to obtain a rate that is sufficiently slow to measure with accuracy. See Critical Parameters for a detailed discussion of dilution considerations.
5. Calculate the specific activity. Since the molar absorbance coefficient of NADH in a 1-cm path-length cuvette is 6220 M-1cm-1, the production of 1 ìmol of glutamate, or the reductive amination of 1 ìmol 2-oxoglutarate in an assay volume of 3.0 ml will give an absorbance change of 2.073. Thus, for a 1-cm path-length cuvette, the specific activity of the enzyme (ìmol product formed.per min per mg protein) will be related to the rate of decrease in absorbance per min (∆A/min), which will be given by:
specific activity =
∆A /min assay volume (ml) × 6.22 protein (mg)
It is most common to express enzyme activities in these terms. 1 unit (U) of enzyme activity is defined as the amount catalyzing the production of 1 ìmol of product (or the disappearance of 1 ìmol of substrate) in 1 min under stated conditions. Purification of Glutamate Dehydrogenase from Liver and Brain
1.4.16 Supplement 29
Current Protocols in Protein Science
PURIFICATION OF RAT OR OX LIVER GDH INVOLVING AFFINITY PRECIPITATION WITH bis-NAD+
ALTERNATE PROTOCOL
Affinity precipitation of enzymes was developed by Mosbach and co-workers (see Flygare et al., 1983; Larsson et al., 1984). The bifunctional ligand bis-NAD+ (N2, N2′-adipodihydrazido-bis-(N6-carbonyl-methyl)NAD+) comprises two molecules of NAD+ joined by a spacer arm (see Fig. 1.4.5). This separates the NAD+ groups by a sufficient distance (∼1.7 nm) to allow them to bind to the coenzyme-binding sites of two different molecules of glutamate dehydrogenase. Mammalian GDH is a polymer, so extensive cross-linking of the enzyme molecules occurs and hence they precipitate from solution, as illustrated in Figure 1.4.3. Since there are many oligomeric dehydrogenases
+ glutamate dehydrogenase
bis-NAD+
Figure 1.4.3 A diagrammatic view of the cross-linking of glutamate dehydrogenase hexamers by bis-NAD+, which results in the formation of an insoluble lattice. The “locking-on” in the presence of glutarate is not shown. Further details of the process are given in the Alternate Protocol.
Strategies of Protein Purification and Characterization
1.4.17 Current Protocols in Protein Science
Supplement 29
in the cell, this process might be expected to be somewhat nonspecific, causing the precipitation of a number of enzymes containing binding sites for NAD+. However, the procedure can be made specific for the precipitation of a selected dehydrogenase by the use of a compound that is a competitive inhibitor of the enzyme with respect to its other substrate. Thus, in the case of GDH, glutarate, which is a competitive inhibitor towards glutamate, is used. This strengthens the binding between the bis-NAD+ and glutamate dehydrogenase, allowing it to be used at concentrations below those that would be necessary to precipitate other dehydrogenases.
ox liver (46 g)
rat liver (10g)
homogenize for 1 min in 10 volumes (w/v) of 4 mM sodium phosphate buffer, pH 7.4, containing 0.5 mM EDTA and 0.1 mM PMSF
Stage 1 (homogenate) add (NH4)2 SO4 (113 g/liter), stir for 20 min
centrifuge and discard pellet add (NH4)2 SO4 (188 g/liter), stir for 20 min centrifuge and discard pellet dialyze against 20 mM sodium phosphate buffer, pH 7.4
Stage 2 [dialyzed (NH4)2 SO4 pellet] apply to DEAE-cellulose column
elute with 20 to 200 mM sodium phosphate, pH 7.4, gradient and concentrate to ~10 ml
Stage 3 (DEAE eluate)
affinity precipitate with the appropriate amount determined from pilot precipitation experiment (Support Protocol 9) of bis-NAD+ in the presence of 79 mM glutaric acid and keep on ice overnight
centrifuge discard supernatant redissolve pellet by stirring for 6 hr in 1 ml of buffer containing 0.6 mM NADH
Stage 4 (purified enzyme)
dialyze against 20 mM sodium phosphate buffer, pH 7.4 purified glutamate dehydrogenase
Purification of Glutamate Dehydrogenase from Liver and Brain
Figure 1.4.4 Outline scheme for the purification of ox and rat liver glutamate dehydrogenase according to the Alternate Protocol. Full details of the steps involved are given in the text.
1.4.18 Supplement 29
Current Protocols in Protein Science
This behavior, which was termed the “locking-on” effect by O’Carra (see O’Carra et al., 1996; O’Flaherty et al., 1999; Mulcahy and O’Flaherty, 2001), was originally developed for increasing the strength of enzyme binding to an immobilized ligand. It depends on the analog of the substrate that is oxidized by NAD+ binding to the enzyme⋅NAD+ binary complex and thus displacing the coenzyme-binding equilibrium by ternary complex formation: +
NAD glutarate + ZZZZZX Z GDH < NAD+ YZZZZZ ZZZZZZ X Z GDH YZZZZ Z Z Z GDH< NAD < glutarate
This “locking-on” behavior occurs only if the oxidizable substrate, or a competitive inhibitor that is an analog of the oxidizable substrate, binds to the enzyme⋅NAD+ binary complex and not to the free enzyme. The basic concept is that, although several enzymes bind NAD+, only the GDH⋅NAD+ complex binds glutarate. The majority of dehydrogenases have ordered sequential kinetic mechanisms in which the coenzyme binds before the second substrate. To date, the technique has been found to work well for the purification of yeast alcohol dehydrogenase and lactate dehydrogenase (see Irwin and Tipton, 1996), and the synthesis of the corresponding bis-ATP analog has extended the application of bis-coenzymes to kinases (Beattie et al., 1987). The precipitated dehydrogenase can then be dissolved by incubation in the presence of NADH, which effectively competes with bis-NAD+ for binding to the enzyme. The procedure described here is that of Graham et al. (1985), as modified by Irwin and Tipton (1996). The steps involved are summarized in Figure 1.4.4. Additional Materials (also see Basic Protocol 1) Bis-NAD+ (see Support Protocol 7) 0.7 M glutaric acid, adjusted to pH 7.0 with NaOH Additional reagents and equipment for pilot-scale precipitation (see Support Protocol 9) NOTE: Unless indicated otherwise all steps are performed at 0° to 4°C. 1. Homogenize the sample and perform ammonium sulfate precipitation and DEAEcellulose chromatography steps (see Basic Protocol 1, steps 1 to 12), concentrating the eluate from the DEAE-cellulose column to ∼10 ml at step 12a or b. Although it is possible to perform affinity precipitation with preparations that have not been subjected to chromatography on DEAE-cellulose, the yield is much lower and the precipitated material is not completely pure.
2. Dialyze the enzyme preparation overnight at 4°C against 200 ml of sodium phosphate buffer, pH 7.4, with at least one change of buffer. Carry out a pilot-scale precipitation as described in Support Protocol 9 to determine the optimal amount of bis-NAD+ to use. Add that amount of bis-NAD+ to the remaining dialyzed enzyme preparation and add 0.7 M glutaric acid (preadjusted to pH 7) to a final concentration of 79 mM glutarate. Keep the mixture on ice overnight.
3. Centrifuge 15 min at 10,000 × g, 4°C. Redissolve the pellet by stirring for 6 hr in 1 ml of 20 mM sodium phosphate buffer, pH 7.4, containing 0.6 mM NADH. Dialyze the redissolved pellet overnight (using an MWCO 12,000 dialysis membrane) against 200 ml of sodium phosphate buffer, pH 7.4. Add glycerol and store as described in Basic Protocol 1, step 18.
Strategies of Protein Purification and Characterization
1.4.19 Current Protocols in Protein Science
Supplement 29
SUPPORT PROTOCOL 7
SYNTHESIS OF N2, N2′-ADIPODIHYDRAZIDO-bis(N6-CARBONYLMETHYL)NAD+ (bis-NAD) This reagent is used in the Alternate Protocol. The steps involved are outlined in Figure 1.4.5. Materials Iodoacetic acid (fresh) 2 M and 1 M lithium hydroxide (LiOH) NAD+ (98%, free acid) 2 M and 6 M HCl 96% (v/v) ethanol 0.24 M NaHCO3 1 M NaOH Nitrogen source Sodium dithionite 2 M Tris (base) Acetaldehyde, redistilled Yeast alcohol dehydrogenase (crystalline, Sigma-Aldrich or Roche Diagnostics) 5 mM CaCl2, pH 2.7, and 50 mM CaCl2, pH 2.0 2 M Ca(OH)2 Adipic acid dihydrazide dichloride (Sigma-Aldrich) 0.5 M 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC; Sigma-Aldrich) 0.25, 1, and 2 M ammonium bicarbonate (NH4HCO3) Sintered-glass funnel (≥10 cm diameter) Rotary evaporator Vacuum desiccator 75°C water bath 4 × 10–cm Dowex AG 1X2 anion-exchange column (Support Protocol 5) Gradient mixer (e.g., UNIT 8.2) 30 × 2.5–cm chromatography column packed with Whatman DE-52 resin and equilibrated (see Support Protocol 5) with 1 M NH4HCO3, pH 8.0 Additional reagents and equipment for resolution of NAD+ derivatives (see Support Protocol 8) Synthesize N(1)-carboxymethyl-NAD+ 1. Dissolve 9 g fresh iodoacetic acid in ∼10 ml of water, neutralize the solution with 2 M LiOH, and add 3 g of NAD+. Adjust the pH to 6.5 with 2 M HCl (the total volume should be ∼30 ml) and leave the solution in darkness for 7 days at room temperature (∼20°C), or alternatively, at 37°C for 2 days. Check the pH daily (or every 4 to 6 hr at the higher temperature) and readjust to 6.5 with 2 M HCl as required. The progress of the reaction should also be followed by TLC and/or HPLC (see Support Protocol 8). The solid iodoacetic acid should be white; if it is discolored as a result of decomposition it should not be used. Solutions of iodoacetic acid should be prepared fresh.
2. When reaction is complete, adjust pH to 3.0 with 6 M HCl and add 2 volumes of 96% (v/v) ethanol to produce a milky, pink-tinged suspension. Add a further 10 volumes of cold 96% ethanol to complete the precipitation. Purification of Glutamate Dehydrogenase from Liver and Brain
The water/ethanol ratio is important; using a wet vessel can give rise to the formation of a brown, sticky substance which is water-soluble.
1.4.20 Supplement 29
Current Protocols in Protein Science
3. Filter the crude N(1)-carboxymethyl-NAD+ on a sintered funnel, wash with ethanol and diethyl ether, and dry in a rotary evaporator at 35°C under vacuum or by lyphilization (average yield 2.9 g). Store the product at −20°C under vacuum. Carry out rearrangement of N(1)-carboxymethyl-NAD+ to N6-carboxymethyl-NAD+ 4. Dissolve the crude N(1)-carboxymethyl-NAD+ in 0.24 M NaHCO3 (90 ml), which gives a pale orange solution, and adjust the pH to 8.5 with 1 M NaOH. 5. Deoxygenate the solution by bubbling N2 gas through it for 2 min, add 1.5 g of sodium dithionite, and leave the solution in the dark until maximum reduction is achieved. Monitor progress of reduction by taking samples, diluting them 1:50 or 1:100, and measuring the increase in absorbance at 340 nm (A340). 6. Terminate the reaction by stirring vigorously for 10 min to oxygenate the solution and then bubble N2 gas through it for 2 min. Adjust the pH to 11.5 with 1 M NaOH and leave in a water bath at 75°C to allow the rearrangement from the N(1)- to the N6-substituted derivative to occur (Dimroth rearrangement; see Engel, 1975). Monitor the rearrangement by HPLC or TLC (see Support Protocol 8). 7. Cool the reaction mixture to room temperature and add 6 ml of 2 M Tris (base) and 1.5 ml of redistilled acetaldehyde. Adjust the pH to 7.5 with 1 M HCl and add 8 to 24 mg (2500 to 7500 U) of yeast alcohol dehydrogenase. 8. Monitor the reaction at 340 nm as in step 5. When a minimum A340 is reached, add 1 volume of 96% ethanol and pour the milky flocculent precipitate into 10 volumes of vigorously stirred 96% ethanol. Leave for 30 min (or overnight, if desired) and collect the precipitate by filtration. Store the crude N6-carboxymethyl-NAD+ at −20°C in a vacuum desiccator for up to a month (yield ∼2.6 g). Purify the crude N6-carboxymethyl-NAD+ 9. Dissolve the crude powder (2.6 g, from step 7) in 30 ml water, adjust the pH to 8.0 with 1 M LiOH, and apply this solution to a 2.5 × 30–cm Dowex AG 1X2 column. See Support Protocol 5 for details of packing and equilibrating the Dowex column.
10. After applying the coenzyme solution, wash the column with 0.5 liter of water, followed by 1 liter of 5 mM CaCl2, pH 2.7, until the pH of the effluent is 2.8. Apply a 2-liter linear gradient from 5 mM CaCl2, pH 2.7, to 50 mM CaCl2, pH 2.0. Collect 10 to 20 ml fractions and monitor the absorbance at 260 nm. The composition of the fractions can be monitored by TLC (see Support Protocol 8).
11. Pool the fractions containing the N6 derivative, adjust the pH to 7.0 with 2 M Ca(OH)2, and concentrate to 5 to 10 ml by rotary evaporation at 40°C. 12. Precipitate with 96% ethanol as in step 2, above, and lyophilize. This gives a pale yellow compound (yield 0.82 g, 25%); ε = 19,300 M−1cm−1 at 266 nm.
Synthesis of bis-NAD+ 13. Dissolve 0.82 g of purified N6-carboxymethyl-NAD+ and 105 mg of adipic acid dihydrazide dihydrochloride in 20 ml water, to produce a brownish solution. 14. Adjust the pH to 4.6 with 1 M HCl and then add 0.5 M EDC at 0°C in 15- to 100-µl aliquots over a period of 35 min. Monitor the pH and readjust it to 4.6 before each addition. 15. Add water (2 liters) to dilute the solution 100-fold, adjust the pH to 8.0 with 2 M NH4HCO3, and apply the solution to a 30 × 2.5–cm DEAE-cellulose (DE-52) column equilibrated with 1 M NH4HCO3, pH 8.0 (Support Protocol 5). Wash the column with
Strategies of Protein Purification and Characterization
1.4.21 Current Protocols in Protein Science
Supplement 29
water until the A260 is <0.1 and apply a 2-liter linear gradient from 0 to 0.25 M NH4HCO3, pH 8.0. 16. Monitor the Rf values of the fractions by TLC (Support Protocol 8). The yield from pure N6-carboxymethyl-NAD+ is ∼14%. ε= 42,800 M−1 cm−1 at 266 nm.
17. Concentrate the product-containing fractions to ∼3 to 5 ml by rotary evaporation at 35°C and store at –20°C. For longer-term storage (>7 to 10 days) the material may be lyophilized and stored in a vacuum desiccator over silica gel at –20°C.
NH2
NH2
N
N
N
N
R
NAD+
ICH2COO–
N
pH 6.5, 25°C, 5 to 7 days
N
+ N
CH2COO–
N N(1) carboxymethyl-NAD+
R
Sodium dithionite pH 8.5, 2 to 4 hr NHCH2 COO–
N N
NH2 Dimroth rearrangement
N
pH 11.5, 75°C, 2 hr
N
RH N 6-carboxymethyl-NADH
alcohol dehydrogenase, acetaldehyde, pH 7.5 NHCH2 COO–
N N R
+ N
N
CH2COO–
N
N RH N(1) carboxymethyl-NADH
CONH2 + N H
O–
OH
H
CH2O P O P OCH2 O O O O H OH OH H N O H H H H OH OH N 6-carboxymethyl-NAD+
R=
N
H2NOC(CH2)4 CONH2 + EDC pH 4.6, 0°C, 35 min 0 HN
N N R
CH2
0
0
C NH NH C (CH2)4 C NH NH C CH2 NH
N
N
N
N
N
bis-NAD+
EDC= CH3CH2-N Purification of Glutamate Dehydrogenase from Liver and Brain
0
N
R
C N
(CH2)3 NH(CH2)2 Cl-
1-ethyl-3-(3)-dimethylaminopropyl) carbodiimide hydrochloride
Figure 1.4.5 Outline of the steps involved in the synthesis of bis-NAD+. Full details of the steps involved are given in Support Protocol 7.
1.4.22 Supplement 29
Current Protocols in Protein Science
RESOLUTION OF NAD+ DERIVATIVES
SUPPORT PROTOCOL 8
Thin-layer Chromatography (TLC) The techniques of TLC are not described in detail here since they are adequately described in many textbooks (e.g., Wilson and Walker, 2000; Hahn-Deinstrop, 2000). Two different TLC solvent systems have been used for monitoring the products of the synthesis of bis-NAD+: System A: 60:100:2 (w/v/v) (NH4)2SO4/0.1 M potassium phosphate, pH 6.8/1-propanol. System B: 5:3 (v/v) isobutyric acid/1 M aqueous NH3, saturated with disodium EDTA. Apply the samples as spots to TLC plates (aluminium backed, silica gel 60, fluorescent indicator F254, layer thickness 0.2 mm; Merck), dry, and develop by ascending chromatography in a TLC developing tank. After developing the plates and allowing them to dry, the spots can be visualized by their fluorescence under UV light (wavelength 254 nm). They appear purple on a green background. The Rf values of bis-NAD+ and the compounds involved as intermediates in its synthesis are shown in Table 1.4.4. High-Performance Liquid Chromatography (HPLC) Inject the samples onto the HPLC column (4 mm × 30-cm C18 reversed-phase; e.g., Waters µBondapak C18) and elute isocratically with 0.1 M KH2PO4, pH 6.0, containing 10% methanol, at a flow rate of 0.7 to 1.0 ml/min. The elution profile is determined by continuously monitoring the absorbance of the eluate at 259 to 266 nm using a UV detector flow cell. Good separation between NAD+ and N(1)-carboxymethyl-NAD+ can be achieved, and N6-carboxymethyl-NAD+ and bis-NAD+ can be well separated, but this system does not resolve N(1)-carboxymethyl-NAD+ and N6-carboxymethyl-NAD+ satisfactorily. Retention times for NAD+ derivatives are given in Table 1.4.4. The retention times are decreased if buffer containing 20% methanol is used. A gradient of 0% to 20% methanol may be used to separate the N(1)- and N6-substituted NAD+ derivatives. The advantage of HPLC over TLC is that it is easier to quantify the levels of any impurities present in the product.
Table 1.4.4
Some Properties of bis-NAD+ and its Precursors
Rfa (TLC)
Compound
Retention timeb Molar absorbance (M-1cm-1) Solvent Ac Solvent Bd (HPLC)
NAD+ N(1)-carboxymethyl-NAD+ N6-carboxymethyl NAD+ Bis- NAD+
0.41 0.31 0.22 0.09
0.44 0.27 0.22 0.05
4.6 min 3.7 min 3.6 min 6.9 min
16,900 (at 259 nm) 17,100 (at 259 nm) 19,300 (at 266 nm) 42,800 (at 266 nm)
aThe R values given for TLC of coenzyme derivatives are not exact. They may vary by up to ±0.05. This may result from f
slight changes in the solvent composition over time, possibly as a result of evaporation. bThe HPLC retention times were obtained for samples chromatographed on a reversed-phase µBondapak C-18 column
(4 mm × 30 cm) and eluted with 0.1 M KH2PO4 containing 10% methanol. cSolvent A: 60:100:2 (w/v/v) (NH ) SO ;/0.1 M potassium phosphate, pH 6.8/1-propanol. 42 4 d5:3 (v/v) isobutyric acid/1 M aqueous NH , saturated with disodium EDTA. 3
Strategies of Protein Purification and Characterization
1.4.23 Current Protocols in Protein Science
Supplement 29
SUPPORT PROTOCOL 9
PILOT-SCALE AFFINITY PRECIPITATION STUDY In order to obtain optimal results from the purification procedure described in the Alternate Protocol, it is necessary to perform a small-scale (pilot) study to determine the optimum concentrations of protein and bis-NAD+ to use (see Fig. 1.4.6). This will vary somewhat between different enzyme preparations, owing to differences in enzyme concentration and the presence of other contaminants that may bind the bis-coenzyme. The optimum ratio of NAD+ equivalents/enzyme subunit may vary with the preparation used; for example, with a preparation of beef liver enzyme that had a specific activity of 2.7 U/mg (see Basic Protocol 3), about half the activity was found to precipitate at a ratio of 2 NAD+ equivalents/GDH subunit. However, a preparation with the lower specific activity of 0.8 U/mg required ∼8 NAD+ equivalents/GDH subunit to precipitate half the enzyme activity. The precipitation yield also depends on the protein concentration, as shown, for example, in Figure 1.4.7. Materials Sample of the enzyme preparation (Alternate Protocol) Bis-NAD+ (see Support Protocol 7) 700 mM glutaric acid, pH 7.0 Additional reagents and equipment for assaying protein concentration (see Basic Protocol 2) and GDH activity (see Basic Protocol 3) 1. Take an aliquot of the enzyme-containing solution from the DEAE-cellulose purification step (see Alternate Protocol and Basic Protocol 1) and assay it for GDH activity (see Basic Protocol 3) and protein concentration (see Basic Protocol 2) to determine its specific activity.
Precipitation (%)
100
50
0 0
5
10
15
20
[bis-NAD+ ] (mol/mol GDH subunit) Purification of Glutamate Dehydrogenase from Liver and Brain
Figure 1.4.6 An example of a pilot-scale affinity precipitation of ox liver glutamate dehydrogenase purified according to steps 1 to 3 of the Alternate Protocol. The experimental details are described in Support Protocol 9. The precise behavior will vary between preparations. The affinity precipitation is expressed as a percentage of the activity remaining in the control sample.
1.4.24 Supplement 29
Current Protocols in Protein Science
Precipitation (%)
100
50
0
0
0.05 0.1 0.2 0.3 0.4
1
5
10
[Protein] (mg/ml)
Figure 1.4.7 An example of the effects of protein concentration on the pilot-scale affinity precipitation of ox liver glutamate dehydrogenase by bis-NAD+. These results are from a sample experiment performed as described in Support Protocol 9 in which the enzyme-containing sample was diluted to the indicated protein concentration before precipitation with a constant amount of bis-NAD+.
2. Calculate the approximate concentration of enzyme, based on the specific activity and subunit relative molecular mass. Assuming each subunit to have a relative molecular mass of 56,700 and the pure enzyme to have a specific activity of 40 ìmol/min/mg protein, this corresponds to ∼2267 mol product/min/mol enzyme subunit. Thus:
mol of subunit =
activity (µmol/min ) 2267 × 10 6
3. Measure effects of bis-NAD+ concentration as follows: a. Add a 100-µl sample of the enzyme preparation to each of 10 microcentrifuge tubes. b. To each tube, add 12.7 µl of 700 mM glutaric acid, pH 7.0, and varying amounts of bis-NAD+ within the range 0 to 10 coenzyme equivalents/enzyme subunit. c. Also prepare sample containing no bis-NAD+ (to which water is added in place of the coenzyme derivative) as well as a control tube that contains no bis-NAD+ or glutarate, so that the percentage inhibition resulting from the presence of the glutarate can be calculated. The concentration of bis-NAD+ can be calculated from the absorbance at 266 nm and the molar absorbance coefficient given in Table 1.4.4. A 1 M solution of bis-NAD+ will give an absorbance, in a 1-cm light-path cuvette, of 42,800, and each mole of bis-NAD+ contains 2 NAD+ equivalents. Thus:
2( A266 ) = coenzyme equivalent concentration in mol/liter 42,800
Strategies of Protein Purification and Characterization
1.4.25 Current Protocols in Protein Science
Supplement 29
4. Allow the tubes to stand at 4°C for at least 30 min (or overnight, if required), then microcentrifuge 5 min at maximum speed (∼13,000 × g), 4°C. 5. Assay the GDH activity remaining in the supernatant (see Basic Protocol 3) of each sample and express it as a percentage of the activity remaining in the control sample. The maximum affinity precipitation has occurred in the tube with the minimal residual activity and thus gives the appropriate concentration of bis-coenzyme to add to obtain maximum affinity precipitation. These experiments should be performed at least in duplicate.
REAGENTS AND SOLUTIONS Use Milli-Q-purified water or equivalent for the preparation of all buffers. For common stock solutions, see APPENDIX 2E; for suppliers, see SUPPLIERS APPENDIX.
Affinity chromatography buffer 100 mM Tris acetate 1 mM KH2PO4 0.1 mM EDTA Adjust pH to 7.15 at 4°C Store at 0° to 4°C up to 1 week; check pH before use and adjust if necessary Biuret reagent Dissolve 1.5 g copper sulfate (CuSO4⋅5H2O) and 6.0 g sodium potassium tartrate (C4H4KNaO6⋅4H2O) in 500 ml distilled H2O. Add 300 ml of 10% (w/v) sodium hydroxide and dilute the mixture to 1 liter with distilled water. Homogenization buffer 4 mM sodium phosphate buffer, pH 7.4 (APPENDIX 2A) 0.5 mM EDTA Store with above components at 0° to 4°C up to 1 week; check pH before use and adjust if necessary 0.1 mM phenymethanesulfonyl fluoride (PMSF; add immediately before use as described below) PMSF is unstable in aqueous solution and must be added to the buffer immediately before use. This is done by adding a suitable volume of a 100 mM PMSF solution in acetone to a small quantity (approximately one-tenth of the final volume) of boiling buffer, and immediately mixing this solution with the remainder of the ice-cold buffer.
COMMENTARY Background Information
Purification of Glutamate Dehydrogenase from Liver and Brain
There are several factors that must be considered in the choice of a purification procedure. The major factors are how much enzyme is needed for the planned studies, how long the procedure will take, and how much it will cost. To these should be added the question of whether the purified enzyme is different from the material that was in the tissues to start with. As discussed below, GDH purified by some older procedures has been shown to have undergone limited proteolysis, which alters its kinetic and regulatory behavior. Clearly, such preparations can give misleading information about the behavior of the enzyme.
Several alternative procedures have been used to purify GDH from different mammalian sources. The procedures described in this unit are preferable to the earlier procedures that involved precipitation with ethanol or acetone and/or detergent extraction followed by fractional precipitation with ammonium sulfate and/or sodium sulfate (see e.g., Fahien et al., 1969). Although that procedure resulted in a crystalline preparation of the enzyme, it has been shown that limited proteolysis results in a loss of a tetrapeptide from the amino-terminal end of the protein (McCarthy et al., 1980). This modification, which results in a slightly faster mobility on SDS (0.1% w/v) PAGE in 13%
1.4.26 Supplement 29
Current Protocols in Protein Science
polyacrylamide gels (McCarthy et al., 1980), significantly affects the kinetic behavior of the enzyme (McCarthy and Tipton, 1984) and its in teraction s with allosteric effectors (McCarthy and Tipton, 1985; Couée and Tipton, 1989a) and with antipsychotic drugs such as perphenazine (Couée and Tipton, 1990a,b). An obvious alternative to the hard work of purifying an enzyme is to buy it from a commercial source. Purified preparations of ox (beef) liver GDH have been available from several commercial sources: BoehringerMann heim (n ow Ro ch e Diagn ostics, Mannheim), Calbiochem, PL Biochemicals (now Pharmacia P-L Biochemicals), Sigma, and United States Biochemical (USB), although some of these sources no longer supply purified preparations of GDH. However, the authors have found the enzyme from all these sources to have suffered the same, or more, proteolytic modification as that suffered by the enzyme prepared by the earlier procedures discussed above (see McCarthy et al., 1980). Cloning and expression of GDH is an alternative source of enzyme (Shashidharan et al., 1994; Plaitakis et al., 2000). An expression system has the advantage that it permits site-directed mutagenesis studies (see Fang et al., 2002; Zaganas and Plaitakis, 2002). It is also, of course, useful in cases where there are rather small quantities of enzyme in the chosen source material. This is not the case with the major isoform of GDH (GLUD1) in liver, but it is the case for the so-called “nerve tissue–specific” form (GLUD2) which is present in much lower abundance in the brain (see Zaganas and Plaitakis, 2002). It is still necessary to purify such an expressed enzyme if one needs to work with a homogeneous preparation. In some cases, this can be facilitated by the insertion of a tag into the gene to be expressed. Such tags range from oligohistidine tails to another protein, such as glutathione-S-transferase. It is common not to remove a tag after purification, and indeed in some cases it is not easy to do so. The assumption that the presence of such a tag will not affect the behavior of the expressed enzyme may sometimes be true, but it is certainly not always so (see e.g., Halliwell et al., 2001; Hiser et al., 2001; Ledent et al., 1997). In the case of GDH, as already discussed, modification at the amino-terminal end results in alterations in its behavior, and the C-terminal region appears to be involved in its allosteric regulation (Peterson and Smith, 1999). This suggests that expression of the protein with a tag at either end would be
likely to produce artefactual results. Indeed, it is necessary to use conventional procedures, involving a GTP affinity column, to purify the enzyme after cloning and expression (see Fang et al., 2002; Zaganas and Plaitakis, 2002). To assess the purity of the protein, polyacrylamide gel electrophoresis (PAGE) in the presence and absence of sodium dodecyl sulfate (SDS) remains the accepted standard for assessing protein purity (UNITS 10.2-10.4). The hexameric glutamate dehydrogenase from ox and some other mammalian species forms higher aggregates at higher protein concentrations (see, e.g., McCarthy et al.,1981). Although this process is reversible, with a dissociation constant of ∼1 mg/ml (Cohen et al., 1976), it hampers attempts to determine the behavior on nondenaturing PAGE. However PAGE in the presence of SDS reveals that the enzyme prepared as described here contains only a few minor impurities (see McCarthy et al., 1980).
Critical Parameters and Troubleshooting
A critical aspect of protein purification procedures is to have everything that will be needed prepared in advance. For example, it is a recipe for disaster to finish one step and then find that the column needed for the next has not yet been equilibrated. Many enzymes are relatively unstable and susceptible to degradation by contaminating peptidases. Generally, to avoid losses of enzyme activity, the procedure should be completed as rapidly as possible. The essence of any robust purification procedure is that any minor problems with one step are corrected by the others. Thus, for example, a somewhat lower degree purification on the DEAE-cellulose column may be compensated for in the affinity-chromatographic step. Some problems that are common to many purification procedures are listed below. Failure to use the highest purity reagents. Analytical grade chemicals should be used for such procedures as preparing buffers and ammonium sulfate precipitation. Less pure materials may contain compounds that inhibit enzyme activity. Working at the wrong temperature. Most of the procedures involved should be executed at 0° to 4°C. This is most easily accomplished in a cold room, although cooling the material in an ice bucket is satisfactory for some steps. Performing those steps at higher temperatures will result in enzyme inactivation. Overzealous stirring. This can cause frothing of protein solutions, which results in some
Strategies of Protein Purification and Characterization
1.4.27 Current Protocols in Protein Science
Supplement 29
Purification of Glutamate Dehydrogenase from Liver and Brain
denaturation. Stirring speeds should be fast enough to ensure adequate mixing, but no faster; if frothing does occur the stirring is too fast. Note that some frothing does occur during steps 1 and 2 of Basic Protocol 1, but this does not result in significant losses of GDH activity, probably because of the high protein concentrations at those stages. Failure to equilibrate chromatographic columns. Equilibration can be judged to have occurred when the pH and conductivity of the out-flowing buffer is the same as that of the in-flowing equilibration buffer. To use a column before complete equilibration has occurred will usually result in poor resolution of the sample components. Using a chromatographic column that is too old. The degradation of GTP-Sepharose after ∼6 months of storage is discussed in Support Protocol 4. DEAE-cellulose is quite stable if stored under the conditions described in Support Protocol 4. However, with time, the accumulation of tightly-bound material may affect the performance of columns, in which case the recycling procedure outlined in Support Protocol 4 should be used, or, alternatively, fresh DEAE cellulose can be used. Failure to check that the pH of buffers is correct. The pH should be adjusted at the temperature at which it will be used. Some buffers contain additional components, such as EDTA, and the pH should be checked and, if necessary, adjusted after all ingredients have been added. Failure to desalt samples before chromatographic steps. The presence of high concentrations of salt may prevent compounds of interest from binding to the column. In all cases where the enzyme is meant to bind to the column, it is important to retain the material that passes unretarded through the column and to assay it for enzyme activity as soon as possible. If material that should have bound passes straight through the column, it may be possible to rescue it by further desalting and application to a freshly equilibrated column. If in doubt about effective desalting, check the conductivity. The flow rate through the column is very slow, or there is apparently no flow at all. Do not load the enzyme-containing material onto a column that is running more slowly than specified. Very slow flow rates may occur if the material in the column has become compacted. This can arise if the column is run at too high a pressure. Always follow the manufacturers’ instructions about the maximum hydrostatic pressure that can be applied, and do not exceed that value. The accumulation of denatured material at the top of
a column can also slow the flow rate. This may be rectified by removing some of the chromatographic material from the top of the column, which is often identifiable by discoloration, adding an equivalent amount of fresh material, and repacking the column (see Support Protocol 4). In the case of DE-52 DEAE-cellulose, failure to remove the “fines” before using the resin (see Support Protocol 5) can result in inadequate flow rates. Flow rates through columns that are flowing well are likely to slow considerably if the sample applied contains appreciable amounts of particulate material. If particulate material is present, it should be removed by centrifugation, or, where appropriate, filtration, before the sample is applied to the column. Air bubbles or cracks are present in columns. This can result in the applied material not coming into adequate contact with the chromatographic material. Air bubbles can occur all too easily in gel-filtration media (e.g., Sephadex and Sepharose, including GTP-Sepharose) unless the manufacturer’s instructions for packing the material into columns are heeded. Cracks can occur if the material in the column is allowed to dry out. If that occurs, the only solution is to remove the material from the column, rehydrate and reequilibrate it, and then repack the column. The following subsections discuss only those steps where difficulties may be encountered through causes other than those discussed above. Should the enzyme lose activity or the final product have a specific activity significantly lower than expected, comparison of the data for each step with those shown in Tables 1.4.5 and 1.4.6 for Basic Protocol 1, or Tables 1.4.7 and 1.4.8 for the Alternate Protocol, should indicate where the problem occurred. Basic Protocol 1: purification of GDH involving affinity chromatography on GTP-Sepharose Ammonium sulfate precipitation. Too rapid addition of solid ammonium sulfate can result in high local concentrations of the salt, causing excess precipitation of material that does not all redissolve. In the present procedure, homogenization between additions minimizes this problem. If the solid ammonium sulfate salt contains lumps, break these up using a pestle and mortar before using it. It is possible to perform the precipitation by continuously stirring the enzyme solution in a beaker and adding the ammonium sulfate to it. If this approach is used, the salt should be added very slowly, over a period of 1 to 2 hr, to minimize the above problem. In either proce-
1.4.28 Supplement 29
Current Protocols in Protein Science
Table 1.4.5 Protocol 1
Purification of Glutamate Dehydrogenase From Ox Brain According to Basic
Stage (see Fig. 1.4.1)
Volume (ml)
Total protein Total activity (mg) (µmol/min)
1500 1100 250 600 90
75,000a 23,000a 6200a 320b 12.5b
1 2 3 4 5
2280 1150 925 775 500
Specific activity Purification (µmol/min/mg) (x-fold) 0.03 0.05 0.15 2.4 40
1 2 5 80 1300
Yield (%) 100 50 41 33 22
aProtein concentration determined by the biuret procedure. bProtein concentration determined from the absorbance at 280 nm.
Table 1.4.6 Purification of Glutamate Dehydrogenase From Ox Liver According to Basic Protocol 1
Stage (see Fig. 1.4.1) 1 2 3 4 5
Volume (ml)
Total protein Total activity (mg) (µmol/min)
500 450 160 500 90
6000a 2500a 880a 150b 25b
1800 15000 1410 1200 1000
Specific activity Purification (µmol/min/mg) (x-fold) 0.3 0.6 1.6 8.0 40
1 2 5 25 120
Yield (%) 100 85 75 67 55
aProtein concentration determined by the biuret procedure. bProtein concentration determined from the absorbance at 280 nm.
Table 1.4.7 Protocol 1
Purification of Glutamate Dehydrogenase From Ox Liver According to Alternate
Stage (see Fig. 1.4.4)
Volume (ml)
Total protein Total activity (mg)a (µmol/min)
370 75 8.4 1.2
8580 2010 139 9.4
1 2 3 4
1920 1640 408 376
Specific activity Purification (µmol/min/mg) (x-fold) 0.2 0.3 2.9 40
1 4 13 180
Yield (%) 100 86 21 20
aProtein concentration determined by the Lowry method.
Table 1.4.8 Purification of Glutamate Dehydrogenase From Rat Liver According to Alternate Protocol 1
Stage (see Fig. 1.4.4) 1 2 3 4
Volume (ml)
Total protein Total activity (mg)a (µmol/min)
90 35 9.8 1.0
2720 980 130 9.4
760 505 195 190
aProtein concentration determined by the Lowry method.
Specific activity Purification (µmol/min/mg) (x-fold) 0.3 0.5 1.5 37
1 2 5 140
Yield (%) 100 67 26 25
Strategies of Protein Purification and Characterization
1.4.29 Current Protocols in Protein Science
Supplement 29
dure, it is important to continue to stir for 20 to 30 min after the last ammonium sulfate addition, to ensure that any overprecipitated material has a chance to redissolve and that any material that should precipitate at that salt concentration does so. The use of a homogenizer during this stage has proven to be effective, but it is not recommended for ammonium sulfate fractionation of purer material, since excessive frothing can result in denaturation. Addition of ammonium sulfate will result in a decrease in pH. For GDH purification, it is not necessary to adjust the pH to the starting value between each addition of ammonium sulfate, although such readjustment is necessary for many other enzymes. Dialysis and concentration. Provided that the dialysis tubing is pretreated as described in UNIT 4.4 and APPENDIX 3B and that it has been tested for leaks, there should be no difficulties with these procedures. It should be stressed again that an air-free space should be left at the top of the knotted dialysis tube, because volume increases during dialysis can otherwise cause the bag to rupture. The concentration procedures should not cause difficulties if the directions given in Support Protocol 6 are followed. Chromatography on DEAE cellulose. Common difficulties with this step have been discussed in the general points at the beginning of this section. Chromatography on GTP-Sepharose. If the GDH enzyme does not bind to the column and the troubleshooting points at the beginning of this section have been taken into account, the likely causes are either that the affinity resin has degraded (see Support Protocol 4) or that there was a problem with its preparation. In first case, the GTP-Sepharose should be replaced by fresh material. If there has been a problem with its preparation, a fresh batch should be prepared using the procedure described in Support Protocol 1 to check for effective GTP coupling. Choice of reaction buffer. As indicated in Basic Protocol 1, the enzyme is unstable in the Tris/acetate buffer and losses of activity can occur if the enzyme is left in that buffer for extended periods.
Purification of Glutamate Dehydrogenase from Liver and Brain
Basic Protocol 3: assay of glutamate dehydrogenase activity In all cases, it will be necessary to dilute the enzyme preparation in order to obtain a rate that is sufficiently slow to measure with accuracy. The amount of dilution will depend on the state of purification of the enzyme, its protein concentation, and also the scale expansion used on
the spectrophotometer. For example, the crude homogenate of liver GDH has a specific activity of 0.3 µmol/min/mg protein (see Table 1.4.6). Since the production of 1 µmol of glutamate in the assay will give an absorbance change of 2.073 (see Basic Protocol 3, annotation to step 5) , 1 mg of this material will give an absorbance decrease, in 1 min, of 0.3 × 2.073 ≈ 0.62. The protein concentration of this crude homogenate is ∼12 mg/ml (see Table 1.4.6); therefore, 50 µl of this would contain 0.6 mg protein, and would be expected to give an absorbance change of ∼0.373 absorbance units per min. This would mean that the reaction would be finished in <3 min, which would be too fast for accurate initial-rate determinations. See, for example, Tipton (2002) for a fuller treatment of enzyme assays and initial-rate determinations. Dilution of this material 20× with the assay buffer before adding 50 µl to the assay would give an absorbance change of 0.01865 absorbance units per min, which would mean that it would take a little over 8 min for the absorbance to fall by 0.15 absorbance units. Similar calculations from the values in Table 1.4.6 for the purified liver GDH show that a dilution factor of 600 would be necessary so that a 50-µl volume added to the assay would give a rate similar to that given by the crude enzyme. The appropriate dilution factors for the other stages of purification and for the brain enzyme can be estimated from the date given in Tables 1.4.6 and 1.4.5, respectively. It should be noted that these numbers are only a rough guide, since the degree of purification and protein concentration may vary for individual steps of the purification. The addition of smaller volumes of the enzyme preparation to the assay will reduce the degree of dilution necessary. Alternate Protocol: purification of GDH involving affinity precipitation with bis-NAD+ The initial steps in this procedure are the same as those of Basic Protocol 1. Affinity precipitation. A pilot-scale precipitation, as described in Support Protocol 9, should always be carried out to determine the optimum concentration of bis-NAD+ to use. Figure 1.4.6 shows an example of a concentration-precipitation relationship, but it should be remembered that the optimum bis-NAD+ concentration may vary with protein concentration. Failure to obtain affinity precipitation could result from: 1. A fault in the synthesis of the bifunctional ligand. Monitoring the success of each step in the preparatory procedure using the pro-
1.4.30 Supplement 29
Current Protocols in Protein Science
cedures outlined in Support Protocol 8 and the data in Table 1.4.2, should reveal any problems in this respect and where they occur. 2. Attempting to precipitate from a solution containing too low a concentration of GDH (see Fig. 1.4.7). Further concentration of the enzymecontaining sample should deal with this problem. Stability The enzyme, stored as described in Basic Protocol 1, is stable for at least 6 months without significant loss of activity or alteration of its mobility on a 13% polyacrylamide gel in the presence SDS. This is important in view of the relatively large amounts of purified GDH that can be prepared. However, changes can occur in its responses to allosteric effectors when the enzyme is stored in an atmosphere of air (Couée and Tipton, 1991). These changes, which may only become apparent after 2 to 3 months, are prevented by storing the enzyme solution under an atmosphere of nitrogen, and tubes containing stored GDH preparations should be routinely flushed with N2 each time they are opened. Safety All personnel involved should have received training in safe laboratory procedures and in the use of radioactive materials if Support Protocol 2 (involving radiolabeled GTP) is to be used. National and local regulations for the disposal of such materials as radiochemical waste and or-
Anticipated Results Basic Protocol 1: purification of ox brain or liver glutamate dehydrogenase involving affinity chromatography on GTP-Sepharose Tables 1.4.5 and 1.4.6 summarize the results obtained from typical purifications of the ox brain and liver enzymes using this procedure.
A280 nm ( ) conductivity ( ) GDH Activity ( )
6
8 4 6 2
GDH activity (µmol/min/ml)
Conductivity (mS)
10
ganic solvents should be followed. Several of the compounds used in these procedures are highly toxic and should be handled with great care. Toxicity information on these compounds is available from the manufacturers (e.g., Sigma-Aldrich at https://www.sigma-aldrich. com) and should be consulted in advance. For the use of animal materials, precautions against infectious and transmissible diseases are necessary. It is advisable that personnel be immunized against such diseases where appropriate. Although the ox tissue samples that the authors have used recently have been certified as being BSEfree, the initial steps of the purification are still performed under biohazard containment, protection and disposal conditions. It is essential that those steps indicated in Support Protocols 1 and 3 be performed under an adequately functioning, biohazard-containment level II fume hood. Safety glasses should be worn, and, in connection with the TLC procedure in Support Protocol 8, these should provide protection from UV light.
4
0 50
100 Fraction number
150
Figure 1.4.8 Chromatography of ox liver glutamate dehydrogenase at step 3 of Basic Protocol 1. A typical elution profile is shown. However the exact behavior may vary between preparations. The fraction size was ∼10 ml. In the left-hand y-axis label, mS stands for millisiemens.
Strategies of Protein Purification and Characterization
1.4.31 Current Protocols in Protein Science
Supplement 29
A280 nm ( ) conductivity ( ) GDH Activity ( )
12
10
2.0
8 30
A280
1.5
1.0
20
10
0.5
Conductivity (mS)
6
4
2
Glutamate dehydrogenase activity (µ mol/min/ml)
2.5
0 15
30 Fraction number
45
Figure 1.4.9 A typical elution profile of affinity chromatography of ox liver glutamate dehydrogenase on GTP-Sepharose at step 4 of Basic Protocol 1. The exact chromatographic behavior may vary between preparations. The fraction size was ∼10 ml. In the label for the inset scale, mS stands for millisiemens.
Examples of the elution profiles from DEAE-cellulose and GTP-Sepharose are shown in Figures 1.4.8 and 1.4.9.
Time Considerations
Day 3: Gel filtration into the GTPSepharose buffer, passage through the hydrazide gel column, and affinity chromatography on GTP-Sepharose. This schedule excludes the time taken to prepare the GTP-Sepharose. This should take 3 days or less, starting from CNBr-activated Sepharose. However much of this time is taken up by incubations, such as the 16- to 18-hr reaction of L-glutamic acid γ-methyl ester with the activated gel (see Support Protocol 1). The affinity resin, once made, can be used several times.
Basic Protocol 1: purification of ox brain or liver glutamate dehydrogenase involving affinity chromatography on GTP-Sepharose The entire purification procedure can easily be performed in 3 days. Day 1: Extraction and ammonium sulfate precipitation, followed by overnight dialysis. Day 2: DEAE-cellulose fractionation and concentration of appropriate column fractions.
Alternate Protocol: purification of rat or ox liver GDH involving affinity precipitation with bis-NAD+ This is a somewhat quicker procedure than Basic Protocol 1 because it avoids the final column chromatography steps. However, it still extends into several days. The first two of these are the same as those for Basic Protocol 1, and the third is for the pilot-scale precipitation study and the affinity precipitation itself. The preparation of bis-NAD+ can be completed in 4 days, provided that the reaction
Alternate Protocol: purification of rat or ox liver GDH involving affinity precipitation with bis-NAD+ Tables 1.4.7 and 1.4.8 summarize the results obtained from typical purifications of the ox and rat liver enzymes using this procedure. The time estimates given below do not include the time involved in pouring and equilibrating the chromatographic columns, which should be done before the purification procedure is started.
Purification of Glutamate Dehydrogenase from Liver and Brain
1.4.32 Supplement 29
Current Protocols in Protein Science
between iodoacetate and NAD+ is performed at 37°C (see Support Protocol 7). Once prepared, the bis-NAD+ may be used for several GDH preparations, as well as for the purification of some other dehydrogenases (see Irwin and Tipton, 1996)
Literature Cited
Beattie. R.E., Buchanan, M.,. and Tipton K.F. 1987. The synthesis of N2, N2-adipodihydrazido-bis(N-carboxymethyl-ATP) and its use in the purification of phosphofructokinase. Biochem. Soc. Trans. 15:1043-1044. Cho, S.W., Lee, J., and Choi, S.Y. 1995. Two soluble forms of glutamate dehydrogenase isoproteins from bovine brain. Eur. J. Biochem. 233:340-346. Cohen, R.J., Jedziniak, J.A., and Benedek, G.B. 1976. The functional relationship between polymerization and catalytic activity of beef liver glutamate dehydrogenase. II. Experiment. J. Mol. Biol. 108:179-199. Couée, I. and Tipton, K.F. 1989a. Activation of glutamate dehydrogenase by L-leucine. Biochim. Biophys. Acta 995:97-101. Couée, I. and Tipton, K.F. 1989b. The effects of phospholipids on the activation of glutamate dehydrogenase by L-leucine. Biochem. J. 261:921-925. Couée, I. and Tipton, K.F. 1990a. The inhibition of glutamate dehydrogenase by some antipsychotic drugs. Biochem. Pharmacol. 39:827-832. Couée, I. and Tipton, K.F. 1990b. Inhibition of ox brain glutamate dehydrogenase by perphenazine Biochem. Pharmacol. 39:1167-1173. Couée, I. and Tipton, K.F. 1991. The sulphydryl groups of ox brain and liver glutamate dehydrogenase preparations and the effects of oxidation on their inhibitor sensitivities.. Neurochem. Res. 16:773-780. Dawson, R.M.C., Elliott, D.C., Elliott ,W.H., and Jones, K.M. 1989. Data for Biochemical Research, 3rd ed. Clarendon Press, Oxford. Engel, J.D. 1975. Mechanism of the Dimroth rearrangement in adenine. Biochem. Biophys. Res. Commun. 64:581 - 585. Fahien, L.A., Strmecki, M., and Smith, S. 1969. Studies of gluconeogenic mitochondrial enzymes. I. A new method of preparing bovine liver glutamate dehydrogenase and effects of purification methods on properties of the enzyme. Arch. Biochem. Biophys. 130:449-455. Fang, J., Hsu, B.Y., MacMullen, C.M., Poncz, M., Smith, T.J., and Stanley, C.A. 2002. Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations. Biochem J. 363:81-87. Flygare, S., Griffin, T., Larsson, P.O., and Mosbach, K. 1983. Affinity precipitation of dehydrogenases. Anal. Biochem. 133:409-416. Godinot, C, Julliard, J.H., and Gautheron, D.C. 1974. A rapid and efficient new method of purification of glutamate dehydrogenase by affinity
chromatography on GTP-sepharose. Anal. Biochem. 61:264-270. Graham, L.D., Griffin, T.O., Beattie, R..E., McCarthy, A..D., and Tipton, K.F. 1985. Purification of liver glutamate dehydrogenase by affinity precipitation and studies on its denaturation. Biochim. Biophys. Acta 828:266-269. Hahn-Deinstrop, E. 2000. Applied Thin-Layer Chromatography: Best Practice and Avoidance of Mistakes. Wiley-VCH, Weinheim, Germany. Halliwell, C.M., Morgan, G., Ou, C.P., and Cass, A.E. 2001. Introduction of a (poly)histidine tag in L-lactate dehydrogenase produces a mixture of active and inactive molecules. Anal. Biochem. 295:257-261. Hiser, C., Mills, D.A., Schall, M., and FergusonMiller, S. 2001. C-terminal truncation and histidine-tagging of cytochrome c oxidase subunit II reveals the native processing site, shows involvement of the C-terminus in cytochrome c binding, and improves the assay for proton pumping. Biochemistry 40:1606-1615. Irwin, J.A., and Tipton, K.F. 1996. Affinity precipitation methods. In Methods in Molecular Biology 59: Protein Purification Protocols (S. Doonan, ed.) pp. 217-238. Humana Press, Totowa, N.J. Jackson, R.J., Wolcott, R.M., and Shiota, T. 1973. The preparation of a modified GTP-sepharose derivative and its use in the purification of dihydroneopterin triphosphate synthetase, the first enzyme in folate biosynthesis. Biochem Biophys. Res. Commun. 51:428-435. Larsson, P.O., Flygare, S., and Mosbach, K. 1984. Affinity precipitation of dehydrogenases. Methods Enzymol. 104:364-349. Ledent, P., Duez, C., Vanhove, M., Lejeune, A., Fonze, E., Charlier, P., Rhazi-Filali, F., Thamm, I., Guillaume, G., Samyn, B., Devreese, B., Van Beeumen, J., Lamotte-Brasseur, J., and Frere J.M. 1997. Unexpected influence of a C-terminal-fused His-tag on the processing of an enzyme and on the kinetic and folding parameters. FEBS Lett. 413:194-196. Lee, W.K., Shin, S., Cho, S.S., and Park, J.S. 1999. Purification and characterization of glutamate dehydrogenase as another isoprotein binding to the membrane of rough endoplasmic reticulum. J. Cell. Biochem. 76:244-253. McCarthy, A.D. and Tipton, K.F. 1984. The effects of magnesium ions on the interactions of ox brain and liver glutamate dehydrogenase with ATP and GTP. Biochem. J. 220:853-855. McCarthy, A.D. and Tipton, K.F. 1985. Ox liver glutamate dehydrogenase: Comparison of the kinetic properties of native and proteolysed preparations. Biochem. J. 230:95-99. McCarthy, A.D., Walker, J.M., and Tipton, K.F. 1980. Purification of glutamate dehydrogenase from ox brain and liver: Evidence that commercially available preparations of the enzyme have suffered proteolytic cleavage. Biochem. J. 191:605-611.
Strategies of Protein Purification and Characterization
1.4.33 Current Protocols in Protein Science
Supplement 29
McCarthy, A.D., Johnson, P., and Tipton, K.F. 1981. Sedimentation properties of native and proteolysed preparations of ox glutamate dehydrogenase. Biochem. J. 199:235-236. McDaniel, H.G. 1995. Comparison of the primary structure of nuclear and mitochondrial glutamate dehydrogenase from bovine liver. Arch. Biochem. Biophys. 319:316-321. Mulcahy, P. and O’Flaherty, M. 2001. Kinetic locking-on strategy and auxiliary tactics for bioaffinity purification of NAD(P)(+)-dependent dehydrogenases. Anal. Biochem. 299:1-18. O’Carra, P., Griffin, T., O’Flaherty, M., Kelly, N., and Mulcahy, P. 1996. Further studies on the bioaffinity chromatography of NAD(+)-dependent dehydrogenases using the locking-on effect. Biochim. Biophys. Acta 1297:235-243. O’Flaherty, M., O’Carra, P., McMahon, M., and Mulcahy, P. 1999. A “stripping” ligand tactic for use with the kinetic locking-on strategy: Its use in the resolution and bioaffinity chromatographic purification of NAD(+)-dependent dehydrogenases. Protein Expr. Purif. 16:424-431.
Purification of Glutamate Dehydrogenase from Liver and Brain
Approach (R. Eisenthal and M.J. Danson, eds.) pp. 1-47. Oxford University Press, Oxford, U.K. Tipton, K.F. and Couée, I. 1988. Glutamate dehydrogenase. In Glutamine and Glutamate in Mammals. (E. Kvamme, ed.) pp.81-100. CRC Press, Baton Roca, Fla. Wilson, K. and Walker, J. (eds.) 2000. Principles and Techniques of Practical Biochemistry, 5th ed.. Cambridge University Press, Cambridge, U.K. Yoon, H.Y., Hwang, S.H., Lee, E.Y., Kim, T.U., Cho, E.H., and Cho, S.W. 2001. Effects of ADP on different inhibitory properties of brain glutamate dehydrogenase isoproteins by perphenazine. Biochimie 83:907-913. Zaganas, I. and Plaitakis, A. 2002. A single amino acid substitution (Gly456Ala) in the vicinity of the GTP binding domain of human housekeeping glutamate dehydrogenase markedly attenuates GTP inhibition and abolishes the enzyme’s cooperative behavior. J. Biol. Chem. 277:2642226428.
Key References
Peterson, P.E. and Smith, T.J. 1999. The structure of bovine glutamate dehydrogenase provides insights into the mechanism of allostery. Structure Fold. Des. 15:769-782.
Glutamate dehydrogenase
Plaitakis, A. and Zaganas, I. 2001. Regulation of human glutamate dehydrogenases, implications for glutamate, ammonia and energy metabolism in brain. J. Neurosci. Res. 66:899-908.
There have been few comprehensive reviews of glutamate dehydrogenase in recent years. The references cited above cover some fundamental aspects.
Plaitakis, A., Metaxari, M., and Shashidharan, P. 2000. Nerve tissue-specific (GLUD2) and housekeeping (GLUD1) human glutamate dehydrogenases are regulated by distinct allosteric mechanisms: Implications for biologic function. J. Neurochem. 75:1862-1869.
Affinity chromatography
Preiss, T., Hall, A.G., and Lightowlers, R.N. 1993. Identification of bovine glutamate dehydrogenase as an RNA-binding protein. J. Biol. Chem. 268:24523-24526.
Affinity precipitation
Rajas, F. and Rousset, B. 1993. A membrane-bound form of glutamate dehydrogenase possesses an ATP-dependent high-affinity microtubule-binding activity. Biochem. J. 295:447-455.
Describes the theory underlying affinity precipitation and reviews its applications.
Shashidharan, P., Michaelides, T.M., Robakis, N.K., Kretsovali, A., Papamatheakis, J., and Plaitakis, A. 1994. Novel human glutamate dehydrogenase expressed in neural and testicular tissues and encoded by an X-linked intronless gene. J. Biol. Chem. 269:16971-16976
Contributed by Martha Motherway and Keith F. Tipton Department of Biochemistry Trinity College Dublin, Ireland
Shashidharan, P., Clarke, D.D., Ahmed, N., Moschonas, N., and Plaitakis, A. 1997. Nerve tissue-specific human glutamate dehydrogenase that is thermolabile and highly regulated by ADP. J. Neurochem. 68:1804-1811.
Alun D. McCarthy GlaxoSmithKline Middlesex, United Kingdom
Smith, T.J., Peterson, P.E., Schmidt, T., Fang, J., and Stanley, C.A. 2001. Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation. J. Mol. Biol. 307:707-720.
Plaitakis, A. and Zaganas, I. 2001. See above. Tipton, K.F. and Couée, I. 1988. See above.
Matejtschuk, P. (ed.) 1997. Affinity Separations: A Practical Approach. Oxford University Press, U.K. A collection of chapters on the theory and practice of different aspects of affinity chromatography.
Irwin, J.A. and K.F. Tipton, K.F. 1995. Affinity precipitation: A novel approach to protein purification. Essays Biochem. 29:137-156.
Ivan Couée Centre National de la Recherche Scientifique Rennes, France Jane Irwin University College Dublin Dublin, Ireland
Tipton K.F. 2002. Principles of enzyme assay and kinetic studies. In Enzyme Assays: A Practical
1.4.34 Supplement 29
Current Protocols in Protein Science
Overview of the Physical State of Proteins Within Cells The word protein comes from the Greek word proteios, meaning primary. And, indeed, proteins are of primary importance in the study of cell function. It is difficult to imagine a cellular function not linked with proteins. Almost all biochemical catalysis is carried out by protein enzymes. Proteins participate in gene regulation, transcription, and translation. Intracellular filaments give shape to a cell while extracellular proteins hold cells together to form organs. Proteins transport other molecules, such as oxygen, to tissues. Antibody molecules contribute to host defense against infections. Protein hormones relay information between cells. Moreover, protein machines, such as actin-myosin complexes, can perform useful work, including cell movement. Thus, studying proteins is a prerequisite in understanding cell structure and function. The physical characterization of proteins began well over 150 years ago with Mulder’s characterization of the atomic composition of proteins. In the latter half of the nineteenth century Hoppe-Seyler (1864) crystallized he-
UNIT 1.5
moglobin and Kühn (1876) purified trypsin. A variety of physical methods have been developed over the years to increase convenience and precision in the characterization and isolation of proteins. These include ultracentrifugation, chromatography, electrophoresis, and others. In many instances our understanding of cell proteins parallels the introduction and use of new techniques to examine their structure and function.
PROTEIN CLASSIFICATIONS All proteins are constructed as a linear sequence(s) of various numbers and combinations of ∼20 α-amino acids joined by peptide bonds to form structures from thousands to millions of daltons in size. Proteins are the most complex and heterogeneous molecules found in cells, where they account for >50% of the dry weight of cells and ∼75% of tissues. Proteins can be classified into three broad groups: globular, fibrous, and transmembrane (Fig. 1.5.1; Table 1.5.1). Globular proteins are, by definition, globe-shaped, although in prac-
globular
fibrous
Figure 1.5.1 General classifications of proteins. In these schematic representations of globular, fibrous, and transmembrane proteins, hydrophobic regions are shaded. Note that the disposition of hydrophobic residues often reflects the protein class.
transmembrane
Strategies of Protein Purification and Characterization Contributed by Howard R. Petty Current Protocols in Protein Science (2002) 1.5.1-1.5.10 Copyright © 2002 by John Wiley & Sons, Inc.
1.5.1 Supplement 31
Table 1.5.1
Broad Classifications for Proteinsa
Type
Location/type
Examples
Globular
Intracellular
Hemoglobin, lactate dehydrogenase, cytochrome c Serum albumin, immunoglobulins, lysozyme
Extracellular Fibrous
Intracellular Extracellular
Transmembrane
Single pass Multipass
Intermediate filaments, tropomyosin, lamins Collagen, keratin, elastins Insulin receptor, glycophorin, HLAsb Glucose transporter, rhodopsin, acetylcholine receptor
aAdditional information regarding fibrous and transmembrane proteins can be found in Squire
and Vibert (1987) and Petty (1993). Information concerning globular proteins can be found in numerous books on proteins and enzymes such as Schultz and Schirmer (1979). bHuman histocompatibility leukocyte antigens.
tice they can be spherical or ellipsoidal. Globular proteins are generally soluble in aqueous environments. Examples of globular proteins are hemoglobin, serum albumin, and most enzymes. Fibrous proteins are elongated linear molecules that are generally insoluble in water and resist applied stresses and strains. Collagen is a physically tough molecule of connective tissue. Just as collagen gives strength to connective tissues, intermediate filaments linked to desmosomes give strength to cells in tissues. The third general class of proteins, transmembrane proteins, contain a hydrophobic sequence buried within the membrane; these proteins are discussed more fully below (see Membrane Proteins). These protein categories are not mutually exclusive. For example, the nominally fibrous intermediate filament proteins also have globular domains. Similarly, transmembrane proteins almost always possess globular domains. Thus, these definitions serve as a useful guide but should not be rigidly applied.
HYDROPATHY PATTERNS OFTEN REFLECT A PROTEIN’S CLASSIFICATION
Overview of the Physical State of Proteins Within Cells
A key physical feature of proteins is their hydropathy pattern (i.e., the distribution of hydrophobic and hydrophilic amino acid residues). Indeed, hydrophobic interactions provide the primary net free energy required for protein folding. Figure 1.5.1 illustrates the disposition of hydrophobic amino acids in proteins. In an intact globular protein, hydrophobic
amino acids are generally shielded from the aqueous environment by coalescing at the center of the molecule, with the more hydrophilic residues exposed at its surface. However, the linear arrangement of hydrophobic residues fluctuates in an apparently random fashion. The α helices within globular proteins may express a hydrophobic face oriented toward the center of the protein. (Within these helices hydrophobic residues are nonrandomly positioned every three or four amino acids to yield a hydrophobic face.) For coiled-coil α helix–containing fibrous proteins, such as tropomyosin and αkeratin, hydrophobic residues at periodic intervals allow close van der Waals contact of the chains and potentiate assembly as hydrophobic residues are removed from the aqueous environment (Schulz and Schirmer, 1979; Parry, 1987). Secondarily, regularly spaced charged groups can also contribute to the shape of fibrous proteins (Schulz and Schirmer, 1979; Parry, 1987). Transmembrane proteins provide a rather different physical arrangement of hydrophobic residues in which hydrophobic residues are collected primarily into a series of amino acids that is embedded within a cell membrane. One important means of analyzing the hydropathy of a sequenced protein is a hydropathy plot (Kyte and Doolittle, 1982). In this method, each amino acid residue is assigned a hydropathy value, an ad hoc measure that largely reflects its relative aqueous solubility; these values are plotted after being averaged. The successful interpretation of hydropathy plots
1.5.2 Supplement 31
Current Protocols in Protein Science
depends on the parameters chosen for averaging. The parameters are the number of residues averaged (amino acid interval or “window”) and how many amino acids are skipped when calculating the next average (step size). Using this approach with a window of ∼10 residues, it is often possible to find the positions of hydrophobic residues coalescing near the interior of globular proteins. The method is particularly useful in predicting transmembrane domains of proteins, generally with a window of ∼20 amino acids. To detect the repetitious pattern of coiled-coil fibrous proteins, however, windows smaller than the repeat length would be required.
MEMBRANE PROTEINS In addition to their presence in the extracellular and intracellular milieus, proteins are also found in association with biological membranes. Proteins constitute one-half to threequarters of the dry weight of membranes. Membrane proteins perform a broad variety of functions including intermembrane and intercellular recognition, transmembrane signaling, most energy-harvesting processes, and biosynthesis in the endoplasmic reticulum (ER) and Golgi complex. Membrane proteins have been traditionally characterized as integral (or intrinsic) or peripheral (or extrinsic) on the basis of operational criteria. Peripheral membrane proteins are associated with membrane surfaces and can be dislodged from membranes using hypotonic or hypertonic solutions, pH changes, or chela-
Table 1.5.2
tion of divalent cations. Components of the erythrocyte membrane skeleton, for example, are peripheral membrane proteins. Although most peripheral proteins are removed by washing a sample with buffers, integral proteins cannot be removed by such treatments. To isolate integral membrane proteins, which are embedded within the lipid bilayer, one must use detergents that disrupt the bilayer and bind to the proteins, thus solubilizing them. In general, integral membrane proteins have a portion of their peptide sequence buried in the lipid bilayer whereas peripheral proteins do not. However, the discovery of glycosylphosphatidylinositol (GPI)-linked membrane proteins added to the ambiguity of the situation. GPI-linked proteins are globular proteins with no membrane-associated peptide sequence, yet they require harsh conditions for solubilization. As the technology for studying membrane proteins improved, it became necessary to develop a more precise vocabulary to describe membrane proteins. Transmembrane integral membrane proteins have at least one stretch of amino acids spanning a membrane. Membrane proteins are classified as type I, II, III, or IV depending on the nature of their biosynthesis and topology in membranes (Spiess, 1995; Table 1.5.2 and Fig. 1.5.2). The biosynthetic insertion of these proteins in membranes is, in turn, dependent on the presence or absence of a cleavable signal peptide, the relative positions of the hydrophobic transmembrane domain and positively charged topogenic signals, and/or
Definitions of Integral Transmembrane Proteins
Type
Definition
I
An N-terminal–cleavable signal peptide is removed at the luminal face yielding a luminal N terminal during biosynthesis. (Positive charges are found on C-terminal side of first long hydrophobic sequence after the signal peptide.) An N-terminal–uncleaved signal peptide leads to a cytoplasmic N terminus. (Positive charges are generally found on N-terminal side of first long hydrophobic sequence.) A long N-terminal hydrophobic sequence is followed by a sequence of positive charges. This leads to a luminal N terminus in the absence of a cleavable signal peptide. A short C terminus is present at the luminal side of membrane. A large N terminus is exposed at the cytoplasmic face.
II
III
IV
Examples LDL receptor, insulin receptor, glycophorin A, thrombin receptor
Transferrin receptor, sucrase/isomaltase, band 3
β-Adrenergic receptor, cytochrome P450
Synaptobrevin, UBC6
Strategies of Protein Purification and Characterization
1.5.3 Current Protocols in Protein Science
Supplement 30
transmembrane
nontransmembrane type I N
type II C
type III
type IV
N C
bilayer
exterior or lumen
cytosol
C
N
+ + +
C
+ + +
N
+ + +
C
N
Figure 1.5.2 Membrane proteins containing hydrophobic anchors. A nontransmembrane or monotopic membrane protein is anchored to the membrane via a hydrophobic amino acid sequence. Transmembrane proteins are classified as types I, II, III, and IV (Table 1.5.2). The first transmembrane segment of a multispanning membrane protein can be inserted as in type I, II, or III proteins. This segment functions as a start-transfer peptide. Subsequent transmembrane segments will function as stop-transfer and start-transfer sequences, resulting in a multispanning membrane topology.
Overview of the Physical State of Proteins Within Cells
the mechanism of nascent protein delivery to the ER. Type I membrane proteins are synthesized with an amino-terminal signal sequence that is inserted into the ER membrane. When the signal sequence is proteolytically removed in the ER lumen, a new luminal amino terminus is exposed. A series of positively charged residues at the C-terminal side of the first hydrophobic transmembrane domain following the signal sequence generally denotes the end of the first transmembrane domain (von Heijne and Gavel, 1988). Although a hydrophobic transmembrane domain followed by a positive sequence of amino acids is sufficient to act as a stop-transfer signal, this motif is not required for stoptransfer events and other, less well-understood regulatory mechanisms are also involved (Andrews and Johnson, 1996). Membrane proteins types I, II, and III are delivered to the ER membrane via a signal recognition particle (SRP)-dependent mechanism. In contrast to type I proteins, type II and III membrane proteins do not have a cleavable N-terminal signal sequence. Instead, they have an internal hydrophobic signal that acts as both a signal sequence for ER delivery and a transmembrane domain in the mature protein. Type II proteins have a cytoplasmic amino terminus and a luminal (or extracellular) carboxyl terminus. In this case a positively charged sequence
of amino acids at the N-terminal side of the first hydrophobic sequence causes the amino terminus to be retained at the cytoplasmic face of the ER membrane. Thus the internal uncleaved signal peptide becomes the transmembrane domain of the mature protein. Type III membrane proteins have the same overall topology as type I proteins, but they are inserted into membranes by a different mechanism. In type III proteins the first hydrophobic sequence of amino acids is immediately followed by a series of positively charged amino acids. Thus, the first hydrophobic sequence becomes the transmembrane domain of the protein, with the amino terminus at the luminal face of the membrane. Type IV membrane proteins are characterized by a large, cytoplasmically exposed amino-terminal domain and a short carboxylterminal domain facing the lumen. Importantly, these proteins are delivered to the ER by an unknown SRP-independent mechanism. In addition to the single-pass membrane proteins just described, integral membrane proteins can display zero, two, three, or more transmembrane domains. Some membrane proteins, such as cytochrome b5, have protein segments buried in the hydrophobic core of membranes but do not cross the membrane. Membrane proteins with multiple membranespanning domains are classified as type I, II, or
1.5.4 Supplement 30
Current Protocols in Protein Science
III depending on the topogenic signals in the first transmembrane domain. For example, a multispan membrane protein with a cleavable signal sequence, luminal amino terminal, and a positively charged sequence following the first transmembrane domain from the amino terminal, such as the thrombin receptor, is a type I membrane protein. The remaining transmembrane domains are inserted into the bilayer depending on the orientation of the first transmembrane domain. Multispanning type II and III proteins are similarly defined according to the properties of their single-spanning counterparts. In addition to hydrophobic protein sequences acting as membrane anchors, membrane proteins may also carry bilayer-associated hydrophobic lipid components. These hydrophobic lipid anchors define three broad groups of lipid-modified proteins: fatty acylated, isoprenoid-linked, and GPI-linked (Fig. 1.5.3). Several cytosolic transmembrane proteins have been identified that contain a covalently attached hydrophobic fatty acyl residue. For example, fatty acids, including palmitic, palmitoleic, cis-vaccenic, and cyclopropylene-
hexadecanoic, are covalently linked to the amino terminus and the amino-terminal glycerylcysteine of E. coli lipoprotein. Moreover, palmitate- and myristate-labeled transmembrane proteins have been observed in eukaryotic cells (e.g., Schlesinger et al., 1980). In both isoprenoid-linked and GPI-linked proteins, globular proteins become membranebound due to the addition of a hydrophobic lipid moiety. Certain proteins containing conserved cysteine residues at or near the C-terminus are modified by prenylation, in which a farnesyl or geranylgeranyl isoprenoid tail is added (Zhang and Casey, 1996). This hydrophobic moiety promotes protein association with the cytoplasmic face of cell membranes. Notably, cytosolic G proteins and protein kinases that participate in signal transduction are prenylated. GPI-linked proteins are a major class of membrane proteins (Cardoso de Almeida, 1992; Englund, 1993). In contrast to isoprenoid-modified proteins, GPI-linked proteins are attached to the luminal or extracellular face of membranes via a glycosylphosphatidylinositol anchor of variable structure (e.g.,
EtN P
P exterior or lumen bilayer
P
cytosol
S
C O
fatty acylated
S GPI-linked
Cys-CH3
isoprenoid-linked
Figure 1.5.3 Membrane proteins containing lipid moieties. In the simplest case, fatty acids can be covalently attached to transmembrane proteins. Hydrophobic tails are also attached to proteins to form isoprenoid-linked proteins. A third class of lipid-attached proteins are the GPI-linked proteins. Hydrophobic regions are shaded.
Strategies of Protein Purification and Characterization
1.5.5 Current Protocols in Cell Biology
Supplement 31
Fig. 1.5.3). Well over 100 GPI-linked proteins have been identified in cells, where they perform numerous functions including acting as enzymes and receptors. The ability of GPIlinked proteins, which possess no transmembrane or cytosolic sequences, to elicit transmembrane signals seems paradoxical. However, studies have suggested that interactions with other proteins, including transmembrane integrins (Petty et al., 1996), contribute to transmembrane signaling of these proteins. In addition, GPI-linked proteins can collect in microdomains called lipid rafts within cell membranes (Rietveld and Simons, 1998). Although GPI-linked proteins must collaborate with other membrane proteins to elicit signals, they do possess certain functional advantages. First, GPI-linked proteins (and isoprenoid-linked proteins as well) diffuse in membranes much faster than transmembrane proteins and thus relay information faster. Second, certain cells, such as leukocytes, can rapidly shed their GPIlinked proteins, thus altering their functional properties in seconds. Although the importance of lipid-linked membrane proteins has only recently been appreciated, the impact of these structures on our understanding of cell properties is growing rapidly.
ADDITIONAL FACTORS AFFECTING THE PHYSICAL HETEROGENEITY OF PROTEINS
Overview of the Physical State of Proteins Within Cells
Additional factors contributing to the physical-chemical heterogeneity of proteins are size, charge, chemical modifications, and assembly. A typical amino acid has a molecular mass of ∼110 Da, and a small protein has a molecular mass of a few thousand daltons (e.g., for insulin, Mr = 5733). Large proteins have molecular masses of several hundred thousand daltons. When proteins are assembled to form large multiprotein complexes such as ribosomes, molecular masses are well into the millions. The diameters of these structures range from 4 Å for an individual amino acid to ∼30 nm for a ribosome. Electrostatic charge is of major importance in protein structure and function. Charged proteins are more soluble than uncharged proteins. The large number of positive charges on histones allow them to bind DNA. The spatial arrangement of charges on cytochrome c allows it to bind the complementary charges of its oxidase and reductase, thereby orienting the proteins prior to electron transfer. Similarly, the arrangement of charges on the apoprotein and receptor for low-density lipoprotein (LDL) al-
lows for lock-and-key–like interactions (Petty, 1993). In addition to structural and binding considerations, electrostatic interactions play a regulatory role. For example, the phosphorylation and dephosphorylation of insulin receptors alter electrostatic interations between the active site and a regulatory loop of the kinase domain, thereby changing its three-dimensional shape (Hubbard et al., 1994). This changes the Vmax of the kinase, thus triggering intracellular signals. In addition to the types of physical heterogeneity listed above, >100 distinct chemical modifications of proteins have been observed. These include, for example, glycosylation, ubiquitin attachment, phosphorylation, acetylation, and hydroxylation (Table 1.5.3). Thus, proteins undergo extensive physical-chemical modification.
PROTEIN ASSEMBLIES Proteins can be assembled in a variety of states in both aqueous media and within membranes. Protein assembly into complex supramolecular structures plays vital roles in enzyme regulation, cell skeleton formation, and transmembrane signaling. Both covalent bonds and noncovalent bonds participate in protein assembly. One frequently encountered covalent mechanism of protein assembly is the formation of disulfide bonds. These covalent linkages often form during protein maturation. They can link two separate proteins together or two portions of the same protein. For example, the two chains of insulin molecules are held together by disulfides, as are the two chains of its membrane receptor. However, disulfide bond formation is mostly limited to oxidative environments such as the ER lumen and the exterior face of the cell surface. One of the best-known examples of noncovalent assembly is the formation of hemoglobin tetramers. Polymerization is another frequently encountered mechanism for protein assembly in cells. The globular protein actin polymerizes to form microfilaments in the absence of covalent bond formation. Intermediate filaments are formed by the polymerization of fibrous proteins. Under certain circumstances transmembrane proteins polymerize as well; bacteriorhodopsin, for example, forms two-dimensional pseudocrystals called purple membranes. Protein assemblies formed from various numbers of similar units are homodimers, homooligomers, and homopolymers. Assembly of protein structures from dissimilar subunits is more common than assem-
1.5.6 Supplement 31
Current Protocols in Protein Science
Table 1.5.3
Common Physical-Chemical Modifications of Proteinsa
Modification
Example
Homodimerization Homooligomerization Homopolymerization Heterodimerization Heterooligomerization Heteropolymerization Proteolytic cleavage Prosthetic group addition Oxidation-reduction Glycosylation Phosphorylation
Transferrin receptor S. typhimurium glutamine synthetase Actin Integrins Histones, proteasomes Ribosomes Signal peptide cleavage in ER Heme addition to cytochromes and hemoglobin Disulfide bond formation in ER Glycoprotein maturation Regulation of protein function, such as the tyrosine kinase activity of insulin receptors Blockage of N-termini of certain membrane proteins Ubiquitin-dependent proteolysis via proteasomes, histones Proline hydroxylation on collagen Insulin receptors, E. coli lipoprotein G proteins Alkaline phosphatase, urokinase receptors
Acetylation Ubiquitination Hydroxylation Fatty acylation Isoprenylation GPI addition
aFor details, see Freedman and Hawkins (1980, 1985), Schlesinger et al. (1980), Englund (1993), and Zhang and
Casey (1996).
bly from identical subunits. For example, heterodimers are formed from the α and β chains of integrins within cell membranes. Complex heterooligomeric and heteropolymeric structures vary from relatively small structures such as histone octamers, which bind to DNA in the nucleus, to large particles such as ribosomes, found both in the cytosol and attached to nuclear and ER membranes. The signal recognition particle is a relatively small heterooligomeric structure, composed of one RNA subunit and six proteins, that potentiates the delivery of secretory and most membrane proteins to the ER membrane. Membrane-associated heterooligomeric structures have also been observed. One of the best examples of such structures is the components of the electron transport systems in chloroplasts and mitochondria (Petty, 1993). For example, the ubiquinone-cytochrome c reductase is composed of eleven different subunits. Thus, proteins can be assembled in a variety of manners within cells. Although some protein assemblies, such as intermediate filaments, are static structures, many are dynamic structures which provide functional flexibility. For example, microfilaments can rapidly assemble and disassemble. In addition to the physical changes in assembly state, compositional dynamics is also observed.
For example, interferon γ treatment alters the composition of proteasomes. Developmental changes in protein composition are also observed. As an example, fetal and newborn forms of a component of cytochrome c reductase are expressed in humans. Thus, protein assemblies can be characterized by both physical and compositional dynamics.
ALTERING THE SOLUBILITY OF PROTEINS: PROTEIN EXTRACTION The in vitro characterization of cellular proteins begins with their extraction from tissues or cells into a buffer. With the exception of globular secretory proteins, such as those found in plasma, proteins are generally not easily accessible for experimental manipulation. For example, many fibrous proteins are not soluble in aqueous buffers. Cellular proteins are entrapped within or on a cell and therefore must be extracted from the cell in a soluble form. A variety of methods including osmotic lysis, enzyme digestion, homogenization using a blender or mortar and pestle, and disruption by French press and sonication have been employed to disrupt cells. For a cytosolic protein such as hemoglobin, no further extraction from the sample is necessary. However, many important cellular proteins, such as those associated
Strategies of Protein Purification and Characterization
1.5.7 Current Protocols in Protein Science
Supplement 30
(CCl3COO−). Hydrophobic interactions are also reduced by exposure to organic solvents and low salt concentrations. Electrostatic interactions are reduced by high salt conditions; this decreases the Debye-Hückel screening length and coulombic attraction. To disrupt hydrogen bonds, high concentrations of urea or guanidine are often employed. More vigorous methods of sample denaturation using very low pH or harsh detergents such as sodium dodecyl sulfate are also used to diminish intermolecular contacts. Once proteins are extracted, their size can be characterized by ultracentrifugation on sucrose gradients (UNIT 4.2), gel filtration chromatography (UNIT 8.3), SDS-PAGE (UNIT 10.1), and other methods (Table 1.5.5). The charge characteristics of proteins can be assessed using isoelectric focusing and ion-exchange chromatography. Specific interactions, such as antigen-antibody and biotin-avidin interactions, can also be employed in the characterization and isolation of proteins. These are useful in immunoblotting (UNIT 10.10) and affinity chromatography methods (Chapter 9).
with membranes, cytoskeletal components, and DNA, remain insoluble. To further solubilize cell proteins, both nonionic (e.g., Triton X-100) and ionic (e.g., sodium dodecyl sulfate) detergents are often employed. Detergents are small amphipathic molecules that interact with both nonpolar and polar environments. Detergents disrupt membranes. They also bind to hydrophobic regions of proteins, such as their transmembrane domains, thereby replacing the unfavorable contacts between hydrophobic protein regions and water with the more favorable hydrophilic domains of the detergent. Thus, instead of the hydrophobic regions of the insoluble protein forming an aggregate in the bottom of a test tube, the protein becomes soluble and can be employed in most in vitro analyses. In addition to detergents, several other solubilization strategies are useful for the extraction and in vitro characterization of proteins (Table 1.5.4). Chaotropic agents enhance the transfer of nonpolar molecules to aqueous environments by their disrupting influence on water structure. Chaotropic agents are generally large molecular ions such as thiocyanate (SCN−), perchlorate (ClO4−), and trichloroacetate
Table 1.5.4
Physical Bases of Common Protein Extraction and/or Elution Methods
Physical property perturbed
Agents
Hydrogen bonds Ion pair interactions Hydrophobic interactions
Urea or guanidine⋅HCl, pH changes High salt, pH changes Detergents, chaotropic agents, organic solvents, low salt
Table 1.5.5 Physical Bases of Common Protein Characterization and Isolation Methods
Overview of the Physical State of Proteins Within Cells
Physical property
Method
References to other units
Solubility
Extraction with salts, detergents, and enzymes
Chapter 4, Racker (1985)
Size
Ultracentrifugation on sucrose gradients Gel filtration SDS-PAGE
UNIT 4.2 UNIT 8.3 UNIT 10.1
Charge
UNIT 10.2 Isoelectric focusing Ion-exchange chromatography UNIT 8.2
Biospecific interaction
Immunoblotting Immunoaffinity chromatography
Hydrophobicity
UNIT 10.10
Chapter 9
Hydrophobic chromatography UNIT 8.4 Reversed-phase HPLC UNIT 8.7
1.5.8 Supplement 30
Current Protocols in Protein Science
LIMITATIONS OF THE IN VITRO MANIPULATION OF PROTEINS The very act of isolating proteins perturbs their physical environment. Although this is not often a major problem, a few cautionary notes should be made. The most primitive compartment of a cell, the cytosol, is a chemically reducing environment. Consequently, free sulfhydryl groups are observed in the cytosol; in fact, multiple cytosolic pathways help in preserving the proper redox conditions. On the other hand, the extracellular milieu and the luminal side of the ER are oxidative environments. The oxidizing condition within the ER is presumably due to the unidirectional transport of glutathione and cystine. Consequently, disulfides are frequently observed in the ER and extracellular environments. Thus, to prevent disulfide formation during manipulation, sulfhydryl blocking reagents such as iodoacetamide are included in extraction buffers. The cytosol is also a K+-rich and Ca2+-poor solution. These parameters should be considered in designing physiologically relevant experiments. The experimental manipulation of membrane proteins is decidedly more difficult. The exterior face exists in a high Na+ and Ca2+ solution that is oxidative; just the opposite is true for the cytoplasmic face. Since no appropriate solvent exists for such isolated proteins, experimental questions can be directed at properties associated with just one face of the molecule. A second limitation common to all in vitro studies of transmembrane proteins is that they must be solubilized using detergents. In addition to solubilizing a transmembrane protein, detergents can also bind to hydrophobic regions in the globular domain(s) of the protein, thus affecting the properties under study. One means of countering this problem is to test several detergents in the hope of finding one that retains the full biological activity of the purified protein. Protein solubilization can also lead to loss of physiologically relevant protein-protein interactions. This can occur by simple dilution or by disruption of noncovalent interactions among proteins. For example, hemoglobin exists as a supersaturated solution in vivo which cannot be duplicated in vitro. Furthermore, protein-protein associations are generally stronger in the restricted confines of membranes than after solubilization into a buffer. Thus, protein assemblies found in cells may disappear during solubilization. One means of countering these potential difficulties is to co-
valently cross-link protein assemblies prior to disruption and to solubilize proteins using mild detergents (e.g., Brij-58).
CONCLUSIONS Structural motifs, especially stretches of hydrophobic amino acids, contribute to the shape of a protein and its classification as globular, fibrous, or transmembrane. Proteins are heterogeneous at many different levels including physical attributes, covalent modifications, and supramolecular assembly. The physical properties of proteins are used to characterize and isolate these molecules. For example, the size of a protein is examined by sedimentation on sucrose gradients (UNIT 4.2), gel filtration (UNIT 8.3), and polyacrylamide gel electrophoresis (UNIT 10.1). Its charge is the key physical parameter in isoelectric focusing and ion-exchange chromatography. The units that follow contain detailed protocols describing the characterization of cellular proteins.
LITERATURE CITED Andrews, D.W. and Johnson, A.E. 1996. The translocon: More than a hole in the ER membrane? Trends Biochem. Sci. 21:365-369. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (eds.) 1998. Current Protocols in Molecular Biology. John Wiley & Sons, New York. Cardoso de Almeida, M.L. 1992. GPI Membrane Anchors. Academic Press, New York. Englund, P.T. 1993. The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors. Annu. Rev. Biochem. 62:121-138. Freedman, R.B. and Hawkins, H.C. 1980. The Enzymology of Post-Translational Modifications of Proteins, Vol. 1. Academic Press, New York. Freedman, R.B. and Hawkins, H.C. 1985. The Enzymology of Post-Translational Modifications of Proteins, Vol. 2. Academic Press, New York. Hoppe-Seyler, F. 1864. Über die chemischen und optischen Eigenschaften des Blutfarbstoffs. Virchows Arch. 29:233-235. Hubbard, S.R., Wei, L., Ellis, L., and Hendrickson, W.A. 1994. Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372:746-754. Kühn, W. 1876. Über das Verhalten verschiedner organisirter und sogenannter ungeformter Fermete. Über das Trypsin (Enzym des Pankreas) [Reprint, FEBS Lett. 62:E3-E7 (1976).]. Kyte, J. and Doolittle, R.F. 1982. A simple method for displaying the hydrophobic character of a protein. J. Mol. Biol. 157:105-132. Strategies of Protein Purification and Characterization
1.5.9 Current Protocols in Protein Science
Supplement 30
Parry, D.A.D. 1987. Fibrous protein structure and sequence analysis. In Fibrous Protein Structure (J.M. Squire and P.J. Vibert, eds.) pp. 141-171. Academic Press, New York. Petty, H.R. 1993. Molecular Biology of Membranes: Structure and Function. Plenum, New York.
KEY REFERENCES Racker, 1985. See above. A wonderful little book on membrane protein manipulation which disproves the hypothesis that scientists can’t write.
Petty, H.R., Worth, R.G., and Todd, R.F. III. 2002. Interactions of integrins with their partner proteins in leukocyte membranes. Immunol. Res. 25:75-95.
Tanford, C. 1961. Physical Chemistry of Macromolecules. Academic Press, New York.
Racker, E. 1985. Reconstitutions of Transporters, Receptors, and Pathological States. Academic Press, New York.
Tanford, C. 1980. The Hydrophobic Effect. John Wiley & Sons, New York.
Rietveld, A. and Simons, K. 1998. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta. 1376:467-479. Schlesinger, M.J., Magee, A.I., and Schmidt, M.F.G. 1980. Fatty acylation of proteins in cultured cells. J. Biol. Chem. 255:10021-10024.
A rigorous introduction to the physical properties of proteins, which remains useful several decades later.
A very readable introduction to the hydrophobic effect.
INTERNET RESOURCES http://www.expasy.ch A user-friendly protein database including two-dimensional PAGE data and 3D protein structures.
Schultz, G.E. and Schirmer, R.M. 1979. Principles of Protein Structure. Springer-Verlag, New York.
ftp://ftp.pdb.bnl.gov/
Spiess, M. 1995. Heads or tails—what determines the orientation of proteins in the membrane. FEBS Lett. 369:76-79.
http://ww.ncbi.nlm.nih.gov
Contains protein crystallography data.
An important protein database.
Squire, J.M. and Vibert, P.J. (eds.) 1987. Fibrous Protein Structure. Academic Press, New York. von Heijne, G. and Gavel, Y. 1988. Topogenic signals in integral membrane proteins. Eur. J. Biochem. 174:671-678.
Contributed by Howard R. Petty Wayne State University Detroit, Michigan
Zhang, F.L. and Casey, P.J. 1996. Protein prenylation: Molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65:241-269.
Overview of the Physical State of Proteins Within Cells
1.5.10 Supplement 30
Current Protocols in Protein Science
CHAPTER 2 Computational Analysis INTRODUCTION
T
he development of the techniques of modern molecular biology, including PCR, cloning, and nucleotide sequencing, has revolutionized the practice of protein chemistry. Whereas the initial phase of detailed study of a new protein activity once involved chemical analysis of the amino acid sequence by Edman degradation of multiple fragments, it is more common today to establish a protein’s linear sequence from the nucleotide sequence of the gene that encodes it. While the number of new sequences reported based solely on classical protein sequence analysis has drastically declined, the molecular biology revolution has generated a rapidly expanding collection of new sequence data. The current efforts to sequence specific genomes, including the human genome, in their entirety will undoubtedly lead to further expansion of this information. Because linear sequence information is so readily available, computer methods for analyzing these data have also developed rapidly. This chapter will present methods for deriving important information on possible familial, structural, and functional relationships using only the linear sequence information as input.
As soon as any sequence information is obtained—for example, by running a newly isolated protein through an N-terminal gas-phase sequencer or by dideoxy sequencing a piece of cloned DNA—searches for similarity to other proteins can begin. If the new sequence can be identified as related to that of a known enzyme or gene from another organism, this provides excellent initial confirmation that the protein or gene under study is worthy of further investigations. Conversely, if a match is found to the sequence of a known protein that could only plausibly arise from sample contamination, the study can be halted immediately at considerable savings of time, energy, and resources. UNIT 2.1 describes procedures for searching sequence databases, provides theoretical background to aid in interpreting the resulting output, and discusses resources for further exploration of sequence relationships. Once substantial sequence information (particularly a whole gene sequence) is obtained, the most pressing question is what structure it is likely to have. A first step toward answering this question is the analysis of the corresponding amino acid sequence for hydrophobic and hydrophilic regions. Of particular interest are patterns or groupings of hydrophobic residues—typically transmembrane helices, leucine zippers, and amphipathic segments—which can indicate structural and even functional features of the protein. Hydropathy scales, indices designed to quantify the relative hydrophobicity of amino acid residues within a protein, and their application to protein sequences are reviewed in UNIT 2.2. More sophisticated forms of analysis can be used to predict overall protein secondary structure based on linear sequence. The procedures developed for this purpose utilize statistical data that has been compiled over the past 25 years as more and more three-dimensional protein structures have become available. Although these methods are not completely accurate at present, the success rate for predictions is now in the 60% to 80% range. This information is fully adequate to develop hypotheses, design experimental tests, and suggest relationships to known tertiary structures. The prediction of protein secondary structure and folding class are reviewed in UNIT 2.3. As well as providing Contributed by Ben M. Dunn Current Protocols in Protein Science (2000) 2.0.1-2.0.2 Copyright © 2000 by John Wiley & Sons, Inc.
Computational Analysis
2.0.1 Supplement 20
theoretical background and detailing the different predictive approaches, the discussion includes an analysis of the strengths and weaknesses of each approach with respect to different types of proteins (using human hemoglobin β, interleukin 1β, and profilin I as examples) and gives some guidance to obtaining the necessary software. To perform any method of computer analysis, especially comparisons with other known protein sequences, it is necessary to have facile methods for transfer and capture of a variety of files. Fortunately, standard methodology now exists to perform many of these functions. UNIT 2.4 provides detailed instructions for the initial steps of getting connected, finding information, and transferring data between computers around the world. Although each university or company will have their own local protocols and systems, and although individuals will need to obtain help from their local computer wizards, UNIT 2.4 is written to provide directions that are generally applicable to most systems. Specific recommendations for utilizing various forms of the BLAST programs for sequence searching and comparison are provided in UNIT 2.5. Protocols for submission of search commands and search sequence are provided in detail, and examples of search results are presented. The ultimate goal of any protein chemist should be to understand the relationship between the three-dimensional structure and the functional properties. Once a new sequence has been discovered, many scientists inevitably begin to speculate on the possible three-dimensional structure. To accomplish this, one must proceed through several steps. An important beginning is the search for proteins of related sequence, as one may find important clues through family relations. The appropriate databases that can be utilized for this purpose are collected in UNIT 2.6. There are several general methods to approach the prediction of structure: homology modeling, fold recognition, and ab initio prediction. The differences between these methods are described in UNIT 2.7. Comparative protein modeling can be extremely successful if there are structurally-defined proteins with a significant degree of sequence relatedness. The definitions and steps necessary for conducting comparative modeling using the SwissModel Web server are detailed in UNIT 2.8. Future updates to this chapter will present alternative methods to complete the sequence to structure algorithm. Ben M. Dunn
Introduction
2.0.2 Supplement 20
Current Protocols in Protein Science
Computational Methods for Protein Sequence Analysis Despite continued advances since the first applications of computers in protein sequence analysis in the late 1960s, computer-assisted biological sequence analysis is still undergoing rapid changes and improvements. With so much activity and growth in the scope and importance of genomic research, the need for efficient biological sequence analysis has become more urgent. Nevertheless, users of computational tools should be aware of the limitations of particular methods. Good results require the user to be able to select the right tools on the basis of some theoretical knowledge and to interpret all results with biological correctness in mind. This unit is presented as a guide to addressing the issue of what to do with a protein sequence once it is obtained. The practical approach depends on how far the investigation has progressed. If only a short part of the protein (e.g., ∼10 to 20 amino acids) has been determined, initial scans of databases to see if there are any significant matches with a known sequence are appropriate. If a complete protein sequence is in hand, it is time to start identifying regions of similarity that resemble functional sites of known proteins.
THEORETICAL BACKGROUND FOR PROTEIN SEQUENCE ANALYSIS Computer representations of protein sequences are of two basic types: artificial and natural. An example of an artificial or symbolic protein sequence is the common 24-letter residue code sequence (ABCDEFGHIKLMNPQRSTVWXYZ*) that represents each amino acid as suggested by the Nomenclature Committee of the International Union of Biochemistry (IUB). This code allows for ambiguities and unknown residue modifications. A natural protein sequence, on the other hand, is directly representative of the physical properties of the individual amino acids; for example, in a natural protein sequence the individual elements might be vectors representing the physical characteristics of the amino acid (Robson and Greaney, 1992; Rohde and Bork, 1993). Most molecular sequence analysis algorithms have been designed for the IUB 24-character amino acid representation. A sequence is an ordered list of elements. Contributed by George Michaels and Robert Garian Current Protocols in Protein Science (1995) 2.1.1-2.1.18 Copyright © 2000 by John Wiley & Sons, Inc.
Sequences can vary in length, composition, and pattern. The number of possible different protein sequences possible of a particular length is 20L, where L is the length. The patterns in such sequences are said to constitute the primary structure of the protein. In general, proteins have nonrandom sequences that are presumed to be related in the sense that all proteins have evolved from other proteins (Doolittle, 1981, 1986, 1989, 1990). Protein sequences are also subject to sequence convergence: different sequences may represent the same native structure of a protein. Some terms that deal with comparisons of protein sequence data are often used and misused in the literature. Similarity is generally used to describe two sequences or structures that resemble one another due to the order of identical residues. Homology means that similar sequences or structures resemble one another due to descent from a common evolutionary ancestor. It is important to realize that the sequence analysis tools used to search data bases detect character patterns that resemble portions of the query sequence. This means that they are finding similarities. Homologies are identified through the recognition of correlated structural and functional data in addition to similarity data. There are three basic types of sequence analyses: listings, traces, and alignments (Kruskal, 1983; Kruskal and Sankoff, 1983). Let a = (a1,..., am) and b = (b1,..., bn) be two sequences and let E be a set of elementary operations including insertion, deletion, and substitution. An indel is either an insertion or a deletion. A listing is a finite sequence of operations taken from E that transform a into b. A trace is a one-to-one correspondence of a subsequence of a and a subsequence of b. An alignment of a and b is a one-to-one correspondence such that each element of one sequence corresponds either to an element of the opposite sequence or to a null element indicating the presence of a gap. The best alignments are obtained when the lengths of a and b are similar. The correspondence between two nonnull elements is called an identity or a continuation if the two elements are identical and a substitution otherwise. Lines representing the correspondence between two sequences should not cross.
UNIT 2.1
Computational Analysis
2.1.1 CPPS
Computational Methods for Protein Sequence Analysis
In the comparison of two different alignments, it is not necessarily the one with the larger number of identities that is better. An alignment with fewer indels (<5%) might be preferable; therefore, some alignment methods set a limit to the number of indels allowed in a given alignment. Alignments are the most frequently used type of sequence analysis. There are two basic types of alignments: local and global. Local alignments are used to identify the most similar common subregions of two sequences. They are especially useful in identifying distantly related sequences. A global alignment, on the other hand, attempts a comparison of two sequences in their entirety and, therefore, often misses small subregions of similarity (Pizzi et al., 1991). Global alignments are most useful for comparing highly similar or homologous sequences that are close to one another in length. Two sequences are said to be homologous if it can be inferred on the basis of all available information that the sequences have a common ancestor. There are no degrees of homology. Divergent sequences are those that can be derived from the same sequence, usually by applying the operations in E. One way that divergent sequences are identified is by applying scoring matrices. There are several scoring matrices available based on allowable amino acid substitutions found in protein alignments of related proteins (see discussion of scoring matrices that follows). The most common matrices used are the protein alignment matrix (PAM; Dayhoff, 1978); the mutation data matrix (MDM; George, et al., 1990), which is a log-odds version of PAM; and BLOSUM (Henikoff and Henikoff, 1993), which incorporates the consideration of the conversation of function data between aligned proteins. It should be noted that the restriction of global alignments to operations in E would fail to align two sequences containing transpositions, in which segments of the protein sequence have been reordered within the sequence (Burks, 1990; States and Boguski, 1990). The similarity of two biological sequences is usually specified by either a similarity measure or a distance measure. Similarity measures typically compute the score for an alignment using an optimizing function that rewards identities and penalizes nonidentities and gaps. Distance measures are usually defined as functions that satisfy the axioms for a metric function:
Distance(a,b) = 0 if and only if a = b; Distance(a,b) = distance(b,a); Distance(a,b) ≤ distance(a,c) + distance(c,b).
Distance functions can be thought of as minimizing differences to find the best alignments, whereas similarity methods search for the best alignments by maximizing similarities. “All problems known to be solvable with distance methods can be solved with similarity methods” (Waterman, 1989). The metric approach appeals to the geometric intuition: sequences can be thought of as points in space, and any three distinct points a, b, and c form a triangle ABC that satisfies the rules above. The smaller the distance between two points, the greater the similarity of the sequences. There are many factors to be considered in protein sequence comparison (Hodgman, 1992). Amino acids are not equally abundant in protein sequences. Moreover, proteins fold into structures having well-conserved hydrophobic interior residues and poorly conserved exterior residues. Indeed, there is a descending order of residue conservation: active-site residues > crucial folding residues > internal packing residues > surface residues. Some residues have preference for position, secondary structure, and substitution; for example, active-site residues are often found in loops that are part of a supersecondary unit and may be partially buried. An identity of >25% implies similarity of function, whereas 18% to 25% identity may indicate similarity of structure or function. The latter range is within the “Twilight Zone” (15% to 25% identity) that, according to Doolittle, arises in the theory of protein evolution (Doolittle, 1986). Alignment methods usually have a specific region of applicability (Taylor, 1988). For example, pairwise alignment is most applicable at high levels of identity (∼70%); consensus methods (∼45%), template methods (∼25%), and structure prediction methods are applicable at even lower levels of identity. These ranges take into account the fact that even two unrelated or random sequences over 100 residues long may show identity in the range of 20%. Two complementary properties of sequence comparison methods are sensitivity and specificity (States and Boguski, 1990). Sensitivity is the ratio of false negatives to the sum of true positives and false negatives; specificity is the ratio of true positives to the sum of true positives and false positives. The goal of this unit is to provide some
2.1.2 Current Protocols in Protein Science
starting points for the analysis of protein sequence data. A theoretical review of principles is complemented by practical examples of computer methods for protein sequence analysis that were done using the GCG package of programs (Genetics Computer Group, 1994). There are many other commercial packages for IBM-compatible computers, Macintoshes, and UNIX workstations that have similar capabilities. There are also many public domain software packages available over the Internet that have identical or enhanced functionalities (see Table 2.1.1). When starting to assemble programs for protein sequence analysis, one is strongly advised to browse the Internet before purchasing. The CD-ROM version of Current Protocols in Protein Science also includes the Entrez and MACAW multiple sequence alignment programs from the National Center for Biotechnology Information (NCBI) at no additional charge. UNIT 2.2 describes the analysis of linear protein sequence with respect to hydrophobic/hydrophilic characterization that can suggest structural or functional segments. UNIT 2.3 presents methods for the prediction of secondary structural features of linear protein sequences.
MATRIX METHODS FOR SEQUENCE COMPARISON: DOT PLOTS Many computer-based sequence comparison methods rely on matrix methods (Fitch, 1966, 1969; Gibbs and McIntyre, 1970; McLauchlan, 1971, 1972; Maizel and Lenk, 1981; Argos, 1987; Landau et al., 1988, 1990). Pairwise comparison of two sequences can be represented in its simplest form by a matrix that is the logical product of the two sequences: if a corresponding pair of elements is identical, then the matrix element at the intersection of the row and column is marked true (dot); if the pair is different, then the matrix element is marked false (blank). The result is a visualization of the similarity of the two sequences. In dot-plot matrix displays, a run of identities will be seen as a continuous diagonal segment within the matrix. Discontinuities along diagonals with horizontal shifts to parallel lines are interpreted as indels and indicate the need for gaps in any alignment. If the two sequences being compared are identical, the matrix will reveal any internal repeats and the main diagonal will be filled in. Self-comparisons always result in symmetrical dot plots. Another commonly used dot-matrix method compares fixed-length segments (windows) of
the sequences instead of individual residues. See Staden (1994a-d) for a description of how to use SIP, a program based on dot-matrix plots. A palindrome is a subsequence that remains the same after being reversed. On a dot plot, palindromes are displayed as segments perpendicular to the main diagonal of the matrix. Palindromes are not usually relevant to protein sequences. In RNA and DNA sequences, a palindrome is defined as an inverted, self- co mp lementary region such as ACTGATATCAGT. More sophisticated comparisons have been defined on dot matrices that filter out isolated dots or small segments as noise. The stringency of the similarity determines the amount of data that will be filtered out before the matrix is displayed or undergoes further processing. In this case, the matrix elements are filled in with weighted numerical scores instead of simple identity values, and the result is plotted as a surface to visualize the regions of greatest similarity. Dot-matrix methods remain an active area of research (Streletc et al., 1991; Landes et al., 1993; Nedde and Ward, 1993). Dot plots are the simplest form of sequence comparison using a matrix display. These graphical methods allow quick observation of the level and extent of similarity between two sequences. For example, a comparison of horse and rat serum albumin protein sequences from the SWISS-PROT protein database is summarized in Figure 2.1.1. Dot-plot analysis is done in two phases: pairwise sequence comparison to generate a matrix of similarity values is followed by generation of the graphic display. The GCG package implements this process by using two programs—COMPARE and DOTPLOT—to generate the dot-matrix plot. COMPARE does a pairwise analysis to define positions of similarity between the two sequences. The parameters to be varied are (1) window size, or the number of residues to be compared, and (2) stringency, or the minimal number of matches per window to score a dot. DOTPLOT generates the graphic matrix display of the COMPARE analysis (Fig. 2.1.1).
SEQUENCE SIMILARITY SEARCHING Once a small portion of protein sequence data from an unknown sample has been generated, the immediate impulse is to ask what other proteins in the database does the unknown resemble, and how similar are the sequences. Several available tools can help answer these
Computational Analysis
2.1.3 Current Protocols in Protein Science
600
Albu_Horse.Sw ck: 307, 1 to 607
1, 1995 17:05
Points: 4,481 Stringency: 18.0
February
400
600
Window: 60
Density: 692.05
200
400
200
COMPARE
DOTPLOT of: albu_rat.pnt
0
0 Albu_Rat ck: 6,355, 1 to 608
Figure 2.1.1 Dot plot generated from comparison of rat and horse albumin protein sequences. The continuous diagonal line of identity traverses the middle of the matrix. Regions of similarity between the two sequences appear as lines parallel and offset to the line of identity. Axis label takes the form filename ck: checksum_value start_position to end_position.
questions. Most commercial sequence analysis packages contain programs for performing pairwise alignments of protein sequences. The most popular tools for searching databases, FASTA (FAST All) and BLAST (the Basic Local Alignment Search Tool), are included in commercial sequence analysis suites and are also freely available to be downloaded to a local computer to be used in a stand-alone manner or as network services.
BLAST Database Searching
Computational Methods for Protein Sequence Analysis
The program BLAST, which is available from the NCBI, conducts rapid searching of sequence databases (Altschul et al., 1990). The program searches for similarity between a query sequence and sequences in a nucleotide database (using BLASTN) or peptide database (using BLASTP). Two versions of the program are available: (1) a version that will run on a local workstation and (2) client software that connects a local computer via the Internet to a high-speed search engine located at the NCBI.
The latter accesses the most recent versions of sequence databases available. BLAST uses a word/dictionary approach to compare fixed-length “words” from the query sequence against the dictionary of words from the database searched. This program is an excellent choice for quickly screening for exact matches—for example, when the end of a new protein has been sequenced. A word of caution is, however, in order: BLAST can create enormous files, especially if the query sequence has repeated residues or is similar to a repeated motif in the databases. The BLAST output file contains (1) the sorted match statistics, probability measure of a random match and the number of matched regions; (2) the alignments generated for the query and the matched sequence region (shown in Fig. 2.1.2); and (3) a copy of the search parameters (not shown). The example in Figure 2.1.2 shows output from a BLAST search conducted using a sequence fragment from an unknown mammalian blood protein as a query against the nonredundant
2.1.4 Current Protocols in Protein Science
Similarity Table
Sequences producing High-scoring Segment Pairs: sp|P35747|ALBU_HORSE sp|P08835|ALBU_PIG gp|M36787|PIGALBA_1 gp|X17055|OASERALB_4 sp|P14639|ALBU_SHEEP sp|P02769|ALBU_BOVIN pir|A47391|A47391 gp|M73993|BOVALBUMIN_1 gp|V01222|RNALBU_4 sp|P02770|ALBU_RAT pir|S17599|S17599 pir|S29749|S29749 gp|A15293|A15293_1 gp|A00279|A00279_1 gp|A16010|A16010_1 gp|A03758|A03758_1 gp|M12523|HUMALBGC_1 gp|A09561|A09561_1 sp|P02768|ALBU_HUMAN pir|A93743|ABHUS
SERUM ALBUMIN PRECURSOR. >pir|S340.. SERUM ALBUMIN PRECURSOR (FRAGMENT).. albumin [Sus scrofa] Sheep mRNA for serum albumin. [Ovi.. SERUM ALBUMIN PRECURSOR. >pir|S069.. SERUM ALBUMIN PRECURSOR. >pir|A388.. serum albumin prepropeptide - rhes.. albumin [Bos taurus] Messenger RNA for rat preproalbumi.. SERUM ALBUMIN PRECURSOR. >pir|A938.. albumin - human serum albumin - dog Mature HSA [Homo sapiens] Human serum albumin [Unknown] synthetic mature HSA [Unknown] serum albumin [Homo sapiens] Human serum albumin (ALB) gene, co.. human serum albumin [Unknown] SERUM ALBUMIN PRECURSOR. >gp|M1252.. serum albumin precursor - human >g..
High Score 101 98 98 96 96 95 94 94 92 92 79 79 85 85 85 85 85 85 85 85
Smallest Sum Probability P(N) N 6.8e-08 1.8e-07 1.8e-07 3.4e-07 3.5e-07 4.8e-07 6.6e-07 6.6e-07 1.3e-06 1.3e-06 1.8e-06 4.0e-06 1.2e-05 1.2e-05 1.2e-05 1.2e-05 1.2e-05 1.2e-05 1.2e-05 1.2e-05
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Alignment >sp|P35747|ALBU_HORSE SERUM ALBUMIN PRECURSOR. >pir|S34053|ABHOS serum albumin precursor - horse >gp|X74045|ECSERALB_1 preproalbumin [Equus caballus] Length = 607 Score = 101 (47.0 bits), Expect = 6.8e-08, P = 6.8e-08 Identities = 22/26 (84%), Positives = 22/26 (84%) Query: Sbjct:
1 TIKSEIAHVFNDLGEPVFKGLVLVAF 26 T KSEIAH FNDLGE FKGLVLVAF 26 THKSEIAHRFNDLGEKHFKGLVLVAF 51
Figure 2.1.2 BLAST output table and alignment for an unknown mammalian blood protein. The Query is the sequence of interest and the sbjct is the sequence region found in the database that matches the query. Note that in searches of the nonredundant databases at the NCBI, matches are found between the test sequence and the translation of mRNAs in GenBank. Important similarities have small probability scores, i.e., P(N) < 10−3. This analysis suggests that the unknown is an albumin, but it is not identical to any known sequence.
protein sequence database maintained at the NCBI. This database contains a compilation of protein sequences found in all of the molecular sequence databases with duplicate sequences removed. Figure 2.1.2 presents a table of the top 20 highest similarity scoring sequences and the best alignment.
FASTA Database Searching FASTA conducts a Lipman and Pearson (1985) search for similarity between a query sequence and any FASTA-formatted database or group of sequences collected in a database by the user. FASTA is a program developed for fast searching using an algorithm that allows for the insertion of gaps during the alignment
phase. This approximates evolutionary insertions and deletions during divergence. However, the gaps are generated to maximize the number of aligned residues. FASTA does a good job of generating a global alignment for a sequence. Figure 2.1.3 and Figure 2.1.4 present results from a FASTA search of the SWISS-PROT database with a short sequence fragment from an unknown mammalian blood protein. The FASTA output contains (1) a histogram that shows the distribution of relevant word matches found between the query sequence and the database searched; (2) the match statistics; and (3) the alignments generated for the query sequence and the matched sequence region. There
Computational Analysis
2.1.5 Current Protocols in Protein Science
Score Init1 Initn (-) (+) < 2 533 533:================================================== 4 4 4:== 6 134 134:================================================== 8 222 222:================================================== 10 1964 1964:================================================== 12 5289 5289:================================================== 14 7609 7609:================================================== 16 9434 9434:================================================== 18 2834 2834:================================================== 20 4914 4914:================================================== 22 2686 2686:================================================== 24 1808 1808:================================================== 26 1241 1241:================================================== 28 721 721:================================================== 30 375 374:================================================== 32 261 259:================================================== 34 138 137:================================================== 36 57 57:============================= 38 27 27:============== 40 18 18:========= 42 4 5:==+ 44 6 7:===+ 46 0 0: 48 0 1:+ 50 3 4:== 52 1 1:= 54 1 1:= 56 2 2:= 58 0 0: 60 0 0: 62 0 0: 64 0 0: 66 0 0: 68 0 0: 70 0 0: 72 0 0: 74 0 0: 76 0 0: 78 0 0: 80 0 0: > 80 6 6:=== Mean score calculations exclude scores greater than 72 mean initn score: 16.3 (s.d. 5.20) mean init1 score: 16.3 (s.d. 5.19) 1838 scores better than 26 saved, joining threshold: 27
Figure 2.1.3 FASTA histogram from a search of the SWISS-PROT database for sequences similar to a fragment from an unknown mammalian blood protein. Numbers of windows at each init1 score are plotted. Note that there are six highly significant alignments, as well as several sequences (those with init1 scores in the 48 to 56 range) that represent protein sequences from more distantly related species.
Computational Methods for Protein Sequence Analysis
are three similarity scores presented in the output from FASTA: init1, the highest similarity score allowing conservative substitutions; initn, the highest score generated by linking nonoverlapping regions; and opt, the score for the best alignment presented. In practice the histogram would be used to determine how many sequences have highly significant levels of similarity. The table of scores allows one to decide quickly how many and which sequence alignments should be viewed.
ALIGNMENT METHOD CONSIDERATIONS Dynamic programming is a different matrix method that is used to find the optimal global alignment of two sequences (Needleman and Wünsch, 1970; Sellers, 1974; Pearson and Miller, 1992; Panjukov, 1993). Let a be a sequence of length m and let b be a sequence of length n. Let D be the working matrix. Then, given a predefined scoring function, the basic steps of the alignment algorithm (Doolittle, 1986) are as follows. Assign the scores for all exact matches to the corresponding matrix el-
2.1.6 Current Protocols in Protein Science
Alignment Score Table The best scores are: init1 initn opt Sw:Albu_Horse P35747 equus caballus (horse). serum album... 99 99 100 Sw:Albu_Rat P02770 rattus norvegicus (rat). serum albumi... 99 99 99 Sw:Albu_Pig P08835 sus scrofa (pig). serum albumin precu... 99 99 101 Sw:Albu_Bovin P02769 bos taurus (bovine). serum albumin ... 98 98 99 Sw:Albu_Sheep P14639 ovis aries (sheep). serum albumin p... 95 95 96 Sw:Albu_Human P02768 homo sapiens (human). serum albumin... 93 93 93 Sw:Albu_Chick P19121 gallus gallus (chicken). serum albu... 56 56 77 Sw:Albu_Mouse P07724 mus musculus (mouse). serum albumin... 55 55 55
Best Scoring Alignment SCORES
Init1: 99 Initn: 99 Opt: 84.6% identity in 26 aa overlap
100
10 20 TIKSEIAHVFNDLGEPVFKGLVLVAF | |||||| |||||| ||||||||| Albu_H MKWVTFVSLLFLFSSAYSRGVLRRDTHKSEIAHRFNDLGEKHFKGLVLVAFSQYLQQCPF 10 20 30 40 50 60 Pc12_P
Figure 2.1.4 Partial FASTA alignment table and best scoring alignment for the same search illustrated in Figure 2.1.3. The table shows the best alignment scores sorted by highest init1 score.
ements. Transform the matrix by beginning with element Dmn and adding its value (less any gap penalty) to Dm−1, n−1 and all the elements directly above it or to its left. Next, select the matrix element in column m − 2 and above row m − 1 that contains the largest score and repeat the summing procedure. Repeat the previous step until the entire matrix is transformed. Next, determine the path from the largest score in the matrix back toward the bottom right-hand corner. The path, with any gaps as indicated by off-diagonal moves, is then used to align a and b. This matching algorithm is used in most global alignment programs, which vary primarily in the sophistication of the scoring functions (similarity or distance). Note that this method assumes (incorrectly) that each residue has equal importance, and it ignores sequential constraints. Local alignments are usually found using some version of the Smith-Waterman method (1981), which applies when common regions are being sought in two sequences whose similarity is unknown or limited to a few regions, as is the case in database searches. The algorithm usually produces a single highest-scoring alignment with respect to the operations in E, although it has been successfully extended to produce the second-best and other alignments (Barton, 1990, 1993; Waterman and Eggert, 1991). In its simplest form (Barton, 1993), the local alignment method is as follows. Given two
sequences a and b, and a working (comparison) matrix H, the matrix elements of H are filled in by applying a scoring rule: the score assigned to a matrix element Hij is either zero or the maximum value of any of the three scores of its neighbors and predecessors that lie directly above, diagonally to the left, or directly to the left of Hij, adjusted for gaps or substitution of residues. The maximum element in H is found and traced back through the matrix to find the alignment.
SCORING MATRICES Scoring matrices (George et al., 1990; States and Boguski, 1990), such as the PAM, BLOSUM (Henikoff and Henikoff, 1993), and related MDM matrices (Dayhoff, 1978), are based on the compilation of frequencies of amino acid substitution in a set of homologous sequences. The data are used as an amino acid transition probability matrix. Increasing powers of the matrix correspond to increasing divergence. Lower powers are used for sequences that seem closely related and higher powers for those that are not so obviously related. Thus, PAM250 represents a matrix with 250 accepted protein mutations per 100 amino acids. The scoring matrix method has greatly improved the quality and sensitivity of alignments; however, it does have the deficiency that it ignores structure and the corresponding sequence constraints which are significant for predicting structure. Not all sequence comparison methods are
Computational Analysis
2.1.7 Current Protocols in Protein Science
Computational Methods for Protein Sequence Analysis
matrix methods. Programs such as FASTP and FASTN are representative of hash-coding methods (Dumas and Nunio, 1982; Wilbur and Lipman, 1983; Lipman and Pearson, 1985; Pearson, 1990, 1994). The methods are based on fast table lookups of subsequences of a target sequence using hash functions. Hash functions transform strings in numbers that serve as pointers into a table containing further information. Thus, a fixed-length subsequence (or k-tuple) of one sequence can quickly be checked for occurrence in another sequence after a hash table of k-tuples and their positions in the sequence is constructed for each sequence. FASTP focuses on regions having the highest density of identities and uses the PAM250 matrix. Readers are referred to Pearson (1994) for an introduction to using FASTA for comparing both DNA and protein sequences. The RDF2 and RSS programs for testing the statistical significance of FASTA alignments are also discussed. Other methods for sequence comparison include finite state machines that are capable of recognizing regular expressions, and various statistical approaches (States and Boguski, 1990; Tyler et al., 1991; Allison et al., 1992; Brendel et al., 1992). Regular expressions are formulas such as (a + b*)c, which represents the set of all strings that begin with the letter a or zero or more b’s and followed by a single c. Complicated patterns can be constructed and detected in sequences using the finite state method. Statistical approaches include the database-searching program BLAST (see above section on BLAST database searching), which approximates gapless alignments that optimize local similarity on the basis of maximal segment pairs. The BLAST strategy is to search for only those segment pairs that contain a word pair whose comparison score exceeds some threshold. It uses the PAM120 scoring matrix to allow for conservative substitutions of residues in a comparison. Statistical methods for sequence alignment (Karlin et al., 1988, 1989, 1991; Brendel, 1992; Pevzner, 1992; Mrazek and Kypr, 1993; Staden, 1994a-d) consider the statistical significance of a variety of protein sequence properties. Such properties include the relative composition of a sequence with respect to residue types; anomalous clusters, runs, and periodic variations of charge; internal repeats; local periodicities that might indicate regularity of structure; and the relative spacings of certain residue types. For a description of routines for
plotting hydrophobicity, charge, and hydrophobic moments using the program PIP, see Staden (1994a-d). In addition to the methods described above, interest in the development of theory and tools for linguistic (formal grammar) analysis of biological sequences is growing (Collado-Vides, 1991; Michaels et al., 1993; Searls, 1993). The next level of sequence analysis is the simultaneous comparison of more than two sequences, as described in the following section on Multiple Alignments.
MULTIPLE ALIGNMENTS Once a group of potentially homologous sequences has been identified, the next step could be to do a multiple alignment that compares the new sequence with the group of sequences determined to have highly significant similarities. There are several programs that will do multiple alignments. PILEUP from the GCG package does a good job with closely related sequences in an automated fashion. MACAW from NCBI, LINEUP from GCG, and DSCE (De Rijk and De Wachter, 1993) allow the investigator to generate an alignment manually. (The CD-ROM version of Current Protocols in Protein Science includes MACAW and Entrez from NCBI.) Figure 2.1.5 demonstrates a multiple alignment generated using PILEUP from five highscoring albumin sequences in the SWISSPROT database identified from the FASTA analysis (Fig. 2.1.4). PILEUP performs a cluster analysis based on pairwise comparisons of each sequence to be aligned. As well as the multiple alignment (Fig. 2.1.5), PILEUP produces a dendrogram (not shown) that displays the clustered relationships between the sequences. The dendrogram is not a phylogenetic tree, but a graphical representation of the clustered similarity statistics. After the multiple alignment is generated, one can begin to infer relationships between conserved regions and function or structure. The program Pro_Anal (Eroshkin et al., 1993) and the program for fast protein block searches (Fuchs, 1994) can help in this process. Programs like OBSTRUCT (Heringa et al., 1992) are useful in identifying clusters of protein sequences on the basis of structural and sequence similarity criteria. Kanaoka et al. (1989) have described a process of aligning protein sequences on the basis of hydrophobicity. Livingstone and Barton (1993) describe a strategy to generate multiple alignments for hierarchical analysis of residue conservation.
2.1.8 Current Protocols in Protein Science
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
1 MKWVTFISLL MKWVTLISFI MKWVTFVSLL MKWVTFISLL EADKSEIADR
LLFSSAYSRG FLFSSATSRN FLFSSAYSRG FLFSSAYSRG YNDLGEIHFK
VFRRDTHKSE LQRFARDAEH VLRRDTHKSE VFRRDAHKSE CAIPNLRENY
IAHRFKDLGE KSEIAHRYND IAHRFNDLGE VAHRFKDLGE GELADCCTKQ
50 EQFKGLVLIA LKEETFKAVA KHFKGLVLVA ENFKALVLIA EPERNECFLQ
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
51 FSQYLQQCPF MITFAQYLQR FSQYLQQCPF FAQYLQQCPF HKDDNPSLPP
DEHVKLVNEL CSYEGLSKLV EDHVKLVNEV EDHVKLVNEV FERPEAEAMC
TEFAKTCVAD KDVVDLAQKC TEFAKKCAAD TEFAKTCVAD TSFKENPTTF
ESHAGCEKSL VANEDAPECS ESAENCDKSL ESAENCDKSL MGHYLHEVAR
100 HTLFGDELCK KPLPSIILDE HTLFGDKLCT HTLFGDKLCT RHPYFYAPEL
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
101 VASLRETYGD ICQVEKLRDS VATLRATYGE VATLRETYGE LYYAEQYNEI
MADCCEKQEP YGAMADCCSK LADCCEKQEP MADCCAKQEP LTQCCAEADK
ERNECFLSHK ADPERNECFL ERNECFLTHK ERNECFLQHK ESCLTPKLDG
DDSPDLPKLK SFKVSQPDFV DDHPNLPKLK DDNPNLPRLV VKEKALVSSV
150 PDPNTLCDEF QPYQRPASDV PEPDAQCAAF RPEVDVMCTA RQRMKCSSMQ
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
151 KADEKKFWGK ICQEYQDNRV QEDPDKFLGK FHDNEETFLK KFGERAFKAW
YLYEIARRHP SFLGHFIYSV YLYEVARRHP KYLYEIARRH AVARLSQTFP
YFYAPELLYY ARRHPFLYAP YFYGPELLFH PYFYAPELLF NADFAEITKL
ANKYNGVFQD AILSFAVDFE AEEYKADFTE FAKRYKAAFT ATDLTKVNKE
200 CCQAEDKGAC HALQSCCKES CCPADDKLAC ECCQAADKAA CCHGDLLECA
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
201 LLPKIETMRE DVGACLDTKE LIPKLDALKE CLLPKLDELR DDRAELAKYM
KVLASSARQR IVMREKAKGV RILLSSAKER DEGKASSAKQ CENQATISSK
LRCASIQKFG SVKQQYFCGI LKCSSFQNFG RLKCASLQKF LQTCCDKPLL
ERALKAWSVA LKQFGDRVFQ ERAVKAWSVA GERAFKAWAV KKAHCLSEVE
250 RLSQKFPKAE ARQLIYLSQK RLSQKFPKAD ARLSQRFPKA HDTMPADLPA
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
251 FVEVTKLVTD YPKAPFSEVS FAEVSKIVTD EFAEVSKLVT IAADFVEDQE
LTKVHKECCH KFVHDSIGVH LTKVHKECCH DLTKVHTECC VCKNYAEAKD
GDLLECADDR KECCEGDMVE GDLLECADDR HGDLLECADD VFLGTFLYEY
ADLAKYICDN CMDDMARMMS ADLAKYICEH RADLAKYICE SRRHPDYSVS
300 QDTISSKLKE NLCSQQDVFS QDSISGKLKA NQDSISSKLK LLLRLAKKYE
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
301 CCDKPLLEKS GKIKDCCEKP CCDKPLLQKS ECCEKPLLEK ATLEKCCAEA
HCIAEVEKDA IVERSQCIME HCIAEVKEDD SHCIAEVEND NPPACYGTVL
IPENLPPLTA AEFDEKPADL LPSDLPALAA EMPADLPSLA AEFQPLVEEP
DFAEDKDVCK PSLVEKYIED DFAEDKEICK ADFVESKDVC KNLVKTNCDL
350 NYQEAKDAFL KEVCKSFEAG HYKDAKDVFL KNYAEAKDVF YEKLGEYGFQ
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw
351 GSFLYEYSRR HDAFMAEFVY GTFLYEYSRR LGMFLYEYAR NAILVRYTQK
HPEYAVSVLL EYSRRHPEFS HPDYSVSLLL RHPDYSVVLL APQVSTPTLV
RLAKEYEATL IQLIMRIAKG RIAKTYEATL LRLAKTYETT EAARNLGRVG
EECCAKDDPH YESLLEKCCK EKCCAEADPP LEKCCAAADP TKCCTLPEDQ
400 ACYSTVFDKL TDNPAECYAN ACYRTVFDQF HECYAKVFDE RLPCVEDYLS
Figure 2.1.5 Multiple alignment of mammalian blood proteins using PILEUP. The first 400 residues of five high-scoring sequences identified from FASTA analysis (Fig. 2.1.4) are aligned.
Similarly, the program PIMA (Smith and Smith, 1992) uses an algorithm that takes advantage of secondary structure features to determine gap penalties during the multiple alignment process. Depiereux and Feytmans (1991) have used simultaneous multivariate multiple alignment methods to reveal a correspondence between physiochemical profiles and structurally conserved regions. The multiple alignment programs described above take advantage of pairwise comparison
algorithms and are subject to their limitations. Alignment algorithms that use a rigorous consideration of more than three sequences at once are computationally infeasible for most labs. Although some speed improvements have been obtained for the optimal alignment of three sequences simultaneously (Murata et al., 1985; Gotoh, 1986), new methods have to be developed for multiple sequence alignment. The earliest methods were sequence editors for interactive alignments. See Pearson and Miller
Computational Analysis
2.1.9 Current Protocols in Protein Science
Computational Methods for Protein Sequence Analysis
(1992) for a discussion of considerably improved dynamic programming algorithms for sequence analysis. Multiple sequence alignment tends to be order-sensitive. A sequence of pairwise comparisons may not lead to the best overall alignment for a given set of sequences because the sequences are not independent (States and Boguski, 1990)—that is, they are not necessarily equidistant from a common ancestor. The consensus sequence approach to multiple sequence alignment (Waterman, 1989, 1990; Waterman and Jones, 1990; Day and McMorris, 1993) is based on the construction of a single sequence that can be used to align all other given sequences; the sequence is determined by an iterative process of alignment followed by consensus sequence modification. A consensus residue can be stringently defined from a multiple alignment when the content of a column is represented by a single amino acid at that position. There are many multiple alignment algorithms—too many to describe here. A list of available sequence similarity and alignment software can be accessed via the Internet as described in the section below on Internet Resources. Once sequences have been aligned, the quality of the alignment should be assessed. It is clearly important to distinguish between chance similarities and true sequence similarities. One method for estimating the quality or statistical significance of an alignment (Doolittle, 1986) is to compare the alignment score with the mean score of a set of randomized sequences that are permutations of the original sequences and which preserve their length and relative composition. The further the alignment score is from the mean of the randomized set, the more confident we can be in the alignment. A possible objection to this data shuffling or permutation method is that the permuted sequences are not like real protein sequences (i.e., permuted sequences are unlikely to fold like real proteins). Other methods (States and Boguski, 1990) include the following: McLachlan’s (1972) “double matching probability” function, which is used to compute the frequency scores in infinite random sequences of the same composition as the given sequences; Reich and Meiske’s stochastic random sequence model for determining the significance of window scores in dot-matrix analysis (Reich and Meiske, 1987); and Argos’ significance tests (Argos and Vingron, 1990), based on actual protein sequences
instead of the randomized sequences used by McLachlan (1972). Despite efforts to determine the quality of alignments, it remains true that low statistical significance does not always imply a lack of biological significance (Collins and Coulson, 1990). Another important aspect of alignments is the accuracy of the original molecular sequence (States, 1992). Errors can be introduced in molecular sequence data in random or biased ways. The translation of nucleic acid sequences into amino acid sequences is very sensitive to indel errors: an error rate of 1% can lead to a frameshifting error in reading frames longer than 24 amino acids. Empirical estimates of sequence accuracy in current databases have revealed a rate of 3 to 5 errors per 1000 bases.
CLUSTER METHODS AND TREES Once a multiple alignment has been performed and regions of common similarity have been identified among the proteins, the question of evolutionary distance will arise. There are several programs for determining the level of divergence between a group of sequences. Some are available over the Internet via the World Wide Web (WWW; see also Internet Resources section). The programs DISTANCES and GROWTREE from the GCG package (Genetics Computer Group, 1994) calculate pairwise distance measures and plot a dendrogram of those measures. The programs depend on an accurate multiple alignment of the sequences involved. This means that the multiple alignments should be examined carefully and then edited as necessary to incorporate additional knowledge that might be available about the structure or function of the proteins. Figure 2.1.6 shows the table of pairwise phylogenetic distances calculated by DISTANCES for the top nine albumins identified from the FASTA analysis (Fig. 2.1.4), and the phylogram produced by GROWTREE is shown in Figure 2.1.7. The purpose of protein sequence comparison is to learn more about the structure, function, and evolution of proteins. It is known that different proteins and different parts of proteins change at characteristic but unequal rates in the course of evolution (Doolittle, 1986). Binding sites and catalytic units are conserved independently of their position, whereas surface regions change faster than buried regions. In addition, entire domains of a genome are subject to a number of editing operations such as domain joining, swapping, and reordering (States and Boguski, 1990). Thus, homologies
2.1.10 Current Protocols in Protein Science
Matrix 1, dimension: 9 Key for column and row indices: 1 2 3 4 5 6 7 8 9
Albu_Bovin.Sw Albu_Chick.Sw Albu_Horse.Sw Albu_Human.Sw Albu_Mouse.Sw Albu_Pig.Sw Albu_Ranca.Sw Albu_Rat.Sw Albu_Sheep.Sw
1 2 3 4 5 6 7 8 9 __________________________________________________________________________ .. | 1 | 0.00 999.99 31.75 192.01 999.99 999.99 999.99 237.70 8.19 | 2 | 0.00 999.99 999.99 999.99 999.99 999.99 999.99 999.99 | 3 | 0.00 190.56 999.99 999.99 999.99 222.61 29.05 | 4 | 0.00 999.99 999.99 999.99 32.75 193.48 | 5 | 0.00 999.99 999.99 999.99 999.99 | 6 | 0.00 999.99 999.99 999.99 | 7 | 0.00 999.99 999.99 | 8 | 0.00 237.70 | 9 | 0.00
Figure 2.1.6 Evolutionary distance table for mammalian blood proteins calculated using the GCG DISTANCES program. Corrections to the calculations were done using the Kimura protein method as described in the GCG manual (Genetics Computer Group, 1994). The matrix values represent the number of matches between each pair of sequences divided by its length (999.9 = identity). These data were used to generate the GROWTREE phylogram presented in Figure 2.1.7.
Growtree Phylogram of: Albu_Bovin.Distances, Tree Tree_ February 3, 1995 15:02 Albu_Ranca.Sw Albu_Pig.Sw Albu_Mouse.Sw Albu_Chick.Sw Albu_Rat.Sw Albu_Human.Sw Albu_Horse.Sw Albu_Sheep.Sw Albu_Bovin.Sw
Figure 2.1.7 GROWTREE phylogram of Albu_Bovin.Distances, Tree Tree_1. Results of graphical cluster analysis of the distance data presented in Figure 2.1.6 are shown. In this representation sequences with the least divergence have the shortest branches.
Computational Analysis
2.1.11 Current Protocols in Protein Science
might be found between entire proteins or just between certain parts of proteins.
IDENTIFICATION OF FUNCTIONAL SITES
Computational Methods for Protein Sequence Analysis
Sequence comparisons are used to test for homology and to find functional sites and motifs. The goal is to establish structure and function for parts of an unknown sequence using known homologous or analogous (i.e., similar, but not homologous) sequences as sources of additional information. The goal is to obtain answers to questions of what functions the protein has and what its structure is. There are several paths the analysis can take. One approach that will reveal much about potential functional sites in the protein is to look for motifs. Motifs are defined in three ways: as consensus patterns of amino acids that correspond to regions of proteins containing the common residues; as the excised alignment of several sequences that contain the motif for use as a database discriminator; or as a single representative sequence (States and Boguski, 1990; Parry-Smith and Atwood, 1992). Motif searches are usually done using a program that takes advantage of a dictionary of sequence patterns which have been identified with specific protein activities. Many programs will do this analysis, and most use the PROSITE database of motifs found through analysis of the SWISS-PROT protein database. Figure 2.1.8 shows an example using the GCG MOTIFS program to analyze an albumin sequence. Note that the output file contains an alignment of the motif found and an extensive annotation describing the motif and listing the asso